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Abstract 
 
Methods for polyamine derivatization with a panel of extrinsic fluorophores followed by 
HPLC with fluorescence and UV absorption detection have been developed.  Four 
fluorophores were examined using polyamines and aminoglycosides.  o-Phthalaldehyde 
(OPA) and fluorescamine are selective fluorophores that only react with primary amines; 9-
fluorenylmethyl chloroformate (FMOC Cl) and dansyl chloride react with both primary and 
secondary amines.  Reaction and HPLC conditions were optimized with each of the above 
fluorophores using a series of model mono- and diamines and then applied to natural and 
semi-synthetic polyamines.  The amines that have been investigated are natural di- and 
polyamines:  putrescine, cadaverine, spermidine, spermine, thermospermine, 
aminoglycosides:  kanamycin, paramomycin, neomycin, and synthetic polyamine conjugates 
e.g. N4,N9-dioleoylspermine, N1-cholesteryl spermine carbamate.  The resultant derivatives 
were confirmed by off-line high resolution electrospray ionization mass spectrometry (HR 
ESI MS). 
 
The results show that the synthesis of polyamine derivatives in quantitative yield depends on 
the time of reaction, the temperature and the ratio of fluorophore reagent.  Linearity of 
derivatization was calculated and regression coefficients ranged from 0.968 to 0.999 with 
good reproducibility.  HR ESI MS analysis of the reaction products demonstrated complete 
derivatization of both primary and secondary amino groups with dansyl and FMOC 
fluorescence derivatives and of primary amine groups for OPA and fluorescamine 
derivatives.  Under the ionization conditions used the dansyl derivatives showed, in addition 
to monovalent ions [M+H]+, divalent cations [M+2H]2+ because this chromophore contains a 
basic amine that can be easily protonated.  FMOC derivatives gave prominent [M+Na]+ ions.  
The OPA derivatization reaction is rapid, but the products have poor stability.  The 
derivatization with fluorescamine gave multiple products with glucosamine due to the 
presence of a chiral centre in the fluorophore.  The relative quantum yields of the polyamine-
fluorophore derivatives were examined to determine the effect of intramolecular 
fluorescence quenching.  Dansylation is the fluorescent derivatization method of choice. 
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Å  angstrom 
aq  aqueous 
oC  degrees Celsius 
CNLSD condensation nucleation light scattering detector 
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DCM  dichloromethane 
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i.e.  id est, that is 
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LC-MS  liquid chromatography-mass spectrometry 
µ, µm  micron, micrometre 
mM  millimolar 
M  molar 
MCE  mercaptoethanol 
Me  methyl 
MeCN  acetonitrile 
µL  microlitre 
mL  millilitre 
mp  melting point 
 v 
M.W.  relative molecular weight 
m/z  mass over charge 
nm  nanometre 
NMR  nuclear magnetic resonance 
ODC  ornithine decarboxylase 
ODS  octadecyl silane 
OPA  o-phthaladehyde 
ppm  part per million 
RIA  radio immunoassay 
Rt  retention time 
RP-HPLC reverse phase-high performance liquid chromatography 
TLC  thin layer chromatography 
UV  ultraviolet 
v/v  volume by volume 
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CHAPTER 1:  INTRODUCTION 
 
1.1  Polyamines - general introduction 
 
Polyamines, the diamines putrescine (1,4-diaminobutane), cadaverine (1,5-diaminopentane), 
the triamine spermidine (N-(3-aminopropyl)-1,4-diaminobutane) and the tetraamine 
spermine (N,N1-bis-(3-aminopropyl)-1,4-diaminobutane), are non-protein nitrogenous bases 
that are ubiquitous in living organisms (Seiler et al., 1978).  Although they were discovered 
many years ago, are relatively unfamiliar to most investigators because they have no striking 
or acute pharmacological effects, and because the significance of their presence was not 
known.  In recent years, several observations and many analytical studies have shown the 
occurrence of polyamines in various species of living organism such as in bacteria, in plants 
and in animal tissues (Hamana et al., 1992, 1993, 1994).  Polyamines constitute a group of 
cell components that are important in biochemical processes, mainly in cell proliferation and 
cell differentiation (Bauza et al., 1995).  As they are polybasic in nature, polyamines have a 
high affinity for cellular polyanions.  Indeed, there is increasing interest in the actions of 
polyamines on polynucleic acids, as the polyvalent cations titrate poly(anionic) phosphate. 
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Figure 1.1  Naturally occurring di- and polyamines (the nomenclature reflects the methylene 
count in the spacing between nitrogen atoms). 
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The separate classification of polyamines and monoamines is based on the fact that the two 
types of compounds exhibit a number of quite different characteristics.  The polyamines are, 
in the main, linear aliphatic molecules.  The polymer-like nature of polyamines has led to an 
abbreviated way of denoting their structures.  The molecule starts with a primary amino 
group (H2N-) link to a chain of methylene groups (-CH2-) interspersed with secondary amino 
group (-NH-) and terminates with another primary amino group (-NH2); the structure can be 
described simply by denoting the number of carbons between each amino group.  Thus 
putrescine is shown as 4, spermidine 3.4, spermine 3.4.3, its regioisomer thermospermine 
3.3.4 etc.  The structures of some simple linear naturally occurring di- and polyamines are 
shown in Figure 1.1. 
 
In 1678, the early period of the Scientific Revolution, Antoni van Lewenhoeck examined 
various fluids include samples of human semen with the aid of a microscope.  He reported 
the existence of motile sperm (spermatozoa) in semen (Lewenhoeck, 1678) and described 
crystals that formed when left to cool.  These crystals are now known to be spermine 
phosphate which is a source of a semen-like odour (Rosenheim, 1924).  From the early 
period, it was believed that the compound spermine was uniquely present in human semen.  
There were several experiments and observations during this period, various names were 
given to the crystals.  In 1878, Schreiner described spermine as a substance present in many 
mammalian tissues not only in semen and he was the first to identify the crystals correctly as 
spermine phosphate (Schreiner, 1878).  In the period of 1923 to 1927, the correct chemical 
structure of spermine was established, determined and confirmed by synthetic spermine 
(Dudley et al., 1924, 1925, 1926; Rosenheim, 1924; Wrede et al., 1923, 1924, 1925, 1926, 
1927).  The diamines’ history is shorter than that of spermine.  1,4-Diaminobutane 
(putrescine) and 1,5-diaminopentane (cadaverine) were first described in decomposing 
animal material, in cadavers by Brieger in 1885 (Middlebrooks et al., 1988), and in urine of 
cystinuric patients (Bremer and Kohne, 1971).  The structures were established by 
comparison with synthetic diamines. 
 
Due to their pKa values, putrescine, cadaverine, spermidine and spermine are di- and 
polycations under physiological conditions and exhibit net charges close to 2+, 2+, 3+ and 4+, 
respectively.  The polyamines form complexes, especially with polyanionic compounds i.e. 
RNA and DNA and with nucleic acid containing structures and membranes.  Spermidine and 
spermine are particularly flexible and have charge distribution along the whole molecule, 
thus facilitating greater interaction with the negatively charged backbone of DNA (Teti et 
al., 2002).  This reduces the net charge and increases the conformational stability of the 
molecules (Liquori et al., 1967).  These interactions form the basis for the role of polyamines 
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in cell metabolism at the replication, transcriptional, and post-transcriptional levels.  Their 
involvement in processes related to cell growth and cell differentiation has attracted much 
interest recently.  There is also evidence suggesting a role for polyamines in programmed 
cell death (Hawell et al., 2002).  As polyamines are synthesized by amino acid 
decarboxylation reactions which consume H+, polyamine accumulation may function as part 
of a homeostatic mechanism to keep intracellular pH at a constant value.  Rapidly growing 
tissues usually have higher amounts of polyamines and they have stimulating effects on 
DNA, RNA and protein synthesis.  Conversely, severe depletion of polyamines reduces 
growth in mammalian cells (Gugliucci, 2004). 
 
Polyamines are reported to have a role in the prevention of nerve damage and duodenal 
mucosal repair.  Spermine has been recommended for the treatment of human prostate 
cancer separately and in combination with other anticancer drugs (Ernestus, 2001).  One 
report indicated the functions of the polyamines as growth factors; antioxidants; stabilizers 
of DNA, RNA, membranes; metabolic regulators; nutrients and second messengers 
(Ekegren, 2005).  Spermidine and spermine bind to the phosphate backbone of poly-nucleic 
acids.  This interaction is mostly based on electrostatic interactions between positively 
charged ammonium groups of the polyamines and the negatively charged phosphates of the 
poly-nucleic acids.  Spermine is an important reagent widely used to precipitate DNA in 
molecular biology protocols.  Spermidine and spermine are derivatives of putrescine which 
is produced from L-ornithine by the action of ornithine decarboxylase (ODC).  Spermidine 
and spermine levels are also affected by the rate of conversion of their respective precursors, 
putrescine and spermidine.  Also, it is known that the reverse conversions of spermine into 
spermidine, and spermidine into putrescine are also important (Khuhawar, 2001). 
 
Early polyamine research was concentrated in the field of cancer and relatively little 
polyamine research was neuroscience related.  However, further research revealed the 
existence of uptake and release mechanisms for brain polyamines, as seen with other 
substances more commonly accepted as neurotransmitters (Ekegren, 2004).  Polyamines also 
play a regulatory role in cellular calcium homeostasis and have a metabolism that is 
deregulated in response to cerebral trauma or ischaemia (Moinard, 2005). 
 
In most cells polyamines are the products of a highly regulated biosynthetic pathway.  It is 
not clear whether the elaborate regulation of polyamine synthesis is a consequence of their 
essential roles in cellular differentiation and development, or part of a defence mechanism to 
prevent over accumulation of compounds that are toxic in excess (Sairam and Tyagi, 2004).  
In addition to their biosynthetic capability, many cells also process transport systems for 
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polyamines that respond to intracellular polyamine levels, and other stimuli, and are 
regulated by mechanisms that are at present incompletely defined. 
 
The widespread occurrence of a variety of polyamine-oxidizing enzymes in animals, plants, 
bacteria and fungi results in the formation of aminoaldehydes as intermediates.  These 
compounds containing one or more amino groups that will be positively charged at 
physiological pH, and an aldehyde functional groups are highly reactive.  Aminoaldehydes 
have been shown to be cytotoxic to a wide variety of cell types (Yu, 2003).  It is not yet clear 
whether these compounds have any biological function or are merely unstable and rapidly 
degraded intermediates in the polyamine catabolic pathway. 
 
Intracellular polyamine concentrations vary throughout the cell cycle.  An increase in 
polyamine synthesis is a very early event in cell proliferation and takes place before any 
increase in protein or nucleic acid synthesis.  Thus, the polyamine biosynthetic pathway 
presents an attractive target in tumour and proliferative disease chemotherapy (Jänne et al., 
2004; Wallace and Niiranen, 2007).  Inhibitors of polyamine biosynthesis have been used 
successfully in the treatment of some protozoan diseases such as African trypanosomiasis 
(Heby et al., 2007). 
 
Adequate intracellular levels of polyamines are necessary for optimal growth and replication 
of animals, plants, bacteria, fungi, protozoa, and probably all living organisms (Jänne et al., 
1978; Tabor and Tabor, 1984; Wallace et al., 2003; Luo et al., 2009).  Polyamines influence 
the transcriptional and translational stages of protein synthesis, interact with the nucleic 
acids, stabilized membranes, alter intracellular free calcium, and have important 
neurophysiological functions (Bernsteina and Müller, 1995).  Fruit-ripening and flower-
setting processes in plants are modulated by polyamines (Toumadje and Richardson, 1988). 
 
1.2  Occurrence of polyamines in biological materials 
 
The three most commonly occurring natural polyamines are putrescine, spermidine, and 
spermine, together with 1,3-diaminopropane and cadaverine.  One or more of these 
compounds are present in every living cell.  All have been found in eukaryotes, but spermine 
is rare in prokaryotes or might be replaced by thermine (norspermine, 3.3.3) and 
thermospermine (3.3.4).  In addition to spermine, spermidine and putrescine, a large number 
of other linear, and some branched-chain, polyamines have been detected in mammalian 
tissues and excreta, or in plants, bacteria and microorganisms (Hamana et al., 1993, 1994). 
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Polyamine moieties are constituents of many compounds found in plants and insects.  
Putrescine, spermidine or spermine containing alkaloids are found in many plants, non-
proteinaceous spider and wasp toxins, and glutathionyl-spermidine conjugates in some 
pathogenic microorganisms (Bollinger, 1995). 
 
Polyamines in animal tissues 
 
The highest concentrations of spermidine and spermine in animal tissues are found in the 
pancreas, prostate, and human semen (Bolliger, 1935; Dudley et al., 1924, 1927; Harrison, 
1931, 1933; Rosenthal, 1958; Wrede, 1925).  The polyamines in human semen are largely in 
the seminal plasma, rather than in the spermatozoa.  The concentration of diamines is very 
low in animal tissues, and they are accordingly difficult to determine with accuracy or 
specificity.  However, several reports have shown the presence of diamines in animal tissues.  
1,3-Diaminopropane has been found in rat and guinea pig liver, and in human semen 
(Weaver and Herbst, 1958).  1,4-Diaminobutane has been found in the pancreas (Fischer and 
Bohn, 1957) and liver (Weaver and Herbst, 1958) of several species, in ox lung, in bovine 
brain, in pig brain, in human semen, in pupae and caterpillars of the silkworm (Weaver and 
Herbst, 1958).  1,5-Diaminopentane was found in liver.  Although most of the polyamines in 
animal tissues are present as free amines, some minor components are present in conjugated 
form e.g. conjugates of spermine and 1,3-diaminopropane with phenolic acids are found in 
the venoms of certain species of spider and wasp as acylpolyamines (Figure 1.2) (Schafer et 
al., 1994, Chesnov et al., 2002).  Spider Paracoelotes birulai produced venoms which 
contained guanidine derivative PA 3334G (Figure 1.3) (Chesnov et al., 2002).  The first 
polyamine alkaloid with the 1,4-diguanidinobutane moiety is Stellettadine A (Figure 1.4), 
obtained from a marine sponge Stelletta sp. (Tsukamoto et al., 1996). 
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Figure 1.3  Guanidine derivative of polyamine (PA 3334G) 
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Figure 1.4  Stellettadine A 
 
The functions of polyamines in animals are reported (Thomas and Thomas, 2003; Childs et 
al., 2003; Umekage and Ueda, 2006) as the essential regulators of growth, gene transcription 
and ribosome-mediated translation. 
 
Polyamines in microorganisms 
 
A very large number of papers have been published on polyamines in a variety of 
microorganisms such as bacteria and yeast (Tabor and Tabor, 1985; Bachrach, 1961; Dubin 
and Rosenthal, 1960).  The polyamines concentrations of the various bacteria vary with the 
pH and other cultural conditions for instance gram-positive organisms contained trace or no 
of polyamines, while high concentration of polyamines were formed in gram-negative 
organisms (Herbst, 1958).  The composition of the culture medium played important role in 
bacteria uptake, since many organism take up amines from the medium, which results in 
intracellular content of both the free amines and derivatives (Tabor et al., 1958; Dubin and 
Rosenheim, 1960).  The presence of high concentrations of polyamines in bacteria even 
when grown on a minimal glucose-salts medium support the concept that these amines are 
important biological compounds, rather than just a result of detoxification (Silverman and 
Harris, 1943). 
 
The most abundant polyamines in bacteria are putrescine and spermidine.  Cadaverine is also 
present but less abundant.  Thermospermine, an isomer of spermine was found in 
thermophillic bacterium Thermus thermophilus (Oshima, 1979), in Halophilic archaeum 
Halobacterium cutirubrum (Carteni-Farina et al., 1985), in Agrobacterium (Hamana et al., 
1989), in Paracoccus denitrificans (Hamana et al., 1990).  There are also a large number of 
polyamine alkaloids from the skeleton of 1,5-diaminopentane (cadaverine), spermidine and 
spermine alkaloids.  Incorporating a cadaverine backbone, Terragines A-E (Figure 1.5) were 
isolated from Streptomyces lividans (Wang et al., 2000). 
 
Various functions of bacteria polyamines have been reported (Wortham et al., 2007) such as 
they are the components of outer membrane of gram-negative bacteria, they are important in 
acid resistance, they play significant role for cellular differentiation, etc. 
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Figure 1.5  Terragines A-E 
 
Polyamines in plants 
 
In plants, putrescine (4), spermidine (3.4), spermine (3.4.3) are concerned as the core 
portions of ubiquitous polyamines.  Cadaverine (5) and thermospermine (3.3.4) are also 
present in legumes e.g. from Pisum sativum and Vicia sativa (Hamana et al., 1991).  
However, the less common polyamines such as polyamine (3.3), (3.5), (4.4), (3.3.4.3.3) also 
found in some alkaloids.  Polyamines in plants have been suggested that they play important 
roles in morphogenesis, growth, embryogenesis, organ development, leaf senescence and 
stress response (Kumar et al., 1997, Walden et al., 1997, Malmberg et al., 1998, Bouchereau 
et al., 1999, Liu et al., 2000).  Most of compounds from putrescine core are N1,N4-
diacylputrescine such as hemileptagline (N1,N4-bis-(3-(methylthio) propenoyl)putrescine 
(Figure 1.6) (Saifah et al., 1999), pyramidatine (Figure 1.7) from Aglaia species (Saifah et 
al., 1993, 1998).  These compounds exhibit cytotoxin and antiviral activities.  Previously, 
sulfur-containing amides had been reported as the constituents of the genus Glycosmis of the 
Rutaceae (Greger et al., 1993).  The putrescine alkaloid magnolamide (Figure 1.8), with a 
substituted pyrrole unit, was isolated by Yu et al. (1998) and was synthesized by Dong et al. 
(2002).  Many of the polyamine alkaloids reported as cinnamoyl, coumaroyl, caffeoyl, 
feruloyl, and sinapoyl derivatives of putrescine ((Figure 1.9), spermidine and spermine such 
as N1,N4,N9-tricoumaroylspermine and N1,N4,N9,N12-tetracoumaroylspermine (Figure 1.10).  
These compounds are believed to prevent photodamage to nucleic acids during the aerial 
transport of the pollen. 
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Figure 1.9  Putrescine-backbone alkaloids in plants. 
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Figure 1.10  N1,N4,N9-Tricoumaroylspermine and N1,N4,N9,N12-tetracoumaroylspermine 
 
1.3  Physico-chemical properties 
 
Due to the proximity of at least two N-atoms in their structures, polyamines show reactivity that 
are distinctively different from those of monoamines.  Polyamines are small molecular mass 
molecules, polybasic, water soluble and at physiological pH many of the amino groups are 
protonated and carry a positive charge.  The distinctive names given to the diamines, putrescine 
and cadaverine, relate to the odour of the free volatile amines, which lack volatility and odour 
when they exist as their cationic salts.  Appropriate combinations of pH and solubility of the 
amines and their salts in aqueous and organic media were exploited early in the isolation and 
estimation of the polyamines.  The loss of the proton from the protonated amine at alkaline pH 
generating the free amine is crucial in the isolation and analysis of the natural polyamines.   
 
Basicity and pKa values of amines 
 
Table 1.1  pKa values of polyamines by potentiometry (Palmer and Powell, 1974). 
 
Polyamines pKa 
Putrescine 10.80, 9.63 
Spermidine 10.95, 9.98, 8.56 
Spermine 10.94, 10.12, 9.04, 7.97 
 
The pKa values of the various amines in the polyamines have been estimated by a variety of 
methods.  Palmer and Powel (1974) studied pKa of polyamines by potentiometric titration 
using glass electrodes (Table 1.1).  The initial protonations are on the sterically more 
accessible (less hindered) primary amines even though secondary amines are more basic.  
Whereas uncharged amines can frequently penetrate lipid-containing membranes by 
diffusion (Guarino and Cohen, 1979), charged amines, including the quaternary ammonium 
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salts, do not cross membranes easily, if at all, in most cellular environments.  The other 
technique used instead of glass electrode potentiometric measurement is spectroscopic, 
nuclear magnetic resonance (NMR) spectroscopy.  By potentiometric titration and by NMR 
chemical shift measurements, the pKa values of polyamines were determined (Table 1.2).  
From 13C-NMR studies it was concluded that in spermidine, the inner secondary amine is 
protonated only after the complete protonation of the primary amines.  Both primary 
nitrogens appeared to be protonated simultaneously, despite attachment to aliphatic chains of 
different length.  The amine protonation is affected by the length of an intervening aliphatic 
chain.  For spermidine and spermine, the initial protonations are on the primary amines.  The 
uncharged amino groups appeared at values above pH 9.5 (Kimberly and Goldstein, 1981). 
 
Table 1.2  pKa values of spermidine by difference measurements 
 
Polyamine pKa by 
15N-NMR 
(Takeda et al., 1983) 
pKa by 
13C-NMR 
(Takeda et al.,1983) 
pKa by
1H-13C NMR 
(Onash et al., 1984) 
Spermidine 11.56, 10.80, 9.52 11.88, 10.77, 9.60 11.02, 10.02, 8.75 
 
Table 1.3  pKa values of diamines (Martell et al., 1997). 
 
Diamine pKa ∆pKa ∆Ka 
1,2-Diaminoethane (2) 9.89, 7.08 2.8 630 
1,3-Diaminopropane (3) 10.56, 8.76 1.8 63 
1,4-Diaminobutane (4) 10.72, 9.44 1.28 19 
1,5-Diaminopentane (5) 10.78, 9.85 0.93 8.5 
1,6-Diaminohexane (6) 10.97, 10.09 0.88 7.6 
 
The comparison of pKa values on the series of diamines (Table 1.3), triamines (Table 1.4) 
and tetramines (Table 1.5) have been reported (Martell et al., 1997).  For diamines, the 
difference between the pKa of the first and second protonation is 2.8 log unit (Ka = 630) for 
1,2-diaminoethane (2) (Table 1.3).  Then this difference is dramatically reduced in (3) (∆pKa 
= 1.8 log unit, ∆Ka = 63) which means that the propylenic spacer between the terminal 
primary amine groups reduces significantly the electrostatic repulsion between both sites.  
This effect is much smaller when ∆pKa is compared between (3) and (4), when one 
methylene group was added, and also clearly when more methylene groups are added in the 
chain to (5), and no such difference of ∆pKa occurs between (5) and (6).  The reduced effect 
of more spatially distant amine groups is reflected in higher pKa values (Table 1.3). 
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Triamines present two kinds of amines, primary at the end and secondary in the middle of 
the molecule.  In triamine, the change of an ethylenic chain by a propylenic (from 2.2 to 2.3) 
increases the basicity by more than two orders of magnitude.  In 2.2, the pKa represents two 
relatively high values and one much lower while the other triamines show a set of two high 
pKa values with one intermediate or three high pKa values as the function of the length of 
the hydrocarbon chains between the nitrogen atoms. 
 
Table 1.4  pKa values of triamines (Martell et al., 1997). 
 
Triamine pKa 
3-Azapentane-1,5-diamine (2.2) 9.84, 9.02, 4.23 
3-Azahexane-1,6-diamine (2.3) 10.21, 9.17, 6.10 
3-Azaheptane-1,7-diamine (2.4) 10.65, 9.42, 6.71 
4-Azapentane-1,7-diamine (3.3) 10.65, 9.57, 7.69 
4-Azaoctane-1,8-diamine (3.4, spermidine) 10.89, 9.81, 8.24 
 
Table 1.5  pKa values of tetraamines (Martell et al., 1997). 
 
Tetraamine pKa 
2.2.2 9.74, 9.07, 6.59, 3.27 
2.3.2 10.08, 9.26, 6.88, 5.45 
3.2.3 10.53, 9.77, 8.30, 5.59 
3.3.3 10.46, 9.82, 8.54, 7.21 
3.4.3 (spermine) 10.80, 10.02, 8.85, 7.96 
 
Tetraamines present two distinct kinds of nitrogen atoms, two primary amines at both ends 
and two secondary amines at the central part of the chain.  From Table 1.5, the trends of 
protonation present two large basicity constants and two intermediate values in (2.3.2) while 
in (3.2.3) shows three large constants and one intermediate.  However, in (2.2.2) the effect of 
repulsion effect of protonated nitrogens separated by ethylenic chains make three groups of 
pKa values, the first is intermediate (9.74, 9.07), the second is small (6.59) and the last is low 
(3.27) which is from the fourth protonation.  The polyamines (3.3.3) and (3.4.3) show a 
group of higher pKa values due to the propylenic or butylenic chains which reduce the 
electrostatic repulsion more than the (shorter) ethylenic chains. 
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1.4  Biological roles and pharmacological effects of polyamines 
 
Polyamines and nucleic acids 
 
Polyamines have been shown to have an important role in cell division and their amount 
increases dramatically under conditions of high cell division for instance tumor growth, 
cystic fibrosis and pregnancy (Russel and Durie, 1978).  As the polyamines carry multiple 
positive charges in vivo due to protonation of the polyamine groups, they will interact with 
negatively charged polynucleic acid and it has been estimated that a large amount of the 
polyamines present in the cell are associated to DNA or RNA (Watanabe et al., 1991).  
Polyamines have been shown to induce DNA condensation and to stabilize compact forms of 
DNA (Bloomfield, 1991, Gosule et al., 1976, Raspaud et al., 1999).  DNA often occurs in 
compact forms, e.g. in chromatin of eukaryotes and in sperm and phage heads, thus it is 
possible that polyamines are largely responsible for the stabilization of these compact DNA 
phases.  It is believed that the primary targets for polyamine binding are the charged DNA 
phosphates (Deng et al., 2000). 
 
Polyamines as the microbial growth factors 
 
The first study was those of Herbst et al. (1958) on Hemophilus parainfluenzae 7901.  In the 
absence of added polyamine no growth occurs on a purified medium.  Growth is obtained 
upon addition of small amounts of 1,3-diaminopropane, 1,4-diaminobutane or any one of 
about twenty other synthetic derivatives of these diamines, including spermidine and 
spermine.  Sneath (1995) described a mutant of Aspergillus nidulans that has an absolute 
requirement of 1,4-diamonobutane.  Several other compounds, including spermine, 
ornithine, arginine, lysine, 1,3-diaminopropane and 1,5-diaminopentane are ineffective, and 
only a small growth response is found with spermidine.  The occurrence of a mutant with 
this specific growth requirement for 1,4-diaminobutane indicate that 1,4-diamonobutane or a 
derivative has an essential function in the cell. 
 
Stabilization of bacterial spheroplasts and protoplasts by polyamines. 
 
The discovery of the stabilization of osmotically fragile bacteria by small amounts of 
spermine indicated that in some unknown way spermine affects the strength of the bacterial 
cell wall or membrane.  This work was demonstrated by Tabor (1962) by treating E. coli 
with lysozyme and ethylenediaminotetraacetate in a 20% sucrose medium; the bacteria are 
converted to spheroplasts (spheroplast is a cell from which the cell wall has been almost 
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completely removed) that lyse if the osmotic pressure is lowered.  Protection against lysis is 
afforded by 0.001 M spermine, spermidine, CaCl2, quinacrine or streptomycin; comparable 
concentrations of KCl, NH4Cl, MgCl2, ornithine, lysine or 1,4-diaminobutane are inactive.  
Spermine has a protective effect also on spheroplasts of E. coli produced by penicillin 
treatment and protoplasts of Micrococcus lysodeikticus made by treatment with lysozyme.  
The striking aspect of these results is the low concentration of spermine (0.001 M) needed to 
prevent lyse, compared to the 0.5 M sucrose usually used.  The interior of cell has a higher 
osmotic pressure than the external medium; the cell is prevented from swelling even in 
distilled water by the rigidity of its cell wall.  When the wall is damaged by lysozyme or its 
synthesis is inhibited by penicillin this restraint is absent and the spheroplast swells until its 
membrane ruptures, lyse occurs.  The 0.5 M sucrose prevents lysis by raising the osmotic 
pressure of the environment to that of the contents of the spheroplast.  Spermine in a 
concentration of 0.001 M does not increase the osmotic pressure significantly and therefore 
presumably acts by strengthening the spheroplast membrane. 
 
Antimicrobial effects 
 
Growth of several bacteria and yeast is inhibited by the polyamines; however, this effect 
varies in different species.  At pH 7, S. aureus is killed by spermine at 5 x 10-4 M, while 0.01 
M is necessary to kill E. coli (Razin and Rozansky, 1957).  A competitive inhibitory effect 
between the penetration of basic amino acids and the corresponding diamines (of similar 
chain length) was observed in Bacterium cadaveris (Mandelstam, 1956).  Various 
polyamines conjugated to cholesterol, cholenic acid and bile acids have been reported (Geall 
et al., 2000, Karigiannis, 2000).  Some of these sterol-polyamine conjugates exhibit 
antimicrobial (Kim, 2000, Kikuchi et al., 1997, Jones et al., 1996, Sadownik et al., 1995) 
and anti-trypanosomal activity (Khabnadideh et al., 2000).  The isolation, structural 
determination, and characterization of a water-soluble cationic steroid from the dogfish 
shark, Squalus acanthias, called squalamine exhibits potent antimicrobial activity against 
fungi, protozoa, and both Gram-negative and Gram-positive bacteria (Figure 1.11) (Moore et 
al., 1993). 
OSO
3
H
N
H
OHN
H
NH
2
 
 
Figure 1.11  Squalamine 
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1.5  Analysis of polyamines 
 
Polyamines content of cells and body fluids are in the range of 0.05–500 µmol/1012 cells and 
0.05 – 15 µmol/L.  The analysis of polyamines had been performed with almost all available 
techniques:  thin-layer and paper and liquid chromatography, electrophoresis, 
immunochemical methods, enzymatic methods, high-performance liquid chromatography 
(HPLC) and gas chromatography (GC).  The difficulties experienced in attempting to 
identify and measure the amount of polyamines in biological materials follow from three 
characteristics: their size as they are low-molecular-mass aliphatic amines, the low 
concentrations in which they are present, and that their only reactive centres are the amino 
groups which make them high basicity and strong adsorption on solid surfaces.  Thus 
methods for polyamine analysis must include procedures to extract, and perhaps concentrate, 
the polyamines; to separate them from other amino-containing compounds (such as amino 
acids), and from each other; to convert them into colour or fluorescence derivatives; to 
identify them; and then to make quantitative measurements.  All available methods have 
definite limitations and there is still no simple, specific method for the quantitative 
determination of the various polyamines.  It is usually necessary to carry out one or more 
preliminary steps to separate the polyamines from each other and from other cellular 
materials. 
 
Analytical methods for polyamines 
 
1.  Thin-layer chromatography (TLC) 
TLC has been used extensively for preliminary identification and semiquantitative of 
polyamines.  TLC is not very precise and specific technique.  However, it is simple, rapid and 
can be used without sophisticated equipment.  In these procedures, the amines are usually 
detected with a ninhydrin spray (Shirahata et al., 1983) or by derivative formation of primary 
and secondary amines with dansyl chloride (5-dimethyl aminonaphthalene-1-sulfonyl 
chloride) (Seiler and Wiechmann, 1965, Boffey et al., 1974, Fleisher et al., 1975, Heby et al., 
1978, Beyer et al., 1983, Wettlaufer, 1988, Madhubala, 1998).  TLC is an easy way to 
determine polyamines in tissue extracts and cell extracts (Madhubala, 1998).  Different 
solvent systems were evaluated for their ability to separate biogenic amines after dansylation 
by TLC and detected by fluorescence densitometry at 330 nm (Lapa-Guimarães et al., 2004).  
Recently, calcium sulphate (CaSO4) coated TLC plates were used for the analysis of aliphatic 
polyamines without derivatization for separation of six di- and polyamines (ornithine, 
citrulline, putrescine, cadaverine, spermidine and spermine) (Khan, 2006). 
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2.  Immunoassays 
The immunoassays which were used for the determination of polyamines are Radio 
Immunoassay (RIA) and Enzyme-Linked Immuno Sorbent Assay (ELISA).  Both techniques 
provide high sensitivity, require small tissue samples and allow multiple analyses in parallel.  
Moreover there is no need to derivatize the samples.  Nevertheless, a major problem is the 
specificity of the antibody produced the inability to obtain antibodies against putrescine and 
also the hazard of handling radioactive reagent in the RIA.  The early efforts to produce 
antibody of spermine had resulted in somewhat less specific antispermine that processed 
cross-reactivity with spermidine (Bartos et al., 1975).  Enzyme immunoassay which 
employed two antibodies against spermine and spermidine was developed by Fujiwara, 
proved to be non-specific again cross-reaction problems were present (Fujiwara et al., 1983). 
 
3.  Gas-liquid chromatography and Gas-chromatography-mass spectrometry 
Methods of analysis of polyamines by using GC were introduced in 1969 (Brooks et al., 
1969).  GC of non-derivatized polyamines is not very popular and not very successful 
because of their polar characteristics which present many problems of loss on the column, 
tailing patterns of elution, difficulties of improvements, non-reproducible.  GC is not as often 
used for the determination of polyamines as liquid chromatography.  One of the main 
problems with GC is that sample introduction as aqueous phase is undesirable, which causes 
problems with serum and urine samples.  Moreover, the presence of non-polar contamination 
in biogenic samples makes difficulty for detection by GC.  However, a GC method for non-
derivatized polyamines was developed to separate and detect polyamines in different organs 
(Beninati et al., 1977).  By using trifluoroacetylacetone as a derivatizing reagent for 
polyamines improved the sensitivity of putrescine and cadaverine quantification in the serum 
of cancer patients (Khuhawar et al., 1999).  The use of capillary columns instead of packed 
columns increased the sensitivity of GC systems and gives reproducible results.  Polyamines 
and acetylpolyamines were analysed simultaneously this minimized the problems of 
adsorption and reduced the analysis-time (Dorhout et al., 1997).  Further developments in 
GC analyses comprised both pre-purification and derivatization procedure improvements.  
Derivatisation usually necessitates isolation of analytes in a water and salt free form.  
Nevertheless, polyamine analyses by GC remained time-consuming and unattractive so GC 
has been become neglected probably because of initially laborious pre-purification.  The pre-
purification were carried out by extraction with alkaline butanol (Beninati et al., 1977), 
trichloroacetic acid (Fujihara et al., 1983, Emonds et al., 1983, Khuhawar et al., 1999), 
cation-exchange chromatography (Rattenbury et al., 1979, Slemr et al., 1984) or adsorption 
with silica gel (McGregor et al., 1976, Yamamoto et al., 1982, Muskiet et al., 1984, Jiang, 
1990, Dorhout et al., 1997).  The derivatizations performed with isobutyloxycarbonyl 
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(Bakowski et al., 1981), pentafluoropropionyl (Rattenbury et al., 1979), ethyloxycarbonyl 
(Yamamoto et al., 1982, 1984), trifluoroacetyl (Jiang, 1990; Khuhawar et al., 1999) or 
heptafluorobutylryl derivatives (Fujihara et al., 1983; Muskiet et al., 1984; van den Berg et 
al., 1986; Dorhout et al., 1997). 
 
GC systems can also be coupled with more selective detector methods such as MS which 
will give the powerful separation and identification technique.  Polyamines can be 
determined more selectively by applying isotopic labelled standards (Smith et al., 1977).  
GC-MS was used for determination of hair polyamines as hair is the noninvasive biosample 
(Choi et al., 2000).  At present capillary GC seems more suitable for profiling of polyamines 
because of its higher number of theoretical plates and its easy convertibility to GC-MS. 
 
4.  High-performance liquid chromatography (HPLC) 
HPLC with on-line detection is the most common applied profiling method for polyamines.  
Cation-exchange and reversed-phase high performance liquid chromatography require pre- 
or post-column derivatization, followed by UV-VIS spectrophotometric or fluorimetric 
detection.  An HPLC method for polyamines was first reported by Samejima in 1976 
(Samejima et al., 1976).  Chromatographic separation of polyamines is based on 
hydrophobic interactions of the residual part of the molecule; therefore retention of non-
derivatized polyamines is not easy on standard reversed-phase chromatographic columns.  
However, there was a method described based on this principle (Fransson et al., 1990).  The 
method was not sensitive and only applicable to high concentrations.  The separation of non-
derivatized polyamines is easily performed with ion-chromatography.  There are three 
methods of operation; (cat) ion-exchange, ion-pair and ion-exclusion chromatography.  The 
first two, ion-exchange chromatography and ion-pair chromatography are more popular than 
ion-exclusion chromatography for the separation of biogenic polyamines (Molnar-Perl, 
2005).  The strong electrostatic interaction between the two or more protonated amines of the 
analytes and the anionic fixed charged of the ion-exchange chromatography stationary phase 
cause strong analyte retention.  Thus, high concentrations of counter ion in the eluent are 
required to elute the polyamines.  The specific detection of non-derivatized polyamines after 
ion-exchange chromatography was done by a condensation nucleation light scattering 
detector (CNLSD) (Sadain et al., 1999).  Another interesting approach to directly detect non-
derivatized polyamines is LC-MS which is sensitive and selective due to the mass 
chromatograms.  However, an LC-MS with ion exchange systems is expensive, and not easy 
for quantification purposes.  The methods mentioned above were carried out by non-
derivatization reaction of polyamines, however, ion-chromatography with selective post-
column derivatization reaction is a very popular method to separate and detect polyamines 
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(Suzuki et al., 1990, Conca et al., 2001, Vidal-Carou et al., 2003).  OPA (o-phthalaldehyde) 
is most often used as the post-column detector.  Polyamine-ninhydrin is another post-column 
derivatization of choice (Bremer et al., 1971; Gehrke et al., 1974).  Pre-column 
derivatization is another alternative way to determine polyamines.  Some advantages of this 
technique over post-column derivatization are as follows:  the pre-column derivatization is 
not related to the mobile phase so unlike the post-column derivatization, the reaction 
conditions can therefore be chosen freely; the rates of the reactions are not usually limiting, 
whereas slow reaction can cause serious mixing and reaction-volume problems in post-
column derivatization; the pre-column derivatization can be use as a pre-clean-up step; 
selective reagents and extraction procedures can result in the easy elimination of much 
interference of reagents in contrast to reaction after separation; pre-column derivatization can 
improve the sensitivity and it uses small amounts of expensive derivatization reagents and 
achieves short analysis times. 
 
Pre- or post-column derivatisation with fluorogenic reagents became popular because of their 
superior sensitivity compared with those that introduce UV-VIS absorbing moieties.  Pre-
column derivatisation with DNS Cl in aqueous solution, followed by reversed-phase 
HPLC/fluorimetry is a widely employed method for polyamines in tissue and body fluids.  
Other examples of pre-column reactions to fluorophores are those with fluorescamine, 
OPA/MCE and OPA/ethanethiol.  Cation-exchange HPLC with post column OPA/ME 
fluorimetry is another option.  A number of pre-column derivatisation techniques have been 
developed for HPLC with UV-VIS spectrophotometric detection.  They include reaction 
with benzoyl chloride, p-toluenesulfonyl chloride (tosyl chloride), 2,4-dinitrofluorobenzene, 
4-fluoro-3-nitrobenzotrifluoride, quinoline-8-sulfonyl chloride and 4-dimethylaminoazo-
benzene-4-sulfonyl chloride (dabsyl chloride). 
 
5.  Mass spectrometric methods 
MS methods can simultaneously separate and identify polyamines on the basis of the 
difference of their mass without use of column (Furuumi et al., 1998).  A quadrupole MS 
with ionspray ionization interface (ISI-Q MS) was the first one used to determine polyamine 
concentrations in rat tissues (Xu et al., 2002).  Recent progress in MS has made it possible to 
use a time-of-flight mass spectrometer with electrospray ionization interface (ESI-TOF MS), 
which is more sensitive and provides a higher resolution (Samejima et al., 2007). 
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1.6  Aims of the study 
 
This study attempts to determine accurate and simple assays for a wide range of polyamines 
by optimizing the derivatization methods and increasing the sensitivity of polyamine 
detection by HPLC using four typical fluorescent chromophores:  o-phthalaldehyde/ 
mercaptoethanol (OPA/MCE), fluorescamine, 9-fluorenylmethyl chloroformate (FMOC Cl) 
and dansyl chloride (DNS Cl) for pre column derivatization and using HR-ESI-MS to 
confirm the structures of the derivatives.  Intramolecular and intermolecular interactions that 
might influence the sensitivity of fluorescence detection have also been investigated.  The 
synthesis of the spermine (3.4.3) regioisomer, thermospermine (3.3.4) has been carried out in 
order to investigate the methods to separate and quantify these two isomers by RP-HPLC. 
 
The objectives of this research are: 
 
1. To study the analytical pharmaceutical chemistry related to polyamines and 
aminoglycosides which are difficult to analyze using current protocols.  In this research 
we will use fluorescence spectroscopy (of e.g. o-phthalaldehyde/mercaptoethanol, 
fluorescamine, FMOC and dansyl derivatives) and the efficiency of poly-derivatization 
(and the quantification of such polyamine-fluorophore conjugates), detailing the 
potential for the regioselective, fluorescent derivatization of basic amines. 
 
2. To investigate the chromatographic and spectroscopic characterization of these 
derivatives of polyamines and aminoglycosides, from a variety of natural product 
sources, concentrating on those which contain several amine functional groups:  2 (as 
found in putrescine and cadaverine), 3 (spermidine), 4 (spermine, kanamycin), 5 
(paramomycin), up to 6 (neomycin). 
 
3. To investigate reactions which selectively convert primary and secondary amines into 
fluorescent derivatives.  Then to develop suitable chromatographic procedures using 
fluorescence detection to resolve and quantify these amine derivatives.  The parent 
polyamines are of interest as novel vectors in non-viral gene delivery.  The intermediates 
involved in their synthesis such di- and polyamines lack any useful chromophores and 
therefore they are intrinsically hard to analyse, to detect and especially to quantify. 
 
4. To synthesize thermospermine (4.3.3) and then to analyse it in the presence of spermine 
(3.4.3) by making deuteriated and fluorescent derivatives which can be easily and 
practically separated by RP-HPLC, ultimately working towards a quantitative analysis. 
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CHAPTER 2:  EXPERIMENTAL 
 
2.1  Materials and general methods 
 
Chemicals, reagents, and solvents were purchased from Fisher and Sigma-Aldrich, all in 
GPR grade, unless otherwise stated and were used without further purification unless 
specified.  Water refers generally to distilled water or to Milli-Q-water for HPLC.  
Concentrated acids and bases were diluted in aqueous solution unless otherwise stated and 
pH adjustments were monitored by pH meter model CCM C625 combined conductivity/pH 
meter, WPA Linton, Cambridge, UK. 
 
Typical extraction or reaction work-ups ended with the organic solution being dried over 
anhydrous magnesium sulfate, filtered, and then evaporated to dryness under reduced 
pressure.  Solvents were evaporated with a rotary evaporator (Büchi rotavapor) using a 
vacuum pump (Vacuubrand PC 2001 vario) with a pressure control (Vacuubrand CVC 2II) 
and a variable temperature water bath (Büchi water bath). 
 
Flash column chromatography (Still et al., 1978) was generally performed on silica gel 60 
(Merck, 0.040-0.063 mm, 230-400 mesh ASTM, pH 6.5-7.5 for a 10% suspension) or on 
activated standard grade, neutral, acidic and basic (Brockmann I) alumina gels (Sigma-
Aldrich, 58Å, ~150 mesh).  The column was packed in an open-glass column with an 
appropriate solvent that could achieve a satisfactory resolution on TLC.  Solvent ratios are 
v/v unless otherwise stated.  The progress of the elution was followed by collecting fractions 
from the eluate, concentrating and monitoring by analytical TLC, HPLC, NMR and HR-ESI-
MS. 
 
Analytical TLC was performed on commercial aluminium-backed plates pre-coated with 
silica GF254 60 in 0.25 mm thickness and commercial aluminium-backed plates pre-coated 
with aluminium oxide GF254 60 neutral purchased from Merck.  TLC samples were applied 
as solutions in methanol.  The four mobile phase systems (ratios in v/v/v) used to monitor the 
reaction are given in Table 2.1. 
 
TLC plates were subjected to a single development to a height of approx. 5 cm in saturated 
vapour conditions.  Compounds were visualized by drying the plate and dipping in (or 
spraying with) a freshly prepared solution of ninhydrin (1.0 g) in a mixture of 95% methanol 
(50 mL) and glacial acetic acid (10 mL) followed by heating for ~3 min.  The amine and 
polyamine components were visible as purple spots on a white background. 
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Table 2.1  TLC mobile phase systems for monitoring thermospermine synthesis. 
 
system 1 dichloromethane: methanol = 10:1 
system 2 dichloromethane: methanol = 4:1 
system 3 dichloromethane: methanol: ammonium hydroxide = 10:5:1 
system 4 dichloromethane: methanol: ammonium hydroxide = 20:10:1 
 
Ultraviolet (UV) spectra were measured in methanolic solution using a Perkin-Elmer 
UV/VIS spectrophotometer Lambda EZ201.  Infrared (IR) spectra were recorded from 
anhydrous KBr discs or NaCl plates using a Perkin-Elmer RX 1 FT-IR instrument. 
 
Fluorescence studies were carried out with a Perkin-Elmer LS 50B Luminescence 
Spectrometer (λex and λem for different chromophores as in Table 2.2) using a 1 cm path 
length, 3 mL glass cuvette, slit width 5 nm.  An IBM compatible personal computer was 
used for data collection, using FL Winlab (Perkin-Elmer) software. 
 
Table 2.2  λex and λem of different chromophores. 
 
Chromophore λex (nm) λem (nm) 
Dansyl derivatives 330 510 
OPA/MCE derivatives 340 450 
FMOC derivatives 264 310 
Fluorescamine derivatives 390 486 
 
The high performance liquid chromatography (HPLC) instrument consisted of a solvent 
delivery system equipped with a Jasco PU-980 Intelligent HPLC pump (Ishikawa-cho, 
Japan) and monitored by a Jasco UV-1575 variable wavelength ultraviolet detector and 
Waters 470 fluorescence detector in series.  HPLC detection was typically by UV with the 
λmax the same as the λex of fluorescence for typical fluorophores in Table 2.2.  
Chromatograms were recorded on a Goerz Metramatt SE 120 recorder with chart speed at 1 
cm/min.  All columns used were commercially pre-packed reversed phase HPLC columns, 
purchased from Phenomenex Inc.  Analytical column:  Phenomenex hypersil ODS C18 5µ 
150 x 4.60 mm, Phenomenex luna C18 5µ 150 x 4.60 mm, Phenomenex luna C8 5µ 150 x 
4.60 mm with guard column H1-5C18 were used for the analytical separation procedures.  
Samples were dissolved in mobile phase and filtered though a 17 mm diameter SYR Filter 
Nylon 0.45 µm before injection using a 20 µL Rheodyne injection loop.  All mobile phase 
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mixtures were pumped at a flow rate of 1 mL/min and at 20oC.  The column was washed 
using the chosen solvent for 20 min or until a stable base line was obtained. 
 
Table 2.3  Mobile phase for HPLC experiments  
 
Chromophore type Mobile phase (%v/v) 
OPA/MCE derivatives Acetonitrile (MeCN) : Milli-Q-water 
(40:60, 60:40, 65:35, 70:30, 80:20, 85:15, 90:10) 
 Methanol : Milli-Q-water 
(70:30) 
OPA/MCE/FMOC derivatives Acetonitrile (MeCN) : Milli-Q-water 
(65:35, 70:30, 80:20, 85:15) 
FMOC derivatives Acetonitrile (MeCN) : Milli-Q-water  
(40:60, 50:50, 60:40, 65:35, 70:30, 80:20, 85:15) 
 Methanol : Milli-Q-water 
(40:60, 70:30) 
Fluorescamine derivatives Acetonitrile (MeCN) : Milli-Q-water 
(40:60, 50:50, 60:40, 65:35, 70:30, 80:20, 85:15)  
 Methanol : Milli-Q-water 
(40:60, 70:30) 
 Acetonitrile (MeCN) : Methanol: Milli-Q-water 
(85:10:5) 
Dansyl chloride derivatives Acetonitrile (MeCN) : Milli-Q-water 
(40:60, 50:50, 60:40, 65:35, 70:30, 80:20, 85:15)  
 Acetonitrile (MeCN) : Milli-Q-water: Formic acid 
(90:10:1, 60:40:0.1, 60:40:2.5)  
 Methanol : Milli-Q-water 
(70:30) 
 Acetonitrile (MeCN) : Methanol: Milli-Q-water 
(20:65:15) 
Semi-preparative column Acetonitrile (MeCN) : Milli-Q-water  
(70:30, 40:60)  
 
Semi-preparative column:  Phenomenex gemini 10 µ C18 110A 250 x 10 mm; guard column:  
Phenomenex gemini 5 µ C18 10 x 10 mm.  Samples were dissolved in pure organic solvent 
or dissolved in mobile phase and filtered by 17 mm SYR Filter Nylon 0.45 µm before 
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injection onto HPLC using a 100 µL loop.  Acetonitrile: Milli-Q-water (70:30, 40:60) was 
used as the mobile phase at flow rate 5 mL/min. 
 
All the HPLC experiments were performed using isocratic elution.  HPLC grade methanol 
and acetonitrile were purchased from Fisher and filtered through a Whatman® Nylon 
membrane prior to use.  The acidic solution (0.1% formic acid) was filtered through Milli-Q 
Plus PF.  The aqueous mobile system was shaken vigorously and then degassed on a Decon 
ultrasonicator for 30 min before use.  The mobile phases that have been used are shown in 
Table 2.3. 
 
NMR spectra were obtained on either JEOL GX 270 (operating at 270 MHz for 1H and 67.8 
MHz for 13C) or a JEOL EX 400, Varian Mercury VX 400 (operating at 400 MHz for 1H and 
100.8 MHz for 13C) spectrometer, in solution of CDCl3 (~0.5 mL) unless otherwise stated.  
Chemical shifts values are recorded in part per million (ppm) on the δ scale.  Spectra were 
referenced internally using either the residual solvent resonance for 13C or to TMS (0.0 ppm) 
for 1H.  COSY and DEPT spectra were all recorded using automated programmes.  Coupling 
constants are reported in Hertz (Hz, absolute values) and the multiplicities abbreviated as:  s 
(singlet), d (doublet), t (triplet), q (quartet), quin (quintet) and m (multiplet).  The 
abbreviation br (broad) is used to indicate significant broadening due to rapid exchange or 
unresolved fine coupling.  The format used for reporting 1H NMR spectra is:  chemical shift 
(integration, multiplicity, coupling constant and assignment). 
 
High Resolution-Electrospray ionization-Mass Spectrometry (HR-ESI-MS) was performed 
on a BRUKER DALTONICS micrOTOF instrument in the Department of Pharmacy and 
Pharmacology, University of Bath. 
 
2.2  o-Phthalaldehyde (OPA)/Mercaptoethanol (MCE) derivatization 
 
Optimization of derivatization conditions 
 
The optimizations of derivatization conditions were done by: 
1. Optimisation the pH of borate buffer to the OPA/MCE reagent using the series, pHs 
4.0, 4.5,5.0, 5.5, 6.0, 6.5, 7.0, 8.3, 9.3 and 10.5. 
2. Optimisation of the molar ratio of OPA/MCE reagent to sample solution. 
3. Optimization of the mole ratio of MCE (mM) to 1 mM of OPA, using the series, 1.4, 
2.8, 5.7, 10.0, 11.4 and 17.0. 
4. Optimisation of the reaction time using the series, 1, 5, 10, 20, 30, 40, 50, 60 and 80 min. 
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5. Optimisation of the condition for maximum stability of the derivatives of amine-
OPA/MCE at 20oC and 1oC. 
6. Optimization the mobile phase for HPLC by using different ratio of acetonitrile: Milli-
Q-water range from 40:60, 70:30, 80:20, 85:15, 90:10 (% v/v). 
 
Optimization the pH of borate buffer 
 
OPA/MCE reagent 
 
The OPA/MCE reagents were prepared at least 90 min before use and stored no longer than 
3 days in the refrigerator (4oC).  The stock solution of OPA contained 0.75 g of OPA in 50.0 
mL methanol is referred to below as methanolic OPA solution. 
 
The mole ratio of [OPA]:[MCE] = [1:10] was obtained by mixing, in order of listing, 2.5 mL 
methanolic OPA, 2.0 mL borate buffer (at various pH, using the series, pHs 4.0, 4.5,5.0, 5.5, 
6.0, 6.5, 7.0, 8.3, 9.3 and 10.5) and 200 µL MCE and completed with methanol up to 10.0 
mL. 
 
Borate buffer solution 
 
Borate buffer pH 4.0 -10.5 (Ref Appendix I E, A69, British Pharmacopoeia 1988) 
A series of borate buffer (200 mM) from pH 4.0 to 10.5 was prepared by the following 
procedure.  To 50 mL of a solution containing 0.6189 g of boric acid and 0.7456 g of 
potassium chloride, 20.0 mL of 0.2 M sodium hydroxide was added.  The pH was adjusted 
by addition of boric acid solution or sodium hydroxide solution using a pH meter measure 
the pH then diluting to 200 mL with water. 
 
Sample solution 
 
Sample solutions of amines were prepared with distilled water at the concentration of 5.0 
mM.  Ethylamine and 1-butylamine were used in the optimisation the pH of borate buffer. 
 
100 µl of 5 mM ethylamine and 100 µL of 200 mM borate buffer solution pH 4.0, 4.5, 5.0, 
5.5, 6.0, 6.5, 7.0, 8.3, 9.3, and 10.5 were pipetted into 10 glass vials and mixed well.  100 µL 
of OPA/MCE reagent = [1:10] was added to each vial and left to react for 1 min.  Then this 
solution was injected onto the HPLC.  All the steps were repeated with 1-butylamine. 
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HPLC system 
 
Column: Phenomenex hypersil C18 5µ 150 x 4.60 mm. 
Mobile phase: Acetonitrile: Milli-Q-water (60:40) the mobile phase was filtered through a 
0.45 µm nylon membrane filter under vacuum and degassed in an ultrasonic 
bath for 30 min, used at a flow rate of 1 mL/min. 
Detection Fluorescence detection at OPA wavelength λex = 340 nm, λem = 450 nm. 
 UV detector at λmax = 340 nm. 
 
Optimization for the mole ratio of MCE to 1 mM of OPA 
 
OPA/MCE reagent 
 
The OPA derivative reagent was prepared by dissolving 0.134 g of OPA into 5.00 mL 
methanol, then adding MCE in series of 100, 200, 400, 700, 800, 1200 µL, which is equal to 
the mole ratio of [OPA]:[MCE] = [1:1.4], [1:2.8], [1:5.7], [1:10], [1:11.4] and [1:17.0] 
respectively and then diluting to 25.0 mL with borate buffer (pH 10.5). 
 
Borate buffer solution 
 
Borate buffer pH 4.0-10.5 (Ref Appendix I E, A69, British Pharmacopoeia 1988).   
A series of Borate Buffers (200 mM) 10.5 was prepared by the following method:  to a 50 
mL of a solution containing 0.6189 g of boric acid and 0.7456 g of potassium chloride, 20.0 
mL of 0.2 M sodium hydroxide was added.  The pH was adjusted by addition of boric acid 
solution or sodium hydroxide solution using a pH meter to measure the pH then diluting to 
200 mL with water. 
 
Sample solution 
 
1-Butylamine (5.0 mM in distilled water) was used in the optimisation the mole ratio of 
OPA/MCE reagent composition. 
 
1. 100 µL of 5 mM 1-butylamine and 100 µL of 200 mM borate buffer solution pH 10.5 
were pipetted into 6 glass vials and mixed well. 
2. 100 µL of OPA/MCE reagent [1:1.4], [1:2.8], [1:5.7], [1:10], [1:11.4] and [1:17.0] was 
added to each vial left to react for 1 min then injected onto HPLC. 
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HPLC system 
 
Column: Phenomenex hypersil C18 5µ 150 x 4.60 mm. 
Mobile phase: Acetonitrile: Milli-Q-water (60:40) the mobile phase was filtered through a 
0.45 µm nylon membrane filter under vacuum and degassed in an ultrasonic 
bath for 30 min, used at a flow rate of 1 mL/min. 
Detection Fluorescence detection at OPA wavelength λex = 340 nm, λem = 450 nm. 
 UV detector at λmax = 340 nm. 
 
Optimizing the mole ratio of OPA/MCE to amines 
 
OPA/MCE reagent 
 
The OPA derivative reagent was prepared by dissolving 0.268 g of OPA in 5.00 mL 
methanol, then adding MCE in series of 1.4 mL, which is equal to the mole ratio of 
[OPA]:[MCE] = [1:10] and then diluting to 25.0 mL with borate buffer (pH 10.5).  The 
concentration of OPA is 80 mM, then this solution was diluted by borate buffer (pH 10.5) to 
obtain the concentration series of 1 mM, 5 mM, 10 mM, 20 mM and 40 mM. 
 
Sample solution 
 
1-Butylamine (5.0 mM in distilled water) was used in the optimisation of the mole ratio of 
OPA/MCE reagent composition, derivatized as follows:  100 µL of 5 mM 1-butylamine and 
100 µL of 200 mM borate buffer solution pH 10.5 were pipetted into 6 glass vials and mixed 
well.  100 µL of OPA/MCE reagent concentration at 1, 5, 10, 20, 40 or 80 mM was added to 
each vial and left to react for 1 min.  After 1 min, this solution was injected onto HPLC. 
 
HPLC system 
 
Column: Phenomenex hypersil C18 5µ 150 x 4.60 mm. 
Mobile phase: Acetonitrile: Milli-Q-water (60:40) the mobile phase was filtered through a 
0.45 µm nylon membrane filter under vacuum and degassed in an ultrasonic 
bath for 30 min, used at a flow rate of 1 mL/min. 
Detection Fluorescence detection at OPA wavelength λex = 340 nm, λem = 450 nm. 
 UV detector at λmax = 340 nm. 
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Stability of amines-OPA/MCE derivatives: 
 
After the procedure had been optimized, the following OPA derivative reagent was used 
routinely, prepared by dissolving OPA (0.134 g) in 5.00 mL methanol, then adding MCE 
(700 µL) which is equal to the mole ratio of [OPA]:[MCE] = [1:10] and then diluting to 25.0 
mL with borate buffer (pH 10.5).  The concentration of OPA = 1 mmol, in 25 mL = 40 mM.  
The reagent was kept in the refrigerator (4oC) and used within 7 days. 
 
Sample solution 
 
The following amines were prepared as aqueous solutions at a concentration of 1 mM:  
ethylamine, 1-butylamine, 1,4-diaminobutane, 1,5-diaminopentane, 1,7-diaminoheptane.  
100 µl of 1 mM ethylamine and 100 µl of 200 mM borate buffer solution pH 10.5 were 
pipetted into a glass vials and mixed well.  Then 100 µl of OPA/MCE reagent (routine 
working reagent) was added to each vial left to react for 1 min and this solution was injected 
onto HPLC at 5, 10, 20, 30, 60, 70, 80 and 90 min (after reaction time).  All the steps were 
repeated with other four amines. 
 
Temperature and stability of the derivatives 
 
An aqueous solution of 1,4-diaminobutane (100 µL, 1 mM) was derivatized with borate 
buffer solution (100 µL, 200 mM, pH 10.5), pipetted into 2 glass vials and mixed well.  100 
µL of OPA/MCE reagent (routine working reagent) was added to each vial, left to react for 1 
min, then one vial was kept at 1oC and the other at 20oC.  After reaction, the solutions were 
injected after 5, 10, 20, 30, 60, 70, 80 and 90 min onto HPLC. 
 
HPLC system 
 
Column: Phenomenex hypersil C18 5µ 150 x 4.60 mm. 
Mobile phase: Acetonitrile: Milli-Q-water (70:30) the mobile phase was filtered through a 
0.45 µm nylon membrane filter under vacuum and degassed in an ultrasonic 
bath for 30 min, used at a flow rate of 1 mL/min. 
Detection Fluorescence detection at OPA wavelength λex = 340 nm, λem = 450 nm. 
 UV detector at λmax = 340 nm. 
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Polyamines-OPA/MCE derivatives 
 
Sample solution 
Amine solutions (concentration from 0.2-1 mM, 100 µl) were prepared.  The following 
amines were investigated:  ethylamine, 1-butylamine, 1,4-diaminobutane, 1,5-
diaminopentane, 1,7-diaminoheptane, 1,8-diaminooctane, 1,9-diaminononane, 1,12-
diaminododecane, spermidine, spermine, N4,N9-didecanoyl spermine, N4,N9-dilinoleoyl 
spermine, glucosamine, kanamycin and neomycin. 
 
Derivatization method 
 
1 100 µL of 5 mM 1-butylamine and 100 µL of 200 mM borate buffer solution pH 10.5 
were pipetted into 6 glass vials and mixed well. 
2 100 µL of OPA/MCE reagent (routine working reagent) was added to each vial left to 
react for 1 min. 
3 After 1 min, this solution was injected onto HPLC. 
 
HPLC system 
 
Column: Phenomenex hypersil C18 5µ 150 x 4.60 mm. 
Mobile phase: Acetonitrile: Milli-Q-water (40:60, 70:30, 80:20, 90:10) the mobile phase 
was filtered through a 0.45 µm nylon membrane filter under vacuum and 
degassed in an ultrasonic bath for 30 min, used at a flow rate of 1 mL/min. 
Detection Fluorescence detection at OPA wavelength λex = 340 nm, λem = 450 nm. 
 UV detector at λmax = 340 nm. 
 
Calibration curve obtained from amine-OPA/MCE derivatives 
 
Sample solution 
 
1-Butylamine, 1,4-diaminobutane, 1,5-diaminopentane, 1,7-diaminoheptane, spermidine and 
kanamycin over the concentration range 0.01 – 10 mM were examined to obtain the 
calibration curves. 
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Derivatization method 
 
1 100 µL of various concentration of 1-butylamine and 100 µL of 200 mM borate buffer 
solution pH 10.5 were pipetted into 6 glass vials and mixed well. 
2 100 µL of OPA/MCE reagent (routine working reagent) was added to each vial left to 
react for 1 min. 
3 After 1 min, this solution was injected onto HPLC. 
4 All the steps were repeated with other models (1,4-diaminobutane, 1,5-
diaminopentane, 1,7-diaminoheptane,spermidine, kanamycin). 
5 A plot of peak area versus the concentration of amines was obtained with R2 at least 
0.99 using Microsoft excel. 
 
HPLC system 
 
Column: Phenomenex hypersil C18 5µ 150 x 4.60 mm. 
Mobile phase: Acetonitrile: Milli-Q-water (40:60, 70:30, 90:10) the mobile phase was 
filtered through a 0.45 µm nylon membrane filter under vacuum and 
degassed in an ultrasonic bath for 30 min, used at a flow rate of 1 mL/min. 
Detection Fluorescence detection at OPA wavelength λex = 340 nm, λem = 450 nm. 
 UV detector at λmax = 340 nm. 
 
Measurement of relative fluorescence yield experiment 
 
Sample solution 
 
The model amines:  1-butylamine, 1,4-diaminobutane, 1,5-diaminopentane, 1,7-
diaminoheptane were used at a concentration of 0.01-0.1 mM. 
1 The sample amines were derivatized by using routine working reagent of OPA/MCE 
by varying the concentration of amine samples from 0.01 to 0.1 mM. 
2 This solution was injected onto HPLC. 
3 A comparison of fluorescence yields of the model series was obtained by comparison 
between the peak area of fluorescence intensity and peak area of UV absorbance. 
4 A plot of fluorescence intensity against absorbance and the FI/UV equation was 
obtained. 
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HPLC system 
 
Column: Phenomenex hypersil C18 5µ 150 x 4.60 mm. 
Mobile phase: Acetonitrile: Milli-Q-water (70:30) the mobile phase was filtered through a 
0.45 µm nylon membrane filter under vacuum and degassed in an ultrasonic 
bath for 30 min, used at a flow rate of 1 mL/min. 
Detection Fluorescence detection at OPA wavelength λex = 340 nm, λem = 450 nm.  
UV detector at λmax = 340 nm. 
 
OPA/MCE derivatives of a series of non-viral gene therapy (NVGT) vectors 
 
10 mM of N4,N9-didecanoyl spermine was dissolved in 1 mL of  methanol then diluted to 5 
mL with distilled water. 
10 mM of N4,N9-dilinoleoyl spermine was dissolved in 1 mL of methanol then diluted to 5 
mL with distilled water. 
 
1 100 µL of N4,N9-didecanoyl spermine and 100 µL of 200 mM borate buffer solution 
pH 10.5 were pipetted into a glass vials and mixed well. 
2 100 µL of OPA/MCE reagent (routine working reagent) was added to each vial left to 
react for 1 min. 
3 After 1 min, this solution was injected onto HPLC. 
4 All the steps were repeated with another model (N4,N9-dilinoleoyl spermine). 
 
HPLC system 
 
Column: Phenomenex hypersil C18 5µ 150 x 4.60 mm. 
Mobile phase: Acetonitrile: Milli-Q-water (90:10) the mobile phase was filtered through a 
0.45 µm nylon membrane filter under vacuum and degassed in an ultrasonic 
bath for 30 min, used  at a flow rate of 1 mL/min. 
Detection Fluorescence detection at OPA wavelength λex = 340 nm, λem = 450 nm.  
UV detector at λmax = 340 nm. 
 
OPA/MCE derivatives of Aminoglycosides 
 
Sample solutions of aminoglycosides kanamycin and neomycin were prepared with distilled 
water the concentration range 1.0 – 10.0 mM. 
 - 30 - 
Optimizing the reaction time of OPA/MCE to kanamycin 
 
1 100 µL of 1 mM kanamycin and 100 µL of 200 mM borate buffer solution pH 10.5 
were pipetted into 4 glass vials and mixed well. 
2 100 µL of OPA/MCE reagent (routine working reagent) was added to each vial left to 
react for 1, 10, 35, 45 min. 
3 After the reaction time, these solutions were injected onto HPLC. 
 
Optimizing the mole ratio of OPA/MCE to amines 
 
1 100 µL of 1 mM kanamycin and 100 µL of 200 mM borate buffer solution pH 10.5 
were pipetted into 7 glass vials and mixed well. 
2 100 µL of OPA/MCE reagent concentration 1 mM, 2 mM, 4 mM, 5 mM, 10 mM, 15 
mM and 25 mM. was added to each vial left to react for 10 min. 
3 After 10 min, this solution was injected onto HPLC. 
4 All steps were repeated with another model (neomycin). 
 
HPLC system 
 
Column: Phenomenex hypersil C18 5µ 150 x 4.60 mm. 
Mobile phase: Acetonitrile: Milli-Q-water (40:60) the mobile phase was filtered through a 
0.45 µm nylon membrane filter under vacuum and degassed in an ultrasonic 
bath for 30 min, used at a flow rate of 1 mL/min. 
Detection Fluorescence detection at OPA wavelength λex = 340 nm, λem = 450 nm.  
UV detector at λmax = 340 nm. 
 
High Resolution-Electrospray ionization-Mass Spectrometry (HR-ESI-MS) 
 
The expected molecular masses of some of the amine-OPA/MCE derivatives were confirmed 
by collection of the peak eluent and examination by HR-ESI-MS. 
 
2.3  o-Phthalaldehyde (OPA)/Mercaptoethanol (MCE)/9-fluorenylmethyl 
chloroformate (FMOC Cl) derivatization 
 
A two step derivatization process was performed by applying the OPA/MCE reagent 
followed by FMOC Cl reagent.  By this method, molecules that contained both primary and 
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secondary amines such as spermidine and spermine should be fully labelled at their primary 
amines by OPA/MCE and their secondary amines by FMOC.  Use the working OPA/MCE 
as described previously.  FMOC Cl was in dissolved acetonitrile (4 mM).  Amine samples:  
Spermidine, spermine (concentration from 0.1 mM-1 mM, 10-100 µL). 
 
Derivatization procedure 
 
100 µL Amine solution was rapidly mixed with 100 µL OPA/MCE reagent (routine working 
reagent) at 20oC.  After 2 min (+/- 20 s), 100 µL of FMOC reagent was added and left for 2 
min, then 50 µL were injected onto the HPLC.  A blank was performed without amine. 
 
HPLC system 
 
Column: Phenomenex hypersil C18 5µ 150 x 4.60 mm. 
Mobile phase: consisted of acetonitrile: Milli-Q-water (65:35, 70:30, 80:20, 85:15) the mobile 
phase was filtered through a 0.45 µm nylon membrane under vacuum and 
degassed, used at a flow rate of 1 mL/min. 
Detection Fluorescence detection at FMOC wavelength λex = 264 nm, λem = 310 nm 
and at OPA wavelength λex = 340 nm, λem = 450 nm. 
 
2.4  Fluorescamine derivatization 
 
A stock solution of fluorescamine was prepared by dissolving 0.2 g fluorescamine in 10 mL 
of acetonitrile.  To 50 mL of a solution containing 0.6189 g of boric acid and 0.7456 g of 
potassium chloride add 36.85 mL of 0.2 M sodium hydroxide, adjust pH to 9.5 and dilute to 
200 mL with water.  Borate buffer pH 9.5 (Ref Appendix I E, A69, British Pharmacopoeia 
1988).  Using 1-butylamine, 1,4-diaminobutane, 1,5-diaminopentane, 1,7-diaminoheptane, 
serial dilutions of amine samples in water were prepared from concentration 0.1-2 mM, 0.1 
mL, added 0.4 mL of 0.4 a borate buffer (pH 9.5), 0.1 mL of water and 0.5 mL of 
fluorescamine solution.  The solution was left to react at 20oC for 5 min then injected onto 
the HPLC. 
 
HPLC system 
 
Column: Phenomenex luna C18 5µ 150 x 4.60 mm. 
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Mobile phase: consisted of methanol: Milli-Q-water (40:60, 50:50, 70:30) the mobile phase 
was filter through a 0.45 µm nylon membrane filter under vacuum and 
degassed, used at a flow rate of l/min. 
Detection Fluorescence detection at fluorescamine wavelength, λex = 390 nm, λem = 
486 nm.  UV detector at λmax = 390 nm. 
 
Measurement of relative fluorescence yield experiment 
 
Model amines:  1-butylamine, 1,4-diaminobutane, 1,5-diaminopentane, 1,7-diaminoheptane 
were dissolved in water to a concentration of 0.01- 0.1 mM.  A comparison of fluorescence 
yields of the model series of amines was carried out by the following procedure: 
 
1. The relevant HPLC peak was collected over 10 – 20 injection (depending upon the 
intensity of the peak). 
2. The identity and stability of the product were confirmed by HR-ESI-MS. 
3. A series of dilutions was prepared using the HPLC mobile phase:  acetonitrile: Milli-
Q-water (70:30). 
4. Absorbance at λex was measured by UV-VIS spectrophotometer and fluorescence 
intensity λem was measured by spectrofluorometer for each compound. 
5. For each compound a plot of Fluorescence Intensity against Absorbance was prepared. 
 
Fluorescamine and glucosamine 
 
A stock solution of fluorescamine was prepared by dissolving 0.2 g fluorescamine in 10 mL 
of acetonitrile.  Amine sample:  glucosamine (0.2 mM).  Borate buffer pH 9.5 (Ref Appendix 
I E, A69, British Pharmacopoeia 1988).  To 50 mL of a solution containing 0.6189 g of boric 
acid and 0.7456 g of potassium chloride add 36.85 mL of 0.2 M sodium hydroxide, adjust to 
pH 9.5 and dilute to 200 mL with water. 
 
Derivatization procedure 
 
1. 100 µL of 2 mM glucosamine in aq. solution and 0.4 mL of borate buffer (pH 9.5), 
were pipetted into a glass vial and mixed well. 
2. 0.5 mL of fluorescamine solution was added and left to react at 20oC for 5 min. 
3. This solution was injected onto the HPLC. 
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HPLC system 
 
Column: Phenomenex luna C18 5µ 150 x 4.60 mm 
Mobile phase: consisted of methanol: Milli-Q-water (30:70) the mobile phase was filter 
through a 0.45 µm nylon membrane filter under vacuum and degassed, used 
at a flow rate of 1 mL/min. 
Detection Fluorescence detection at fluorescamine wavelength, λex = 390 nm, λem = 
486 nm.  UV detector at λmax = 390 nm. 
 
The expected molecular masses of some of the amine-fluorescamine derivatives were 
confirmed by collection of the peak eluent and examination by HR-ESI-MS. 
 
2.5  9-Fluorenylmethyl chloroformate (FMOC Cl) derivatization 
 
Optimization of the FMOC Cl derivatization method 
 
The optimization was done by:  
1. Optimisation of the reaction time. 
2. Optimisation of the concentration of FMOC Cl reagent. 
3. Optimization for the effect of pH of borate buffer 
4. Methods to stop the reaction of FMOC Cl. 
5. Optimization of the mobile phase for HPLC by using different ratio of acetonitrile: 
Milli-Q-water range from 60:40, 70:30, 80:20, 85:15 (%v/v), using C-18 Phenomenex 
luna analytical reverse phase column. 
6. Stability of amine-FMOC derivatives. 
 
FMOC Cl solution was prepared by dissolving FMOC Cl reagent in acetonitrile to obtain the 
concentration series of 1, 2, 4, 6, 8, 10 and 40 mM.  The amines for optimization procedure 
were 1-butylamine (monoamine) and 1,5-diaminopentane (diamine).  Both were prepared at 
the concentration of 1mM in Milli-Q-water. 
 
Buffer preparation 
 
A series of borate buffers pH 4.0–10.5 (200 mM) was prepared by adding 20.0 mL of 0.2 M 
sodium hydroxide to 50 mL of a solution containing 0.6189 g of boric acid and 0.7456 g of 
potassium chloride.  The pH was adjusted to the required value by the addition of a solution 
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of boric acid or sodium hydroxide and using a pH meter measure the pH, then diluting to 200 
mL with water (Ref Appendix I E, A69, British Pharmacopoeia 1988). 
 
Optimization of the reaction time 
 
1. 100 µL of 1 mM 1-butylamine and 100 µL of 200 mM borate buffer solution pH 9.0, 
were pipetted into 8 glass vials and mixed well. 
2. 100 µL of 4 mM FMOC Cl reagent was added to each vial and left to react for 1, 5, 10, 
20, 30, 40, 50 and 60 min. 
3. At the appropriate time, 50 µL of 20 mM L-alanine solution (L-alanine 0.018 g in 10 
mL of acetonitrile) was added to stop the reaction and left for another 5 min. 
4. 100 µL of methanol was added to the vial and mixed well using a vortex mixer. 
5. 200 µL of this solution was diluted with methanol to 1.00 mL. 
6. This solution was injected onto HPLC. 
7. All the steps were repeated with another model (1,5-diaminopentane). 
 
Optimisation of the concentration of FMOC Cl reagent 
 
1. 100 µL of 1 mM 1-butylamine (and then 1,5-diaminopentane) and 100 µL of 200 mM 
borate buffer solution pH 9.0, were pipetted into 8 glass vials and mixed well.  
2. 100 µL of 1, 2, 4, 6, 8 and 10 mM FMOC Cl reagent were added to separate vials and 
left to react for 5 min. 
3. After 5 min, 50 µL of 20 mM alanine solution was added to stop the reaction and left 
for another 5 min. 
4. 100 µL of methanol was added to the vial and mixed well using a vortex mixer. 
5. 200 µL of this solution was diluted with methanol to 1.00 mL. 
6. This solution was injected onto the HPLC. 
 
Optimization for the effect of pH of borate buffer 
 
1 100 µL of 1 mM 1-butylamine and 100 µL of 200 mM borate buffer solution pH 4.0, 
4.5, 5.0, 5.5, 6.0, 6.5, 7.0, 8.0, 8.5, 9.0, 9.5, 10.0 and 10.5 were pipetted into 13 glass 
vials and mixed well. 
2 100 µL of 4 mM FMOC Cl reagent was added to each vial left to react for 5 min. 
3 After 5 min, 50 µL of 20 mM alanine solution was added to stop the reaction and left 
for another 5 min. 
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4 100 µL of methanol was added to the vial and mixed well using vortex mixer. 
5 200 µL of this solution was diluted with methanol to 1.00 mL. 
6 This solution was injected onto HPLC. 
7 All the steps were repeated with another model (1,5-diaminopentane). 
 
Methods to terminate the reaction of FMOC Cl 
 
Three main methods of termination of the reaction and removal of the excess FMOC Cl were 
investigated.  In method 1, the excess of FMOC was removed by the reaction with alanine 
100 mM.  Method 2 removed the excess of FMOC Cl by extraction of amine-FMOC 
derivatives with pentane after derivatization.  Method 3 used glacial acetic acid to stop the 
reaction at the desired time by acidifying the medium mixture. 
 
Eight experiments were designed to examine and compare the methods to terminate the 
reaction of FMOC Cl as: 
 
Experiment 1  Control experiment 
 
1. 100 µL 5 mM 1-butylamine and 100 µL of 200 mM borate buffer pH 9.5 were placed 
in a glass vial. 
2. 100 µL 10 mM FMOC Cl reagent was added and left to react for 5 min. 
3. 200 µL methanol was added to this solution, and mixed well. 
4. 200 µL was taken and diluted by 800 µL mobile phase [acetonitrile: Milli-Q-water, 
(70:30)].  This was injected onto the HPLC. 
 
Experiment 2  Termination of the reaction with alanine 
 
1. 100 µL 5 mM 1-butylamine and 100 µL of 200 mM borate buffer pH 9.5 were placed 
in a glass vial. 
2. 100 µL 10 mM FMOC Cl reagent was added and left to react for 5 min. 
3. 100 µL 100 mM alanine solution was added and left for 1 min then 100 µL methanol 
was added to this solution. 
4. 200 µL was taken and diluted by 800 µL mobile phase [acetonitrile: Milli-Q-water 
(70:30)].  This was injected onto the HPLC. 
 
 
 - 36 - 
Experiment 3  Termination of the reaction with glacial acetic acid 
 
1. 100 µL 5 mM 1-butylamine and 100 µL of 200 mM borate buffer pH 9.5 were placed 
in a glass vial. 
2. 100 µL 10 mM FMOC Cl reagent was added and left to react for 5 min. 
3. 100 µL glacial acetic acid was added and left for 1 min then 100 µL methanol was 
added to this solution. 
4. 200 µL was taken and diluted by 800 µL mobile phase [acetonitrile: Milli-Q-water 
(70:30)].  This was injected onto the HPLC. 
 
Experiment 4  Termination of the reaction with alanine and glacial acetic acid 
 
1. 100 µL 5 mM 1-butylamine and 100 µL of 200 mM borate buffer pH 9.5 were placed 
in a glass vial. 
2. 100 µL 10 mM FMOC Cl reagent was added and left to react for 5 min. 
3. 100 µL 100 mM alanine solution was added and left for 1 min then 100 µL glacial 
acetic acid was added and left for 1 min. 
4. 200 µL was taken and diluted by 800 µL mobile phase (acetonitrile: Milli-Q-water 
(70:30)].  This was injected onto the HPLC. 
 
Experiment 5  Termination of the reaction by extraction with pentane 
 
1. 1 mL of 5 mM 1-butylamine and 1 mL of 200 mM borate buffer pH 9.5 were placed in 
a glass vial. 
2. 1 mL of 10 mM FMOC Cl reagent was added and left to react for 5 min. 
3. This solution was extracted with pentane 3 x 5 mL. 
4. The pentane phase was combined and evaporated. 
5. 5 mL of methanol was used to dissolve the residue. 
6. 200 µL of this solution was taken and diluted by 800 µL mobile phase [acetonitrile: 
Milli-Q-water (70:30)].  This was injected onto the HPLC. 
 
Experiment 6  Termination of the reaction with alanine and extraction with pentane 
 
1. 1 mL of 5 mM 1-butylamine and 1 mL of 200 mM borate buffer pH 9.5 were placed in 
a glass vial. 
2. 1 mL of 10 mM FMOC Cl reagent was added and left to react for 5 min. 
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3. 1 mL 100 mM alanine solution was added and left for 1 min. 
4. This solution was extracted with pentane 3 x 5 mL. 
5. The pentane phase was combined and evaporated. 
6. 5 mL of methanol was used to dissolve the residue. 
7. 200 µL of this solution was taken and diluted by 800 µL mobile phase [acetonitrile: 
Milli-Q-water (70:30)].  This was injected onto the HPLC. 
 
Experiment 7  Termination of the reaction with glacial acetic acid and extraction with 
pentane 
 
1. 1 mL of 5 mM 1-butylamine and 1 mL of 200 mM borate buffer pH 9.5 were placed in 
a glass vial. 
2. 1 mL of 10 mM FMOC Cl reagent was added and left to react for 5 min. 
3. 1 mL glacial acetic acid was added and left for 1 min (pH of the solution = 3.35). 
4. This solution was extracted with pentane 3 x 5 mL. 
5. The pentane phase was combined and evaporated. 
6. 5 mL of methanol was used to dissolve the residue. 
7. 200 µL of this solution was taken and diluted by 800 µL mobile phase [acetonitrile: 
Milli-Q-water (70:30)].  This was injected onto the HPLC. 
 
Experiment 8  Termination of the reaction with alanine and glacial acetic acid then 
extraction with pentane 
 
1. 1 mL of 5 mM 1-butylamine and 1 mL of 200 mM borate buffer pH 9.5 were placed in 
a glass vial. 
2. 1 mL of 10 mM FMOC Cl reagent was added and left to react for 5 min. 
3. 1 mL 100 mM alanine solution was added and left for 1 min then 1 mL glacial acetic 
acid was added and left for 1 min (pH of the solution = 3.05). 
4. This solution was extracted with pentane 3 x 5 mL. 
5. The pentane phase was combined and evaporated. 
6. 5 mL of methanol was used to dissolve the residue. 
7. 200 µL of this solution was taken and diluted by 800 µL mobile phase (acetonitrile: 
Milli-Q-water (70:30)].  This was injected onto the HPLC. 
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Calibration curve of amine-FMOC derivatives 
 
Preparation of sample solutions 
 
Amine samples were ethylamine, 1-butylamine (monoamine), 1,4-diaminobutane, 1,5-
diaminopentane, 1,7-diaminoheptane, piperidine, piperazine, spermidine, spermine 
(polyamine), kanamycin, neomycin (aminoglycosides) 
 
Stock solutions of sample were prepared by dissolving the suitable amount of each in Milli-
Q-water.  A range of concentrations from 1 mM – 10 mM were prepared from the stock 
solution by dilution with Milli-Q-water.  All solutions were stored in the dark at 2oC.   
 
Working Method for FMOC derivatization 
 
1. 1 mL of sample solution and 1 mL of 200 mM borate buffer pH 9.5 were placed in a 
glass vial. 
2. 1 mL of 40 mM FMOC Cl reagent was added and left to react for 5 min. 
3. 1 mL 100 mM alanine solution was added and left for a further 1 min. 
4. This solution was extracted with pentane 3 x 5 mL. 
5. The pentane phase was combined and evaporated. 
6. 5 mL of methanol was used to dissolve the residue. 
7. 200 µL of this solution was taken and diluted by 800 µL mobile phase [acetonitrile: 
Milli-Q-water (70:30)]. 
8. This was injected onto the HPLC. 
9. A calibration curve of each amine-FMOC derivative was plotted. 
 
HPLC system 
 
Column: Phenomenex luna C18 5µ 150 x 4.60 mm. 
Mobile phase: Methanol: Milli-Q-water (60:40, 70:30, 80:20, 85:15) the mobile phase was 
filtered through a 0.45 µm nylon membrane filter under vacuum and 
degassed in an ultrasonic bath for 30 min, used at a flow rate of 1 mL/min. 
Detection Fluorescence detection at FMOC wavelength, λex = 264 nm, λem = 310 nm.  
UV detector at λmax = 264 nm. 
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Stability of amine-FMOC derivatives 
 
1. 1 mL of 1 mM of 1-butylamine was reacted with 1 mL 4 mM FMOC Cl reagent for 5 
min in the presence of 1 mL of 200 mM borate buffer pH 9.5. 
2. The reaction was terminated by reaction with alanine and extraction with pentane (as 
in Experiment 7) then after pentane phase was combined and evaporated, 5 mL of 
methanol was used to dissolve the residue. 
3. This solution was injected onto HPLC at various times from 5-70 min then stored the 
sample at 20oC, and injected at day 2, day 3, day 4, day 5, 1 week and 2 weeks.  
Measure the peak area. 
 
Measurement of relative fluorescence yield 
 
Sample solution: 
 
The amines:  1,5-diaminopentane, 1,7-diaminoheptane, piperidine, piperazine and 
spermidine were dissolved in water.  A comparison of fluorescence yields of the model 
series of amines was carried out by the following procedure: 
 
1. The relevant HPLC peak was collected over 10 – 15 injection (depending upon the 
intensity of the peak). 
2. The identity and stability of the product was confirmed by HR-ESI-MS. 
3. A series of dilutions was prepared using the HPLC mobile phase [acetonitrile: Milli-Q-
water (70:30)]. 
4. Absorbance at λex and fluorescence intensity λem was measured for each compound. 
5. For each compound a plot of Fluorescence Intensity against Absorbance was prepared. 
 
Analysis of spermidine and spermine as their hexahydropyrimidine derivatives 
 
N-(4-Aminobutyl)hexahydropyrimidine 
 
Spermidine was converted into N-(4-aminobutyl)hexahydropyrimidine by the reaction with 
formaldehyde.  
1. Spermidine 1.0 g. (6.88 mmol) in a 100-mL round bottomed flask was dissolved in 
distilled water (25 mL).  The solution was cooled to 5oC. 
2. Aqueous formaldehyde (0.5 mL of 37% solution: 1 equiv.) was slowly added to the 
cold solution. 
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3. The mixture was stirred for 1 h at 20oC. 
4. The aqueous layer was saturated with solid sodium chloride (NaCl) and extracted four 
times with chloroform. 
5. The combined chloroform extracts were dried (MgSO4) filtered and concentrated to 
dryness by evaporator. 
6. Dilution to the desired concentration. 
 
After this the FMOC derivative was prepared by the standard method. 
 
1,4-(Dihexahydropyrimidine) butane 
 
Spermine was converted into 1,4-(dihexahydropyrimidine) butane by the reaction with 
formaldehyde.  
1. Spermine 1 g. (4.95 mmol) in a 100-mL round bottomed flask was dissolved in 
distilled water (25 mL).  The solution was cooled to 5oC. 
2. Aqueous formaldehyde (1 mL of 37% solution: 2 equiv.) was slowly added to the cold 
solution. 
3. The mixture was stirred for 1 hr at 20oC. 
4. The aqueous layer was saturated with solid sodium chloride and extracted four times 
with chloroform. 
5. The combined chloroform extracts were dried (MgSO4) filtered and concentrated to 
dryness. 
 
FMOC derivatives of experimental non-viral gene therapy (NVGT) vectors 
 
Stock solutions of samples N4,N9-didecanoyl spermine, N4,N9-didodecanoyl spermine and the 
synthetic intermediate diphthalimido-4,9-diazadodecane were prepared by dissolving the 
suitable amount of each in methanol.  A range of concentrations from 1 mM–10 mM were 
prepared from the stock solutions by dilution with methanol.  These were derivatized with 
FMOC using the standard method. 
 
HPLC system 
 
Column: Phenomenex luna C18 5µ 150 x 4.60 mm. 
Mobile phase: consisted of methanol: Milli-Q-water (85:15) the mobile phase was filter 
through a 0.45 µm nylon membrane filter under vacuum and degassed in an 
ultrasonic bath for 30 min at a flow rate of 1 mL/min. 
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Detection Fluorescence detection at FMOC wavelength, λex = 264 nm, λem = 310 nm.  
UV detector at λmax = 264 nm. 
 
FMOC derivatization of aminoglycosides 
 
Stock solutions of samples (kanamycin, paramomycin) were prepared by dissolving the 
suitable amount of each in Milli-Q-water.  A range of concentrations from 1 mM–10 mM 
were prepared from the stock solution by dilution with Milli-Q-water. 
 
1. 1 mL of sample solution and 1 mL of 200 mM borate buffer pH 9.5 in glass vial. 
2. 1 mL of 40 mM FMOC Cl reagent was added and left to react for 5 min. 
3. 1 mL 100 mM alanine solution was added and left for a further 1 min. 
4. This solution was extracted with pentane 3 x 5 mL. 
5. The pentane phase was combined and evaporated. 
6. 5 mL of methanol was used for dissolve the derivative. 
7. This solution was pipetted 200 µL and diluted by 800 µL mobile phase to get 1mL.  
Injected onto the HPLC. 
 
HPLC system 
 
Column: Phenomenex hypersil C18 5µ 150 x 4.60 mm 
Mobile phase: consisted of methanol: Milli-Q-water (60:40) the mobile phase was filter 
through a 0.45 µm nylon membrane filter under vacuum and degassed in an 
ultrasonic bath for 30 min, used  at a flow rate of 1 mL/min. 
Detection Fluorescence detection at FMOC wavelength, λex = 264 nm, λem = 310 nm.  
UV detector at λmax = 264 nm. 
 
2.6  Dansylation derivatization 
 
Stability of Dansyl chloride (DNS Cl) reagent 
 
1. DNS Cl was prepared in series of concentrations from 0.1 to 0.8 mM in acetone. 
2. These solutions were injected onto HPLC (5 replicates). 
3. A calibration curve was plotted. 
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HPLC conditions 
 
Column: Phenomenex luna C18, 150 mm x 4.6 mm. i.d. cartridge column (5 µm 
particle size) with guard column, H1-5C18. 
Mobile phase: Acetonitrile: Milli-Q-water (70:30) at a flow rate of 1.00 mL/min. 
Detector: Waters Fluorescence detector 470 at λex = 330 nm and λex = 510 nm 
  Jasco UV detector at λmax = 330 nm. 
 
Blank-DNS reaction 
 
1. 1 mL of Milli-Q-water and 1 mL of saturated sodium carbonate solution were placed in 
a glass vial. 
2. 1 mL of 10 mM DNS Cl reagent (in acetone) was added and left at 60oC for 15 min. 
3. The excess of DNS Cl was removed by 20 mM alanine solution, then the reaction was 
left for 5 min at 20oC. 
4. This solution was extracted with toluene 3 x 5 mL. 
5. The toluene phase was combined and evaporated. 
6. 2 mL of mobile phase [acetonitrile: Milli-Q-water (70:30)] was used to dissolve the 
residue.  This was injected onto the HPLC. 
7. The peaks were eluted by HPLC, collected and then analyzed by HR-ESI-MS. 
 
HPLC conditions 
 
HPLC column: Phenomenex luna C18, 150 mm x 4.6 mm. i.d. cartridge column 
(5µm particle size) with guard column, H1-5C18. 
Mobile phase:  Methanol: Milli-Q-water (70:30) at a flow rate of 1.00 mL/min. 
Detector:  Waters Fluorescence detector 470 at λex = 330 nm and λex = 510 nm. 
   Jasco UV detector at λmax = 330 nm. 
 
HPLC condition establishment of mobile phase 
 
In order to optimize the mobile phase for HPLC condition, the following mobile phases were 
used: 
 
Acetonitrile: Milli-Q-water (60:40) 
Acetonitrile: Milli-Q-water (70:30) 
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Acetonitrile: 0.1 % formic acid in Milli-Q-water (60:40) 
Acetonitrile: 2.5 % formic acid in Milli-Q-water (60:40) 
Methanol: acetonitrile: Milli-Q-water (65:20:15) 
 
Selection of the excitation and emission wavelengths of amine-DNS derivatives 
 
The amines:  1-butylamine, 1,5-diaminopentane, 1,7-diaminoheptane, 1,8-diaminooctane, 
piperidine, piperazine, spermidine and spermine were examined by collecting the HPLC 
eluate after dansylation. 
 
Method 
 
1. 1 mL of sample solution (concentration at 2 mM) and 1 mL of saturated sodium 
carbonate were placed in glass vial. 
2. 1.00 mL of 10 mM DNS Cl in acetone was added. 
3. The reactant solution was incubated in a water bath for 15 min at 60oC  
4. This solution was extracted with toluene 3 x 2 mL. 
5. The toluene phase was combined and evaporated to dryness. 
6. The residue was dissolved with 5 mL of methanol. 
7. This solution was injected onto HPLC and the eluent of the amine-DNS derivatives 
were collected and confirmed by HR-ESI-MS. 
8. The excitation and emission wavelengths of these elutes of amines-DNS derivatives 
were determined by using Hitachi Fluorescence F-2000 spectrophotometer and 
methanol was used as the blank. 
 
Optimization of DNS Cl derivatization method 
 
Method 1  Without removing the excess of DNS Cl 
 
The reaction solution consisted of 1.0 mL DNS Cl (5-40 mM) in acetone, 1.00 mL of sample 
solution (1-5 mM) and 1.0 mL of saturated sodium carbonate.  The reactant solution was 
incubated in a water bath for 15 min at 60oC.  This solution was injected directly without any 
procedure to remove the excess DNS Cl. 
 
 
 
 
 - 44 - 
Method 2  With alanine to remove the excess DNS Cl 
 
This derivatization method was based on the work of Minocha and Long (Minocha and 
Long, 2004).  To 1.0 sample solution, 1.0 mL of saturated aqueous of Na2CO3 was added to 
give a pH of 9-10 and then 1.0 mL DNS Cl solution was added.  The vials were capped, 
vortexed and incubated in a water bath at 60°C.  After 15 min, aqueous L-alanine (0.5 mL, 
10 mg/ mL) was added to react with the excess of DNS Cl, followed by further 5 min 
incubation.  The amine-DNS derivatives were extracted with toluene (3 x 4.0 mL), and the 
toluene phase evaporated to dryness under vacuum.  Methanol (7.0 mL) was added and 
vortexed for 2 min to redissolve the amine-DNS derivatives.  At this stage in the final 
development of dansylation method, mobile phase 2.0 mL was used to redissolve the amine-
DNS derivative.  The products were filtered through a 0.45 µm nylon syringe filter to 
remove particulate matter before being injected onto the HPLC column.  Blank HPLC runs 
were conducted using the procedure above without the amines. 
 
In all these methods, dansylation was performed in dark since the derivatives are light 
sensitive.  The solution of DNS Cl in acetone can be stored for 2 weeks at 4oC in the dark.  
After the dansylation reaction, the sample was kept in the dark or in dark vials. 
 
Optimization of DNS Cl derivatization method 
 
The aims of optimization condition of DNS derivatization (dansylation) were: 
1. Optimization of the pH of buffer for DNS Cl reaction with amines. 
2. Optimization of the ratio of molarity of DNS Cl reaction with amines. 
3. Optimization of the reaction time of DNS Cl with amines. 
4. Optimization of the temperature of DNS Cl of the reaction. 
 
Optimization of the pH of buffer for DNS Cl reaction with amines 
 
1. Method 2 was used to derivatize 1 mM 1-butylamine with 10 mM DNS Cl reagent 
using borate buffer at various pHs from 4.5-10.5. 
2. The vials were incubated at 60oC for 15 min. 
3. Toluene 3 x 5 mL was used to extract the DNS derivatives, then the combined organic 
phase was evaporated to dryness. 
4. The residue was dissolved with 2 mL methanol. 
5. This solution was injected onto HPLC. 
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Comparison between borate buffer pH 10.5 and saturated sodium carbonate 
 
1. Method 2 was used to derivatize 1 mM 1-butylamine with 10 mM DNS Cl reagent 
with borate buffer pH 10.5 and another vial was prepared in the same way but used 
saturated sodium carbonate. 
2. The vials were incubated at 60oC for 15 min. 
3. Toluene 3 x 5 mL was used to extract the DNS derivatives, then the combined organic 
phase was evaporated to dryness. 
4. The residue was dissolved with 2 mL methanol. 
5. This solution was injected onto HPLC. 
 
Optimization of the reaction temperature of dansylation 
 
1. Method 2 was used to derivatize 1 mM 1-butylamine with 10 mM DNS Cl reagent 
with 1 mL saturated sodium carbonate. 
2. The vials were incubated at various temperatures from 20, 40, 60, and 80oC for 15 
min. 
3. Toluene 3 x 5 mL was used to extract the DNS derivatives, then the combined organic 
phase was evaporated to dryness. 
4. The residue was dissolved with 2 mL methanol.  This solution was injected onto 
HPLC. 
 
Optimization of the reaction time of dansylation 
 
1. Method 2 was used to derivatize 1 mM 1-butylamine with 10 mM DNS Cl reagent 
with 1 mL saturated sodium carbonate. 
2. The vials were incubated at various times from 1, 5, 10, 15, 20, 30, 40, 50 and 60 min 
at 60oC. 
3. Toluene 3 x 5 mL was used to extract the DNS derivatives, then the combined organic 
phase was evaporated to dryness. 
4. The residue was dissolved with 2 mL methanol.  This solution was injected onto 
HPLC. 
 
Optimization of the concentration ratio of DNS Cl for dansylation  
 
For the optimization for DNS Cl concentration, DNS Cl solution of concentration range from 
1 to 100 mM was reacted with 1 mM solutions of ethylamine, 1-butylamine, 
 - 46 - 
phenylethylamine, 1,4-diaminobutane, 1,7-diaminoheptane, piperidine, piperazine, 
spermidine. 
 
1. Method 2 was used to derivatize these amines with various concentrations of DNS Cl 
reagent 1-100 mM, 1 mL saturated sodium carbonate was used to adjust the pH. 
2. The vials were incubated at 60oC for 15 min. 
3. Toluene 3 x 5 mL was used to extract the DNS derivatives, then the combined organic 
phase was evaporated to dryness. 
4. The residue was dissolved with 2 mL methanol.  This solution was injected onto 
HPLC. 
 
General derivatization of amines 
 
DNS Cl reagent was prepared in acetone (2 concentrations, 10 mM prepared by dissolving 20 
mg of DNS Cl in 10 mL acetone and 148 mM by dissolving 40 mg in 10 mL acetone). 
 
An alanine solution was prepared from 100 mg of L-alanine dissolved in 10 mL of Milli-Q-
water to give a concentration of 112 mM. 
 
Amines examined were:  1-butylamine, 1,4–diaminobutane, 1,5-diaminopentane, 1,6-
diaminohexane, 1,7-diaminoheptane, 1,8-diaminooctane, 1,9-diaminononane, 1,12-
diaminododecane, piperidine, piperazine, 1,4-diaminobutanol, 1,5-diaminopentanol, 
spermidine, spermine, thermospermine, N4,N9-didecanoyl spermine, N4,N9-dihexadecanoyl 
spermine, N1,N12-di-trifluoroacetyl- spermine, N1,N4,N9-tri-t-Boc-spermine derivative, N4,N9-
digeranoyl spermine, N4-decanoyl-N9-cholesteryl carbamate spermine, N4,N9-Oleoyl 
spermine and N4,N9-Dioctadecanoyl spermine.  Amine samples were dissolved in water from 
0.1 mM – 15 mM 
 
Amines for calibration curves 
 
The following amines were used to construct a calibration curve over the concentration range 
0.2-1 mM, all were in 5 replicates:  ethylamine, 1-butylamine, 1,4-diaminobutane, 1,7-
diaminoheptane, 2-phenylethylamine, piperidine, piperazine, spermidine, glucosamine, 
kanamycin.  Most of the semi-synthetic non-viral gene therapy agents and their synthetic 
intermediates are not soluble in water, so some drops of methanol were routinely added to 
help dissolution before they were dissolved in water otherwise the reaction was performed in 
dichloromethane. 
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Conditions for the separation of N4,N9-oleoyl spermine and N4,N9-dioctadecanoyl spermine: 
 
1. 1 mL of 10 mM Samples (MKS pH = 9.07, Lipogen pH = 8.81) + 1 mL sat. Na2CO3 
(pH 11.20)  pH mixture = 11.96 (MKS C18) and pH = 11.91 (Lipogen). 
2. Added DNS (2 mL of 70 mM DNS), left 30 min at 60oC. 
3. Extract with toluene 3 x 5 mL, and evaporate. 
4. Redissolved with 1 mL acetonitrile: 1% formic acid in Milli-Q-water (90:10). 
5. Inject onto HPLC column C 8, acetonitrile: 1% formic acid in Milli-Q-water (90:10). 
 
HPLC conditions 
 
HPLC column: Phenomenex luna C18, 150 mm x 4.6 mm. i.d. cartridge column 
(5µm particle size) with guard column, H1-5C18  
Mobile phase: Acetonitrile: Milli-Q-water (85:15, 90:10, 95:5), used at flow rate of 
1.00 mL/min. 
Detector:  Waters fluorescence detector 470 at λex = 330 nm and λex = 510 nm. 
   Jasco UV detector at λmax = 330 nm. 
 
Aminoglycosides  
 
Aminoglycosides (1 mL of 10 mM, glucosamine, kanamycin) were reacted with 1 mL sat. 
Na2CO3 and DNS reagent (2 mL of 70 mM DNS) was added, left for 30 min at 60
oC, then 
extracted with toluene (3 x 5 mL), and evaporated.  The residue was redissolved with 1 mL 
40% MeCN in water.  This solution was injected onto HPLC. 
 
HPLC conditions: 
 
HPLC column: Phenomenex luna C18, 150 mm x 4.6 mm. i.d. cartridge column 
(5µm particle size) with guard column, H1-5C18  
Mobile phase: Acetonitrile: Milli-Q-water (40:60), used at flow rate of 1.00 
mL/min. 
Detector:  Waters Fluorescence detector 470 at λex = 330 nm and λex = 510 nm 
   Jasco UV detector at λmax = 330 nm 
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Measurement of relative fluorescence yield experiment: 
 
The dansylation method 2 was applied to these amines:  1-butylamine, 1,4-diaminobutane, 
1,7-diaminoheptane and spermidine. 
 
Derivatization method to obtain the monoDNS derivatives and diDNS derivatives 
 
For diamines such as 1,4-diaminobutane both the mono- and di-DNS derivatives were 
prepared for a study of relative quantum yield.  To obtain the diDNS derivatives of the 
diamines, method 3 was used.  To obtain the monoDNS derivatives of diamines, the 
concentration of DNS Cl used was reduced to below 10 mM.  This yielded both mono- and 
diDNS derivatives which were easily resolved by HPLC and collected separately. 
 
HPLC conditions: 
 
HPLC column: Semi-preparative column:  Phenomenex Gemini 10 µ C18 110A 250 
x 10 mm; Guard column:  Phenomenex Gemini 5 µ C18 10 x 10 mm. 
Mobile phase: Methanol: Milli-Q-water (70:30), used at flow rate of 5.00 mL/min. 
Injection Volume: 100 µL 
Detector:  Waters Fluorescence detector 470 at λex = 330 nm and λex = 510 nm 
   Jasco UV detector at λmax = 330 nm. 
 
After collection of the peak of amine-DNS derivative, the expected molecular weight of the 
product was confirmed by HR-ESI-MS. 
 
To measure the relative fluorescent yield of each product the following procedure was used.  
The UV-VIS absorbance spectrum of the solvent background for the chosen sample was 
recorded and the absorbance at the excitation wavelength to be used was noted.  The 
fluorescence spectrum of the same solution in the 10 mm fluorescence cuvette was recorded. 
 
Increasing concentrations of each sample of the five solutions were analyzed and a graph of 
integrated fluorescence intensity vs. absorbance was plotted.  The slopes of the graphs 
obtained are proportional to the quantum yield of the different samples. 
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2.7  Synthesis of thermospermine 
 
Method 1  Thermospermine was synthesized from spermidine using the method of Ganem 
and Chantrapromma (1983) following the scheme shown in Figure 2.1. 
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Figure 2.1  Scheme of thermospermine synthesis. 
 
1.  N-(4-Aminobutyl) hexahydropyrimidine (2)  
 
Spermidine (1) 9.0 g (62 mmol), was dissolved in distilled water (225 mL) and the solution 
cooled to 5oC under N2.  37% Aqueous solution of formaldehyde (4.52 mL) (0.9 equiv.) was 
added dropwise then the solution was stirred for 1 h at 20oC.  The aqueous layer was 
saturated with solid NaCl and extracted four times with CHCl3.  The combined CHCl3 
extracts were dried (MgSO4) filtered and concentrated to dryness, giving N-(4-aminobutyl) 
hexahydropyrimidine (2) (94%, 9.2 g) as a waxy white solid.  TLC (dichloromethane: 
methanol: ammonia (20: 10: 1), detection by ninhydrin) Rt = 0.1. 
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NH N
NH
2
1
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δH (CDCl3) (400 MHz) 3.298 (2H, s, C(8)H2), 2.732 (2H, m C(1)H2), 2.643 (2H, m, C(7)H2), 
2.626 (2H, m, C(4)H2), 2.172 (2H, m, C(5)H2), 1.985 (1H, s, NH), 1.536 (2H, p, C(3)H2), 
1.410 (4H, m, C(2)H2, C(6)H2). 
 
δC (CDCl3) (100 MHz) 24.151, 26.957, 31.471, 41.716, 44.997, 52.943, 55.236, 69.736. 
C8H19N3 requires M.W. = 157.1579, HR-ESI-MS:  m/z [M+H]
+ = C8H20N3 requires 
158.1657, found = 158.1630. 
 
2.  4-(N-Benzylideneaminobutyl) hexahydropyrimidine (3) 
 
N-(4-Aminobutyl) hexahydropyrimidine (2) 2.50 g. (15.90 mmol) was dissolved in toluene 
(30 mL).  Benzaldehyde (1.69 g, 15.90 mmol) was added and the mixture was refluxed at 
130oC for 3 h using a Dean-Stark apparatus to remove water azeotropically.  After removal 
of the solvent, the N-(4-aminobutyl)hexahydropyrimidine (2) with its primary amine 
protected as a benzylidine derivative, 4-(N-benzylideneaminobutyl) hexahydropyrimidine (3) 
was obtained as colourless oil (2.95g, 75%). 
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δH (CDCl3) (400 MHz) 8.235 (H, s, C(9) H), 7.680 (2H, m, C(10)H, C(11)H), 7.374 (3H, m, 
C(12)H, C(13)H, C(14)H), 3.584 (2H, t, C(1)H2), 3.071 (2H, s C(8)H2), 2.547 (2H, t, 
C(7)H2), 2.476 (2H, t, C(4)H2), 2.336 (2H, t, C(5)H2), 1.671 (2H, m, C(3)H2), 1.578 (4H, m, 
C(2) H2, C(6)H2). 
 
C15H23N3 requires M.W. = 245.1892, HR-ESI-MS: m/z [M+H]
+ = C15H24N3 requires 
246.1970, found = 246.1945. 
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3.  N1-(N-Benzylidene-(1-hexahydropyrimidinebutyl)-N3-propionitrile (4) 
 
4-(N-Benzylideneaminobutyl) hexahydropyrimidine (3) 2.44 g (9.9 mmol) was dissolved in 
anhydrous methanol (15 mL) then acrylonitrile (0.66 mL, 9.9 mmol) was added dropwise 
with stirring under N2.  After 15 h, more acrylonitrile (0.5 mL) was added and stirring 
continued for 9 h, then concentrated under reduced pressure to yield N1-(N-benzylidene-(1-
hexahydropyrimidinebutyl)-N3-propionitrile (4) (2.39 g, 80%). 
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δH (CDCl3) (400 MHz) 8.3 (H, s, C(9) H), 7.7 (2H, m, C(10)H, C(11)H), 7.4 (3H, m, 
C(12)H, C(13)H, C(14)H), 3.6 (2H, t, C(1)H2), 3.5 (2H, s C(8)H2), 3.2 (2H, t, C(16)H2), 2.7 
(2H, t, C(15)H2), 2.3 (4H, t, C(5)H2, C(7)H2), 2.5 (2H, t, C(4)H2), 1.6 (2H, m, C(2)H2), 1.6 
(2H, m, C(6)H2), 1.5 (2H, m, C(3) H2). 
 
C18H26N4 requires M.W. = 298.2157, HR-ESI-MS: m/z [M+H]
+ = C18H27N4 requires 
299.2236, found = 299.2201. 
 
4.  Deprotection of the N1-(N-benzylidene-(1-hexahydropyrimidinebutyl)-N3-
propionitrile (4) to give 12-amino-4,8-diaza-dodecanenitrile (5) 
 
A solution of N1-(N-benzylidene-(1-hexahydropyrimidinebutyl)-N3-propionitrile (4) (0.665 
g, 2.23 mmol) in 2M HCl-methanol (15 mL) was heated under reflux at 80oC for 8 h.  After 
evaporation of methanol under reduced pressure, the resulting residue was redissolved in 
water (4mL) and extracted with diethyl ether (3x 15 mL) to remove benzaldehyde.  The 
aqueous layer was alkalinized with 20% NaOH (8 mL) and extracted with CHCl3.  The 
CHCl3 extracts were dried (MgSO4), filtered and concentrated to yield 12-amino-4,8-diaza-
dodecanenitrile (5) (0.17 g, 40%). 
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δH (CDCl3) (400 MHz) 2.86 (2H, t, C(9) H2), 2.76 (6H, m, C(4)H2, C(5)H2, C(7)H2), 2.66 
(2H, m, C(8)H2), 2.48 (2H, m, C(1)H2), 1.55 (4H, m, C(2)H2, C(6)H2), 1.45 (2H, m, C(3)H2). 
 
C10H22N4 requires M.W. = 198.1844, HR-ESI-MS: m/z [M+H]
+ = C10H23N4 requires 
199.1923, found = 199.1923. 
 
5.  Thermospermine 
 
An ice-cold solution of 12-amino-4,8-diaza-dodecanenitrile (5) (0.150 g, 0.76 mmol) in dry 
methanol (15 mL) was mixed with CoCl2
. 6H2O (0.360 g, 1.52 mmol); then NaBH4 was 
added in portions (0.286 g, 10 equiv.).  After the addition was complete, stirring was 
continued for 3 h at 20oC.  The reaction mixture was acidified with 3M HCl and stirred until 
the black precipitate (Co2B) dissolved.  After concentration in vacuo, the resulting aqueous 
solution was alkalinized with 30% NaOH and extracted with CHCl3, to give the desired 
thermospermine (6) (0.05 g, 35%). 
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δH (CDCl3) (400 MHz) 2.740 (4H, m, C(1)H2, C(10)H2), 2.645 (8H, m, C(3)H2, C(4)H2, 
C(6)H2, C(7)H2), 2.180 (H, s, N(2΄)H), 2.150 (H, s, N(3΄)H), 1.654 (2H, m, C(2)H2), 1.610 
(2H, m, C(5)H2), 1.562 (2H, m, C(9)H2), 1.424 (2H, m, C(8)H2). 
 
δC (CDCl3) (100 MHz) 24.504, 27.538, 31.867, 40.580, 42.181, 47.967, 48.585, 48.691, 
49.971. 
 
C10H26N4 requires M.W. = 202.2157, HR-ESI-MS: m/z [M+H]
+ = C10H27N4 requires 
203.2236, found = 203.2236. 
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Method 2  By protection of N-(4-aminobutyl) hexahydropyrimidine (2) with phthalimide:  
the scheme shown in Figure 2.2. 
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Figure 2.2  Scheme of thermospermine synthesis by method 2. 
 
1.  2-(N-Butylhexahydropyrimidine) isoindoline-1,3-dione (7) 
 
N-(4-Aminobutyl)hexahydropyrimidine (2) 2.50 g. (15.90 mmol) was dissolved in 
dichloromethane (30 mL).  A solution of N-carbethoxyphthalimide 15.90 mmol in 
dichloromethane (10 mL), was added and stirred for 3 h at 20oC to obtain 2-(N-
butylhexahydropyrimidine) isoindoline-1,3-dione (7) (3.8 g, 85%). 
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δH (CDCl3) (400 MHz) 7.846 (2H, m, C(10) H, C(11)H), 7.814 (2H, m, C(9)H, C(12)H), 
4.101 (2H, s, C(8)H2), 3.703 (2H, t, C(1)H2), 3.204 (2H, t C(7)H2), 3.015 (2H, t, C(4)H2), 
2.898 (2H, t, C(5)H2), 1.912 (2H, quin, C(3)H2), 1.824 (2H, quin, C(2)H2), 1.695 (2H, quin, 
C(6) H2). 
 
C16H21N3O2 requires M.W. = 287.1634, HR-ESI-MS: m/z [M+H]
+ = C16H22N3O2 requires 
288.1712, found = 288.1699. 
 
2.  2-(N1-Butylhexahydropyrimidine)-isoindoline-1,3-dione-N3-propionitrile (8) 
 
The amine (7) 2.44 g (9.9 mmol) was dissolved in dry methanol (15 mL) then acrylonitrile 
(0.66 mL, 9.9 mmol) was added dropwise with stirring under N2.  After 15 h, more 
acrylonitrile (0.5 mL) was added and stirring continued for 9 hr.  Methanol was removed 
under reduced pressure to yield 2-(N1-butylhexahydropyrimidine)-isoindoline-1,3-dione-N3-
propionitrile (8) (2.00 g, 80%). 
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δH (CDCl3) (400 MHz) 7.804 (2H, m, C(10) H, C(11)H), 7.691 (2H, m, C(9)H, C(12)H), 
3.659 (2H, m, C(8)H2), 3.659 (2H, t, C(1)H2), 2.863 (2H, t, C(14)H2), 2.732 (2H, m, 
C(13)H2), 2.683 (2H, m, C(4)H2),  2.490 (4H, m, C(5)H2, C(7)H2), 1.850 (2H, quin, C(3)H2), 
1.683 (2H, quin, C(2)H2), 1.567 (2H, m, C(6) H2). 
 
3  12-(1,3-Dioxoisoindolin-2-yl)-4,8-diaza-dodecanenitrile (9) 
 
A solution of (8) (0.665 g, 2.23 mmol) in 2 M HCl-methanol (15 mL) was heated under 
reflux at 80oC for 8 h.  Evaporation of the methanol gave a white solid which was 
redissolved in water (4 mL).  The aqueous solution was alkalinized with 20% (w/v) NaOH (8 
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mL) and extracted with CHCl3..  The CHCl3 extracts were dried (MgSO4) and concentrated 
to yield 12-(1,3-dioxoisoindolin-2-yl)-4,8-diaza-dodecanenitrile (9) (0.56 g, 85%). 
 
4  Removal of the phthalimide group to give 12-amino-4,8-diaza-dodecanenitrile (5) 
 
A solution of amine (9) in 40 mL of CH2Cl2/THF (1:1) was treated with hydrazine 
monohydrate (1.0 mL) and heated under reflux for 4 h at 80oC.  The solvent was evaporated 
to dryness under reduced pressure to yield 12-amino-4,8-diaza-dodecanenitrile (5) (0.30 g, 
50%).  
 
5  Simultaneous removal of phthalimide and hexahydropyrimidine from (8) to give 12-
amino-4,8-diaza-dodecanenitrile (5) 
 
A solution of amine (8) in 40 mL of CH2Cl2/ THF (1:1) was treated with hydrazine 
monohydrate (2 mL) and heated under reflux for 4 h at 80oC.  The solvent was evaporated to 
dryness under reduced pressure to yield the 12-amino-4,8-diaza-dodecanenitrile (5) (0.42 g, 
75%). 
 
2.8  Purification of intermediates 
 
Silica gel column chromatography (Merck, 40–63 µm, 230–400 mesh ASTM, pH 6.5–7.5) 
was used to purify the products from steps (7) of the thermospermine preparation.  The 
column was packed in an open-glass tube with dichloromethane.  The samples were 
dissolved in methanol, then applied to the column in a minimum volume.  The column was 
eluted with a mixture of dichloromethane: methanol: ammonia solution (10:5:1).  The 
progress of the elution was followed by collecting fractions (50 mL), concentrating and 
monitoring by analytical TLC, HPLC, NMR and HR-ESI-MS.  Semi-preparative HPLC 
column:  Phenomenex Gemini 10 µ C18 110A 250 x 10 mm; Guard column:  Phenomenex 
Gemini 5 µ C18 10 x 10 mm.  HPLC mobile phase used for separation was acetonitrile in 
Milli-Q-water (40:60) with amine (7) dissolved in methanol. 
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2.9  Analysis of thermospermine and spermine 
 
Hexahydropyrimidine derivative of spermine 
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H
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N NH
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in water 
1 h, 20oC
10
11  
 
Spermine (10) 0.09 g (0.445 mmol), was dissolved in distilled water (25 mL) and the 
solution cooled to 5oC under N2.  37% Aqueous solution of formaldehyde 0.1 mL (2 equiv.) 
was added dropwise then the solution was stirred for 1 h at 20oC.  The aqueous layer was 
saturated with solid NaCl and extracted four times with CHCl3.  The combined CHCl3 
extracts were dried (MgSO4), filtered and concentrated to dryness, giving the dihexahydro-
pyrimidine ring derivative of spermine, 1,4-(dihexahydropyrimidine)butane (11). 
 
1,4-(dihexahydropyrimidine) butane (11) (C12H26N4, M.W. = 226.2157,) HR-ESI-MS: 
expected m/z [M+H]+ ion = 227.2236 , found = 227.2217. 
 
Hexahydropyrimidine derivative of thermospermine 
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Thermospermine (6) 0.09 g (0.445 mmol), was dissolved in distilled water (25 mL) and 
cooled to 5oC under N2.  An aq. solution of formaldehyde (37%, 0.1 mL, 2 equiv.) was added 
dropwise then the solution was stirred for 1 h at 20oC.  The aqueous layer was saturated with 
solid NaCl and extracted four times with CHCl3.  The combined CHCl3 extracts were dried 
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(MgSO4), filtered and concentrated to dryness, giving the hexahydropyrimidine ring 
derivative of thermospermine, 1-(hexahydropyrimidine)-4-aza-aminooctane (12) 
 
1-(Hexahydropyrimidine)-4-aza-aminooctane (12) (C11H26N4, M.W. = 214.2157,) HR-ESI-
MS expected m/z [M+H]+ ion = 215.2236, found = 215.2216 and doubly charged ion 
[M+2H]2+ = 108.1157, found = 108.1175. 
 
Tetradeuterio hexahydropyrimidine derivative of spermine 
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Spermine (10) 0.09 g (0.445 mmol), was dissolved in distilled water (25 mL) and the 
solution cooled to 5oC under N2.  An aqueous solution of dideuteriated formaldehyde 0.1 mL 
(2 equiv.) was added dropwise then the solution was stirred for 1 h at 20oC.  The aqueous 
layer was saturated with solid NaCl and extracted four times with CHCl3.  The combined 
CHCl3 extracts were dried (MgSO4) and concentrated to dryness, giving the di-
hexahydropyrimidine ring derivative of spermine, 1,4-(dihexahydropyrimidine-2,2,2′,2′-
tetradeuterio) butane (13). 
 
1,4-(Dihexahydropyrimidine-2,2,2′,2′-tetradeuterio) butane (C12H22N4D4, M.W. = 230.2408,) 
HR-ESI-MS expected m/z [M+H]+ ion = 231.2486, found = 231.2472 and doubly charged 
ion of [M+2H]2+ = 116.1282, found = 116.1258. 
 
Dideuterio of hexahydropyrimidine derivative of thermospermine 
 
Thermospermine (6) 0.09 g (0.445 mmol), was dissolved in distilled water (25 mL) and the 
solution cooled to 5oC under N2.  Aqueous solution of dideuteriated formaldehyde 0.1 mL (2 
equiv.) was added dropwise then the solution was stirred for 1 h at 20oC.  The aqueous layer 
was saturated with solid NaCl and extracted four times with CHCl3.  The combined CHCl3 
extracts were dried (MgSO4) filtered and concentrated to dryness, giving the 
hexahydropyrimidine ring derivative of thermospermine, 8-(1-hexahydropyrimidine-2,2-
dideuterio)-4-aza-aminooctane (14). 
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8-(1-Hexahydropyrimidine-2,2-dideuterio)-4-aza-aminooctane (C11H24N4D2, M.W. = 
216.2283) HR-ESI-MS expected m/z [M+H]+ ion = 217.2361, found = 217.2348, doubly 
charged ion [M+2H]2+ = 109.1219, found = 109.1201 
 
Reaction of formaldehyde:dideuteriated formaldehyde (1:1) to spermine 
 
This experiment was repeated using an approximate 50:50 (v/v) mixture of formaldehyde 
and dideuteriated formaldehyde react with spermine. 
 
1,4-(Dihexahydropyridine)butane(11) (C12H26N4, M.W. = 226.2157) HR-ESI-MS expected 
m/z [M+H]+ ion = 227.2236, found = 227.2223.  1-(hexahydropyrimidine)-5-aza-
aminooctane (C12H24N4D2, M.W. = 228.2283) HR-ESI-MS expected m/z [M+H]
+ ion = 
229.2361, found = 229.2343.  1,4-(Dihexahydropyrimidine tetradeuterio)butane 
(C12H22N4D4, M.W. = 230.2408) HR-ESI-MS expected m/z [M+H]
+ ion = 231.2486, found = 
231.2480. 
 
Reaction of formaldehyde:dideuteriated formaldehyde (1:1) to thermospermine 
 
This experiment was repeated using an approximate 50:50 (v/v) mixture of formaldehyde 
and dideuteriated formaldehyde react with thermospermine. 
 
1-(Hexahydropyrimidine)-4-aza-aminooctane (12) (C11H26N4, M.W. = 214.2157) HR-ESI-
MS expected m/z [M+H]+ ion = 215.2236, found = 215.2225.  1-(Hexahydropyrimidine 
dideuterio)-4-aza-aminooctane (C11H24N4D2, M.W. = 216.2283,) expected m/z [M+H]
+ ion = 
217.2361, found = 217.2355. 
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CHAPTER 3:  SELECTIVE POLYAMINE DERIVATIZATIONS 
 
3.1  Primary amine-o-phthalaldehyde/mercaptoethanol (OPA/MCE) derivatization 
 
ortho-Phthalaldehyde (OPA) is selective reagent reacting only with primary amines in the 
presence of alkylthiols to form fluorescent isoindole derivatives.  This reaction was 
introduced by Roth (1971) to investigate amino acids and the method has become widely 
used for the determination of amino acids (Patchett, 1988), peptides (Mendez, 1985), 
aminoglycoside antibiotics (Essers, 1984; Tawa, 1998), biogenic amines, polyamines and 
other primary amino group-containing compounds. 
 
In Roth’s original studies, 2-mercaptoethanol (MCE) was the thiol used (Roth, 1971) though 
later workers have explored a variety of thiols (Simons and Johnson, 1978).  The main 
advantage of the derivatization by OPA/MCE is that the reaction is easy to perform at pH 10 
in aqueous solution (usually borate buffer) under ambient temperature, with a short reaction 
of few minutes, yielding 1-alkylthio-2-alkylisoindole derivatives (Simons and Johnson, 
1976, 1977) which are highly fluorescent (Figure 3.1).  However, it has been reported that 
secondary amino groups do not form isoindoles (Lee, 1979; Roth, 1973). 
 
1-Alkylthio-2-alkylisoindoles exhibit several excitation maxima.  Usually the maximum 
wavelength at 340 nm is used, but wavelength 230 nm which gives higher fluorescence 
intensity could be used in order to improve the excitation of fluorescence (Schuster, 1988). 
 
The isoindoles are unstable, and decompose via an intramolecular rearrangement to non-
fluorescent 2,3-dihydro-1H-isoindole-1-one (Figure 3.2) (Simons and Johnson, 1978).  The 
degree of instability depends somewhat on the thiol and the amines (Lindroth, 1979; 
Stobaugh, 1983). 
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Figure 3.1  Formation of a 1-alkylthio-2-alkylisoindoles by reaction the OPA, a thiol and a 
primary amine. 
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Figure 3.2  2,3-Dihydro-1H-isoindole-1-one. 
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In aqueous medium, OPA undergoes hydration quite extensively to form a mixture of cis-, 
trans-cyclic-1,3-phthalandiols (Figure 3.3).  The 1,3-phthalandiols also absorb light at the 
same wavelength as the amine-OPA derivatives so the peak of this molecules always shows 
up in the chromatograms where UV absorbance detection is used. 
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Figure 3.3  Hydration of OPA in basic medium. 
 
The optimization of amine-OPA/MCE derivatization was by: 
1.  Optimisation the pH of borate buffer 
2.  Optimisation of the molar ratio of OPA/MCE reagent to sample solution. 
3.  Optimization of the mole ratio of MCE (mM) to 1 mM of OPA. 
4.  Optimisation of the reaction time. 
5.  Optimisation of the condition for maximum stability of the derivatives of amine-
OPA/MCE. 
6.  Optimization the mobile phase for HPLC. 
 
Optimization the pH of borate buffer 
 
The reactions of OPA/MCE at various pHs with ethylamine as a model primary amine were 
performed to optimize the pH.  The result (Figure 3.4) shows the range of pH from 8.3 to 
10.5 gave the highest derivative yields while acidic and neutral pH gave lower yields.  
Calibration curves were constructed at pHs 8.3, 9.3 and 10.5 (Figure 3.5 and Table 3.1). 
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Calibration curves of the reactions at the 3 pHs examined (8.3, 9.3, 10.5) showed 
approximately the same slopes.  However, the chromatogram of the reaction at pH 10.5 
showed the best resolution and fewer by-products.  Borate buffer pH 10.5 was used to 
determine the optimum reaction time by varying the reaction time of amines and OPA/MCE.  
The results were obtained with ethylamine (Figure 3.6) and also 1-butylamine (Figure 3.7).  
The best reaction time is 1 min, as longer reaction times gave smaller peak areas due to the 
instability of the reaction products. 
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Figure 3.4  Effect of various borate buffer pHs on the ethylamine-OPA/MCE derivatives 
yield (n = 5).  Peak areas were calculated by height x 0.5 width of peak, and peak areas are 
reported in cm2. 
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Figure 3.5  Calibration curve of ethylamine-OPA/MCE derivatives at various pHs (n = 5).  
Peak areas were calculated by height x 0.5 width of peak, and peak areas are reported in cm2. 
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Table 3.1  The calibration curves’ equations of ethylamine-OPA/MCE derivatives at various pHs. 
 
Ethylamine-OPA/MCE derivatives at various pH Calibration curve R2  (n = 5) 
pH 8.3 y = 2.23x – 0.078 0.984 
pH 9.3 y = 1.93x – 0.008 0.999 
pH 10.5 y = 1.915x + 0.025 0.999 
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Figure 3.6  Reaction of 1 mL 1mM ethylamine with 1 mL of OPA/MCE at various reaction 
times (n = 5).  Peak areas were calculated by height x 0.5 width of peak, and peak areas are 
reported in cm2. 
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Figure 3.7  Reaction of 100 µl 5mM 1-butylamine with 100 µl of OPA/MCE at various 
reaction times (n = 5).  Peak areas were calculated by height x 0.5 width of peak, and peak 
areas are reported in cm2. 
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Optimizing the mole ratio of reagent composition 
 
Mole ratios of MCE to OPA in the OPA reagent were altered from 1:1 to 17:1.  Thus, the 
behaviour of 1-butylamine has been compared with variation in the OPA/MCE mole ratio 
(Figure 3.8).  Further increasing the concentration of MCE in the reagent might result in 
increasing the rate of reaction as well as increasing of peak area.  In this study, it was found 
that there is insignificant increase in the peak area, the observed rate suppression at high 
thiol concentration is probably due to one or more OPA-thiol adducts which decrease the 
free OPA concentration (Figure 3.9) (Wong, Sternson and Schowen, 1985).  Thus the ratio 
of MCE: OPA = 10:1 was used for the next and subsequent studies. 
0
2
4
6
8
10
12
14
16
0 5 10 15 20
ratio of MCE (mM) per 1 mM of OPA
pe
ak
 a
re
a
 
Figure 3.8  Reaction of 1 µL 5mM 1-butylamine with 1 µL of OPA/MCE at various ratio of 
MCE (mM) per 1 mM of OPA (n = 5).  Peak areas were calculated by height x 0.5 width of 
peak, and peak areas are reported in cm2. 
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Figure 3.9  Reaction of thiol and OPA. 
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The derivatization method has been used to determine glucosamine (eluted by acetonitrile in 
Milli-Q-water (40:60), Rt = 2.0 min) which showed that the derivative is also unstable 
(Figure 3.10). 
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Figure 3.10  Glucosamine-OPA/MCE derivatives at various reaction times (n = 5).  Peak 
areas were calculated by height x 0.5 width of peak, and peak areas are reported in cm2. 
 
Optimizing the mole ratio of OPA/MCE to amines 
 
1-Butylamine (1 mM) was reacted with various mole ratios of OPA/MCE [1:10] at 0.2, 1, 2, 
4, 8, 16 fold.  Figure 3.11 shows that the completed yield was obtained from 1:1 mole ratio. 
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Figure 3.11  Ratio of concentration of OPA/MCE to 1-butylamine (by fold of mole, n = 5).  
Peak areas were calculated by height x 0.5 width of peak, and peak areas are reported in cm2. 
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After the optimization reactions for amine-OPA/MCE, these optimization conditions were 
then applied to:  1,4-diaminobutane, 1,5-diaminopentane and 1,7-diaminoheptane.  The 
conditions used were:  1 mL, 40 mM of OPA/MCE in borate buffer pH 10.5 and the reaction 
time was 1 min.  The OPA-MCE-polyamines derivatives were formed rapidly, but the 
products were unstable (Figure 3.12 and Table 3.2). 
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Figure 3.12  Polyamine-OPA/MCE derivatives at various reaction times (n = 5).  Peak areas 
were calculated by height x 0.5 width of peak, and peak areas are reported in cm2. 
 
Table 3.2  Time for 50% decrease in peak area of amine-OPA/MCE derivatives. 
 
Amine-OPA/MCE derivative Time (min) for peak area to 
decrease by 50% 
Ethylamine-monoOPA/MCE 9 
1-Butylamine-monoOPA/MCE 25 
1,4-Diaminobutane-diOPA/MCE 28 
1,5-Diaminopentane-diOPA/MCE 38 
1,7-Diaminoheptane-diOPA/MCE 45 
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The stability of the derivatives prepared under the same conditions, proved to be associated 
with the aliphatic chain length of the amine as the longer the chain length the slower the 
decomposition of the total of derivatives formed.  This also proved that particular 
optimization of the reaction needs to be done for particular amines.  The stability of the 
derivatives of OPA/MEC could be improved by putting the vial in an ice bath after 1 min 
reaction time; results are shown in Figure 3.13. 
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Figure 3.13  1,4-Diaminobutane-diOPA/MCE derivatives at various storage times at two 
different temperatures (20oC and 1oC, n = 5).  Peak areas were calculated by height x 0.5 
width of peak, and peak areas are reported in cm2. 
 
Polyamine-OPA/MCE derivatives 
 
Using the optimized conditions, derivatizations were carried out with 1-butylamine, 1,4-
diaminobutane, 1,5-diaminopentane, 1,7-diaminoheptane, 1,9-diaminononane, spermidine, 
and spermine.  For the mono- and di-amines, the chromatograms showed good resolution 
and peak symmetry (Figure 3.14).  The peak of 1,7-diaminoheptane-diOPA/MCE derivative 
was collected and the structure confirmed by HR-ESI-MS (Figure 3.15).  By adjusting the 
mobile phase, the retention time of some amine-OPA/MCE derivatives is shorter and they 
also show improved (more symmetrical) peak shape (Table 3.3).   
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Figure 3.14  HPLC chromatogram of amines-OPA/MCE derivatives, HPLC conditions:  
column: Phenomenex hypersil C18 5µ 150 x 4.60 mm, mobile phase is acetonitrile: Milli-Q-
water (70:30) with flow rate 1 mL/min, fluorescence detection at λex = 340 nm, λem = 450 
nm.  The chromatogram shows the solvent front at Rt = 1.3 min, peak 1 = 1-butylamine-
monoOPA/MCE at Rt = 3.4 min, peak 2 = 1,4-diaminobutane-diOPA/MCE at Rt = 5.6 min, 
peak 3 = 1,5-diaminopentane-diOPA/MCE at Rt = 7.0 min, peak 4 = 1,7-diaminoheptane-
diOPA/MCE at Rt = 12.2 min, peak 5 = 1,9-diaminononane-diOPA/MCE at Rt = 24.0 min. 
 
 
Figure 3.15  HR-ESI-MS spectra of 1,7-diaminoheptane di-OPA/MCE derivative, (M.W. = 
482.2062, C27H34N2O2S2) expected m/z [M+H]
+ ion = 483.2140 (found = 483.2124) and [M+ 
Na]+ ion m/z = 505.1959 (found = 505.1966). 
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Table 3.3  The retention time (Rt) of various amine-OPA/MCE derivatives with different 
mobile phases. 
 
 
Amine-OPA/MCE derivatives 
Rt (min) 
eluted by  
70% MeCN 
Rt (min) 
eluted by 
80% MeCN 
Rt (min) 
eluted by  
90% MeCN 
1,4-Diaminobutane-diOPA/MCE 5.6 4.0 - 
1,5-Diaminopentane-diOPA/MCE 7.0 4.7 - 
1,7-Diaminoheptane-diOPA/MCE  12.2 7.5 - 
1,8-Diaminooctane-diOPA/MCE 21.3 - 3.0  
1,12-Diaminododecane-diOPA/MCE 73.0 - 6.2 
 
By varying the concentration of the amines, linearity of derivatization was calculated for 
each amine and the coefficient of regression ranged from 0.984 to 0.997 as shown in Table 
3.4 and in Figure 3.16 for the calibration curves obtained from fluorescence detector and in 
Figure 3.17 from ultraviolet detector.  These results mean that mono- and di-amines can be 
determined quantitatively by this method.  The calibration curve equations have high 
intercepts especially 1,7-diaminoheptane-diOPA/MCE derivative which might be due to 
high fluorescence background. 
 
Table 3.4  The calibration curve equations of various amine-OPA/MCE derivatives was 
detected by fluorescence. 
 
Amine-OPA/MCE derivatives Calibration curve equations R2 
1-Butylamine-monoOPA/MCE y = 82.64x + 0.24 0.989 
1,4-Diaminobutane-diOPA/MCE y = 31.69x + 0.72 0.989 
1,5-Diaminopentane-diOPA/MCE y = 23.79x + 0.47 0.984 
1,7-Diaminoheptane-diOPA/MCE  y = 20.57x + 1.48 0.997 
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Figure 3.16  Calibration curves of amine-OPA/MCE derivatives by fluorescence detection 
(n = 5).  Peak areas were calculated by height x 0.5 width of peak, and peak areas are 
reported in cm2. 
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Figure 3.17  Calibration curve of amine-OPA/MCE derivatives by UV detection (n = 5).  
Peak areas were calculated by height x 0.5 width of peak, and peak areas are reported in cm2. 
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Spermidine and spermine-OPA/MCE derivatization 
 
Spermidine and spermine, have two terminal primary amine groups while in the middle of 
the molecule are one and two secondary amine groups for spermidine and spermine 
respectively.  Thus, the derivatization reaction between OPA/MCE and spermidine, and 
spermine leads to the formation of di-isoindol-derivatives (Figures 3.18 and 3.19). 
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Figure 3.18  Spermidine-diOPA/MCE derivative. 
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Figure 3.19  Spermine-diOPA/MCE derivative. 
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Figure 3.20  Spermidine-OPA/MCE reaction after various times (n = 5).  Peak areas were 
calculated by height x 0.5 width of peak, and peak areas are reported in cm2. 
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Figure 3.21  HPLC chromatogram of spermidine-diOPA/MCE (10 mM), HPLC conditions:  
column:  Phenomenex luna C18 5µ 150 x 4.60 mm, mobile phase:  acetonitrile: Milli-Q-
water (90:10), flow rate 1 mL/min, fluorescence detection at λex = 340 nm, λem = 450 nm.  
The chromatogram shows the solvent front at Rt = 1.5 min and spermidine-diOPA/MCE 
derivative at Rt = 3.7 min. 
 
 
 
Figure 3.22  HR-ESI-MS spectra of spermidine-diOPA/MCE derivative, (M.W. = 497.2171, 
C27H35N3O2S2) expected m/z [M+H]
+ ion = 498.2249 (found = 498.2225) and [M+ Na]+ ion 
m/z = 520.2068 (found = 520.2068). 
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Figure 3.23  Calibration curve of spermidine-OPA/MCE derivatives by fluorescence 
detection.  Calibration curve equation: y = 0.6333x +1.1615, R2 = 0.995, (n = 5).  Peak areas 
were calculated by height x 0.5 width of peak, and peak areas are reported in cm2. 
 
For both spermidine and spermine a graph of yield against reaction time (Figure 3.20) 
showed a rapid degradation of the product.  The HPLC chromatogram of the spermidine-
diOPA/MCE derivative was symmetrical and sharp when eluted by 90% acetonitrile in 
Milli-Q-water at Rt = 3.7 min (Figure 3.21).  HR-ESI-MS (Figure 3.22) showed a peak 
corresponding to the expected value, but the major peak at m/z 420.2098 could not be 
identified.  By varying the concentration of the spermidine, linearity of derivatization was 
calculated and the coefficient of regression is 0.995 for fluorescence detection and 0.991 for 
UV detection.  Figure 3.23 shows the calibration curve obtained from the fluorescence 
detector and in Figure 3.24 from the UV detector.  For spermine-diOPA/MCE derivative, the 
peak was broad and also decreased rapidly in just 10 min of reaction and nearly disappeared 
after 30 min (Figure 3.25). 
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Figure 3.24 Calibration curve of spermidine-OPA/MCE derivatives by UV detection.  
Calibration curve equation: y = 3.5453x +1.1215, R2 = 0.991, (n = 5).  Peak areas were 
calculated by height x 0.5 width of peak, and peak areas are reported in cm2. 
 
Although the stability of both spermidine-diOPA/MCE derivatives and spermine-
diOPA/MCE derivative were low, the spermidine-diOPA/MCE derivative was more stable, 
perhaps due to the lower number of secondary amine groups in the molecule. 
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Figure 3.25  HPLC chromatogram of spermine-diOPA/MCE (10 mM), HPLC conditions:  
column:  Phenomenex luna C18 5µ 150 x 4.60 mm, mobile phase:  acetonitrile: Milli-Q-
water (90:10) flow rate 1 mL/min, fluorescence detection at λex = 340 nm, λem = 450 nm.  
The chromatogram shows the solvent front at Rt = 1.5 min and spermine-diOPA/MCE 
derivative as the broad peak start at Rt = 4.9 min. (A) reaction time 1 min (B) reaction time 
15 min. 
 
Relative quantum yield of amines-OPA/MCE derivatives 
 
A comparison of fluorescence yields of the model series was obtained by comparison 
between the peak area of fluorescence intensity and peak area of UV absorbance rather than 
by collected the elution product from HPLC and separate measurement by UV/VIS 
spectrophotometer and fluorescence spectrometer due to the low stability of the amines-
OPA/MCE derivatives.  A plot of fluorescence intensity against absorbance (Figure 3.26) 
and the FI/UV equation (Table 3.5) were obtained. 
 
Table 3.5  The FI/UV equation of amine-OPA/MCE derivatives. 
 
Amine-OPA/MCE derivatives FI/UV equation 
1-Butylamine y = 3.22x – 0.56 
1,4-Diaminobutane y = 0.91x – 0.04 
1,5-Diaminopentane y = 1.79x – 0.72 
1,7-Diaminoheptane y = 3.49x – 0.75 
0 6 12 mins 
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Figure 3.26  Plots of fluorescence intensity against absorbance at λex of amine-OPA/MCE 
derivatives (n = 5).  Peak areas were calculated by height x 0.5 width of peak, and peak areas 
are reported in cm2. 
 
From the results, it is concluded that fluorescence yield is reduced when the two 
fluorophores are tethered in close proximity, but that the seven carbon chain of 1,7-
diaminoheptane allows sufficient flexibility for this not to occur. 
 
OPA/MCE derivatives of a series of non-viral gene therapy (NVGT) vectors 
 
The OPA/MCE derivatization method was applied to investigate two synthetic fatty acyl 
amides of spermine, N4,N9-didecanoyl spermine (Figure 3.27) and N4,N9-dilinoleoyl 
spermine (Figure 3.29).  These C10 and C14 conjugates are experimental non-viral vectors 
for DNA condensation with potential in gene delivery and therefore in non-viral gene 
therapy (NVGT).  The OPA/MCE labelling method was applied to these molecules and 
HPLC chromatograms of derivatives of N4,N9-didecanoyl spermine and N4,N9-
dibutadecanoyl spermine (Figure 3.30) were obtained.  The HR-ESI-MS of N4,N9-didecanoyl 
spermine (Figure 3.28) and N4,N9-dibutadecanoyl spermine (Figure 3.31) showed the mass 
expected for bis-isoindole derivatives. 
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Figure 3.27  N4,N9-Didecanoyl spermine-diOPA/MCE derivative. 
 
 
Figure 3.28  HR-ESI-MS spectra of N4,N9-didecanoyl spermine-diOPA/MCE derivative, 
(M.W. = 862.5465, C50H78N4O4S2) expected m/z [M+H]
+ ion = 863.5543 (found = 863.5518) 
and [M+ Na]+ ion m/z = 885.5362 (found = 885.5385). 
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Figure 3.29  N4,N9-Dibutadecanoylspermine-diOPA/MCE derivative. 
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Figure 3.30  HPLC chromatogram of N4,N9-dibutadecanoylspermine-diOPA/MCE 
derivative. (10 mM), HPLC conditions:  column: Phenomenex luna C18 5µ 150 x 4.60 mm, 
mobile phase is acetonitrile: Milli-Q-water (90:10) with flow rate 1 mL/min.  The 
chromatogram shows the solvent front at Rt = 1.5 min and N4,N9-Dibutadecanoylspermine-
diOPA/MCE derivative as the broad peak starting at Rt = 7.9 min, (A) from fluorescence 
detector x10 sensitivity at λex = 340 nm, λem = 450 nm, (B) from UV detector 0.16 range at 
λmax = 340 nm. 
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Figure 3.31  HR-ESI-MS spectra of N4,N9-Dibutadecanoylspermine-OPA/MCE derivative, 
(M.W. = 974.6717, C58H94N4O4S2) expected m/z [M+H]
+ ion = 975.6795 (found = 975.6758), 
[M+ Na]+ ion m/z = 997.6614 (found = 997.6584) and [M+K]+ ion m/z = 1013.7700. 
 
OPA/MCE derivatives of aminoglycosides 
 
Aminoglycoside antibiotics present a problem of detection by spectroscopic methods.  One 
approach to this problem is to derivatize the antibiotic with a UV or fluorescent 
chromophore for HPLC analysis. 
 
Kanamycins (Figure 3.32) are aminoglycoside antibiotics, which are synthesized by 
Streptomyces kanamyceticus.  Kanamycin A is the main component (>95%) kanamycin B is 
minor component (<5%) so kanamycin A is usually chosen as the detected target compound.  
The official British Pharmacopoeia method for the detection of kanamycin A is a 
microbiological method.  However, this method is time consuming and has a low sensitivity 
which can hardly provide reliable results.  There are also other analytical methods for 
determination of kanamycin A such as nuclear magnetic resonance (NMR) (Fourmy et al., 
1998), mass spectrometry (MS) (Oertel et al., 2004) and high performance liquid 
chromatography (HPLC) (David et al., 2001).  Compared to NMR and MS methods, HPLC 
is a simple procedure for detecting aminoglycosides, relatively easy to develop, and is well 
suited for the analysis of small compounds.  Simple chromatographic methods are not 
applicable due to lack of chromophores and strong hydrophilicity of aminoglycosides. 
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Figure 3.32  Kanamycin. 
 
The OPA/MCE derivatization method was applied to the polyamine glycoside antibiotics, 
kanamycin and neomycin.  The time of derivatization and the amount of derivative reagent 
were studied to optimize the derivatization conditions for kanamycin-OPA/MCE.  For the 
optimization of reaction time, kanamycin was derivatized at 1, 10, 30, 45 min.  The 
maximum peak area was reached at 10 min (Figure 3.33).  The amount of OPA/MCE to 
kanamycin was also investigated from 1- to 24-fold.  The results from the HPLC 
chromatogram show that the reaction was not complete with 2-fold mole ratio of OPA/MCE 
reagent (Figure 3.34), but appeared to be complete when a 10-fold mole ratio excess of 
reagent was used (Figure 3.35).  The retention time of kanamycin-OPA/MCE is 9.7 min 
(mobile phase: 40% acetonitrile in Milli-Q-water).  The graph of mole ratio of OPA/MCE 
vs. kanamycin (Figure 3.36) and the calibration curve were obtained (Figure 3.37). 
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Figure 3.33  Reaction of 100 µL 1mM kanamycin with 100 µL of OPA/MCE at various 
reaction times (n = 5).  Peak areas were calculated by height x 0.5 width of peak, and peak 
areas are reported in cm2. 
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Figure 3.34  HPLC chromatogram of kanamycin-OPA/MCE (10 mM), HPLC conditions:  
column: Phenomenex luna C18 5µ 150 x 4.60 mm, mobile phase is acetonitrile: Milli-Q-
water (40:60) with flow rate 1 mL/min, (A) from fluorescence detection at λex = 340 nm, λem 
= 450 nm.  (B) from UV detector at λmax = 340 nm.  The chromatogram shows the solvent 
front at Rt = 1.0 min and kanamycin-OPA/MCE derivative as the broad multiple peak 
starting at Rt = 3.0 min. 
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Figure 3.35  HPLC chromatogram of kanamycin-triOPA/MCE (10 mM), HPLC conditions:  
column:  Phenomenex luna C18 5µ 150 x 4.60 mm, mobile phase:  acetonitrile: Milli-Q-water 
(40:60), flow rate 1 mL/min, (A) fluorescence detection at λex = 340 nm, λem = 450 nm.  The 
chromatogram shows the solvent front at Rt = 1.0 min and kanamycin-triOPA/MCE 
derivative at Rt = 9.7 min (B) from UV detector at λmax = 340 nm. 
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Figure 3.36  Reaction of 100 µL 1mM kanamycin with 100 µL of OPA/MCE at various 
mole ratio (n = 5).  Peak areas were calculated by height x 0.5 width of peak, and peak areas 
are reported in cm2. 
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Figure 3.37  Calibration curve of kanamycin-OPA/MCE derivatives (n = 5).  Peak areas 
were calculated by height x 0.5 width of peak, and peak areas are reported in cm2. 
 
However, the HR-ESI-MS suggested that this product was kanamycin-triOPA/MCE (Figure 
3.38) instead of the expected tetra-OPA/MCE (Figure 3.39).  This might due to the steric 
effect of the two amine groups on the same 2-deoxy streptamine ring allowing only one 
molecule of OPA/MCE to react at one of the amine positions of this ring.  HR-ESI-MS from 
the broad peak of the incomplete reaction in Figure 3.34 showed the m/z kanamycin-
diOPA/MCE derivatives (Figure 3.40), for which several different structures are possible. 
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Figure 3.38  HR-ESI-MS spectra of kanamycin-triOPA/MCE derivative, (M.W. = 
1012.3268, C48H60N4O14S3) expected m/z [M+H]
+ ion = 1013.3346 (found = 1013.3363) and 
[M+ Na]+ ion m/z = 1035.3166 (found = 1035.3171). 
 
N
N
S
O
O
OH
OH
OH
O O
OH
OH
OH
OH
N
S
N
S
OH
OH
OH
S
OH
 
 
 
Figure 3.39  Kanamycin-tetraOPA/MCE derivative. 
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Figure 3.40  HR-ESI-MS spectra of kanamycin-diOPA/MCE derivative, (M.W. = 836.2972, 
C38H52N4O13S2) expected m/z [M+H]
+ ion = 837.3050 (found = 837.3063), [M+ Na]+ ion m/z 
= 859.2869 (found = 859.2879) and [M+K]+ ion m/z = 875.3955 (found = 875.2673). 
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Figure 3.41  Neomycin B. 
 - 86 - 
 
   
(A) 
 
 
 
(B) 
Figure 3.42  HPLC chromatogram of neomycin-pentaOPA/MCE (10 mM), HPLC 
conditions:  column: Phenomenex luna C18 5µ 150 x 4.60 mm, mobile phase is acetonitrile: 
Milli-Q-water (40:60) flow rate 1 mL/min, (A) fluorescence detection at λex = 340 nm, λem = 
450 nm.  (B) UV detection at λmax = 340 nm.  The chromatogram shows the solvent front at 
Rt = 1.0 min and neomycin-pentaOPA/MCE derivative at Rt = 16.7 min. 
 
The method for derivatization of kanamycin with OPA/MCE was also used to investigate 
neomycin.  Neomycin (Figure 3.41) is mainly composed of a mixture of neomycin B and its 
stereoisomer neomycin C (3-15% of the mixture) (Dutcher et al., 1951).  It is produced by 
cultures of Streptomyces fradiae (Waksman, 1949).  The structure contains three sugar 
residues linked to 2-deoxystreptamine.  One of these is the common sugar D-ribose.  
0 6 12 18 mins 
0 6 12 18 mins 
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Neomycin has very good activity against Gram-positive and Gram-negative bacteria, but it 
has a narrow therapeutic range and is ototoxic  For neomycin, ratios of OPA/MCE to 
neomycin up to 15-fold were required to achieve a symmetrical peak at 16.7 min (Figure 
3.42) eluted with mobile phase 40% acetonitrile in Milli-Q-water.  HR-ESI-MS analysis of 
the derivative peak showed neomycin-pentaOPA/MCE (Figure 3.43).  Instead of the 
expected hexaOPA/MCE as with kanamycin-triOPA/MCE, this may be due to the steric 
effect of the two amine groups on the same 2-deoxy streptamine ring.  The two amine groups 
on the D-neosamine and L-neosamine of neomycin are unlikely to show such a steric effect 
due to the rigidity of the ring which holds the amine groups at positions two and six well 
apart. 
 
 
Figure 3.43  HR-ESI-MS spectra of neomycin-pentaOPA/MCE derivative, (M.W. = 
1494.4602, C73H86N6O18S5) expected m/z [M+H]
+ ion = 1495.4680 (found = 1495.4711), 
[M+ Na]+ ion m/z = 1517.4499 (found = 1517.4464) and [M+K]+ ion m/z = 1533.5585 
(found = 1533.4270). 
 
This OPA/MCE method for aminoglycosides is easy and simple to perform, the time of 
reaction (10 min) is also practical, and no process of extraction is needed.  The derivatives of 
aminoglycosides-OPA/MCE are more stable than the aliphatic amines.  RP-HPLC with C-18 
column and isocratic mobile phase of acetonitrile and Milli-Q-water were used to separate 
aminoglycosides.  By this method, we could use either UV or fluorescence detection to 
examine the aminoglycosides-OPA/MCE derivatives.  Thus it is possible to introduce HPLC 
in official monographs to replace a microbiological assay (Adams et al., 1998). 
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The two step derivatization of OPA/MCE/FMOC 
 
The method of derivatization by OPA/MCE did not give stable peaks for spermidine and 
spermine-OPA/MCE derivatives in the HPLC chromatogram.  Derivatives for molecules 
such as spermidine and spermine may be unstable due to their secondary amine groups 
which do not form OPA/MCE derivatives, but which may lead to rapid breakdown of the 
primary amine derivatives.  A two-step derivatization process, by applying OPA/MCE 
followed by FMOC reagent was explored.  By this method, spermidine and spermine should 
be fully labelled, at their primary amines with OPA/MCE and at their secondary amines with 
FMOC.  This process resulted in more stable derivatives, detected by both fluorescence and 
UV absorption of both chromophores and gave reproducible responses.  The derivatization 
product of spermidine-diOPA/MCE-monoFMOC (Figure 3.44) and spermine-diOPA/MCE-
diFMOC (Figure 3.47) gave symmetrical HPLC peaks (Figures 3.45 and 3.49, respectively) 
in terms of increased fluorescent responses and better reproducibility.  Table 3.6 shows the 
retention times of spermidine-diOPA/MCE-monoFMOC and spermine-diOPA/MCE-
diFMOC derivative using hypersil C-18 column when the mobile phase was changed.  
Spermidine-diOPA/MCE-monoFMOC derivative and spermine-diOPA/MCE-diFMOC 
derivatives show the expected m/z by HR-ESI-MS (Figures 3.46 and 3.48 respectively). 
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Figure 3.44  Spermidine-diOPA/MCE-monoFMOC. 
 
Table 3.6  Retention time of spermidine-diOPA/MCE-mono derivative and spermine-
diOPA/MCE-diFMOC derivative. 
 
Rt (min) Mobile phase 
Spermidine Spermine 
65% Acetonitrile : 35% Milli-Q-Water 25.7 - 
70% Acetonitrile : 30% Milli-Q-Water 22.0 49.5 
80% Acetonitrile : 20% Milli-Q-Water 6.5 18.0 
85% Acetonitrile : 15% Milli-Q-Water 5.3 9.0 
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Figure 3.45  HPLC chromatogram of spermidine-diOPA/MCE-monoFMOC derivative, 
HPLC conditions:  column: Phenomenex hypersil C18 5µ 150 x 4.60 mm, mobile phase is 
acetonitrile: Milli-Q-water (65:35) with flow rate 1 mL/min, fluorescence detection at λex = 
340 nm, λem = 450 nm.  The chromatogram shows the solvent front at Rt = 1.0 min and 
spermidine-diOPA/MCE-monoFMOC derivative at Rt = 25.7 min. 
 
 
Figure 3.46  HR-ESI-MS spectrum of spermidine-diOPA/MCE-monoFMOC derivative, 
(M.W. = 719.2852, C42H45N3O4S2) expected m/z [M+H]
+ ion = 720.2929 (found = 
720.2919), [M+ Na]+ ion m/z = 742.2749 (found = 742.2709) and [M+K]+ ion m/z = 
758.3835 (found = 758.2474). 
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Figure 3.47  Spermine-diOPA/MCE-diFMOC. 
 
 
Figure 3.48  HR-ESI-MS spectra of spermine-diOPA/MCE-diFMOC derivative, (M.W. = 
998.4111, C60H62N4O6S2) expected m/z [M+H]
+ ion = 999.4189 (found = 999.4192), [M+ 
Na]+ ion m/z = 1021.4009 (found = 1021.3971) and [M+K]+ ion m/z = 1037.5093 (found = 
1037.3732). 
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Figure 3.49  HPLC chromatogram of spermine-diOPA/MCE-diFMOC derivative, HPLC 
conditions:  column: Phenomenex hypersil C18 5µ 150 x 4.60 mm, mobile phase is 
acetonitrile: Milli-Q-water (85:15) with flow rate 1 mL/min, fluorescence detection at (A) 
FMOC wavelength λex = 264 nm, λem = 310 nm (B) OPA wavelength λex = 340 nm, λem = 
450 nm.  The chromatogram shows the solvent front at Rt = 1.0 min and peak 1 = spermine-
diOPA/MCE-diFMOC derivative at Rt = 9 min. 
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3.2 Primary amine-fluorescamine derivatives 
 
Fluorescamine, (4-phenylspiro [furan-2(3H),1-phthalan]-3,3-dione) a heterocyclic dione, is a 
selective fluorophore which reacts with primary amines to form a highly fluorescent product.  
Udenfriend first described that phenylacetaldehyde, which is formed by oxidative 
decarboxylation of phenylalanine by ninhydrin, reacts with an excess of ninhydrin and with a 
primary amino group to give a 5-(2-carboxyphenyl)-5-hydroxy-3-phenyl-2-pyrroline-4-one 
derivative with  highly fluorescent yield (λex = 275, 390 nm, λem = 480 nm) (Udenfriend et 
al., 1972).  This main fluorescent product was characterized as a pyrrolinone which led to 
the synthesis of fluorescamine (Debernar et al., 1974).  Ammonia also reacts with 
fluorescamine, but the product has little fluorescence.  The scheme of amine-fluorescamine 
reaction is shown in Figure 3.50. 
O
O
O
O
RN
OH
O
O
OH
O
O
O
O
NH
R
+ RNH2
Fluorescamine
Fluorophore  
Figure 3.50  Amine-fluorescamine reaction. 
 
Fluorescamine is a non-fluorescent compound that reacts with primary amines at room 
temperature to yield a highly fluorescent product.  The excess of reagent is destroyed by 
water to form a non-fluorescent hydrolysis product (Stein et al., 1974).  The reaction of 
fluorescamine with primary amines is strongly pH dependent and also the fluorescence is 
developed only in alkaline media (pH of 8.0-9.5) and disappears completely in acidic media.  
The derivatives of amines-fluorescamine are formed immediately and are stable for at least 1 
day so they are more stable than OPA derivatives.  The method of preparation of the amines-
fluorescamine was tested (HPLC chromatogram shown in Figure 3.51, retention time shown 
in Table 3.7) and the calibration curves obtained were linear (Table 3.8, Figure 3.52).  The 
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good linearity of the calibration curves is clearly evident by the values of the correlation 
coefficients.  Derivatization of spermidine and spermine was attempted, but no stable 
products were observed by HPLC. 
 
 
 
 
Figure 3.51  HPLC chromatogram of various amine-fluorescamine derivatives, HPLC 
conditions:  column: Phenomenex hypersil C18 5µ 150 x 4.60 mm, mobile phase is 
methanol: Milli-Q-water (40:60), flow rate 1 mL/min, fluorescamine fluorescence detection 
at λex = 400 nm, λem = 475 nm.  The chromatogram shows the solvent front at Rt = 1.3 min, 
peak 1 = 1-Butylamine-monofluorescamine at Rt = 3.2 min, peak 2 = 1,4-diaminobutane-
monofluorescamine at Rt = 3.8, peak 3 = 1,5-diaminopentane-monofluorescamine at Rt = 8.8 
min, peak 4 = 1,7-diaminoheptane-monofluorescamine at Rt = 12.8 min. 
 
Table 3.7  Retention time of various amine-fluorescamine derivatives. 
 
Amine-fluorescamine derivatives Rt (min) 
eluted by 
40% MeOH  
Rt (min) 
eluted by 
50% MeOH 
Rt (min) 
eluted by 
70% MeCN 
1-Butylamine-monofluorescamine 3.2 2.30 1.5 
1,4-Diaminobutane-monofluorescamine 3.8 - - 
1,5-Diaminopentane-monofluorescamine 8.8 - - 
1,7-Diaminoheptane-monofluorescamine 12.8 8.30 1.8 
 
1 
2 
3 4 
0 6 12 mins 
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Table 3.8  The calibration curves’ equations for various amine-fluorescamine derivatives. 
 
Amine-fluorescamine derivatives Calibration curve equation R2 
1-Butylamine-monofluorescamine y = 1.245x +0.08 0.997 
1,4-Diaminobutane-monofluorescamine y = 1.501x + 0.16 0.994 
1,5-Diaminopentane-monofluorescamine y = 2.223x + 0.19 0.995 
1,7-Diaminoheptane-monofluorescamine y = 2.349x - 0.04 0.991 
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Figure 3.52  Calibration curves of amine-fluorescamine derivatives (n = 5). Peak areas were 
calculated by height x 0.5 width of peak, and peak areas are reported in cm2. 
 
HR-ESI-MS 
 
The HR-ESI-MS for fluorescamine derivatives was investigated to confirm the structures of 
the derivatives as 1-butylamine gave the expected mono-fluorescamine derivative (Figure 
3.53).  1,4-Diaminobutane (putrescine) could potentially form both mono- and di-fluorescent 
derivatives, but from the HPLC and MS results only the mono-derivative of fluorescamine 
was observed (Figure 3.54).  The di-fluorescamine moiety attached to putrescine is expected 
to give m/z [M+H]+ ion = 645.2237 (M.W = 644.2159, C38H32N2O8) which was not 
observed.  This may be due to some steric hindrance in forming the second derivative of 
monofluorescamine-1,4-diaminobutane. 
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Figure 3.53  HR-ESI-MS spectra of 1-butylamine-monofluorescamine derivative, (M.W. = 
351.1471, C21H21NO4) expected m/z [M+H]
+ ion = 352.1549 and [M+ Na]+ ion m/z = 
374.1368 (found = 374.1362).  
 
 
Figure 3.54  HR-ESI-MS of 1,4-diaminobutane (putrescine)-monofluorescamine derivative, 
M.W. = 366.1579, C21H22N2O4, the expected m/z [M+H]
+ ion = 367.1658 (found = 
367.1649). 
 
For 1,5-diaminopentane (cadaverine) the monofluorescamine derivative was the major 
product with a trace of the di-fluorescamine derivative as shown in Figures 3.55 and 3.56. 
 
 
Figure 3.55  HR-ESI-MS of 1,5-diaminopentane (cadaverine)-monofluorescamine 
derivative M.W. = 380.1736, C22H24N2O4, the expected m/z [M+H]
+ ion = 381.1814 (found 
= 381.1784). 
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Figure 3.56  HR-ESI-MS of 1,5-diaminopentane (cadaverine)-difluorescamine derivative 
(C39H34N2O8, M.W. = 658.2315) is expected at m/z [M+H]
+ ion = 659.2393 (found = 
659.2422) and [M+ Na]+ ion as C39H34N2NaO8 m/z = 681.2213 (found = 681.2210). 
 
For 1,7-diaminoheptane-monofluorescamine derivative, M.W. = 408.2049 C24H28N2O4, the 
expected m/z [M+H]+ ion = 409.2127.  Also, the 1,7-diaminoheptane-difluorescamine 
moiety is expected at m/z [M+H]+ ion = 687.2706 (M.W. = 686.2628, C41H38N2O8) (Figure 
3.57). 
 
 
Figure 3.57  HR-ESI-MS of 1,7-diaminoheptane-monofluorescamine derivative, M.W. = 
408.2049, C24H28N2O4, the expected m/z [M+H]
+ ion = 409.2127. 
 
The derivatives of fluorescamine were stable in neutral and mildly alkaline media.  In acidic 
solutions the fluorescence rapidly deteriorated. 
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Relative quantum yield of amine-fluorescamine derivatives 
 
A comparison of fluorescence yields of the model amine series was obtained by comparison 
between the fluorescence intensity and UV absorption by collected the elution products from 
HPLC and separate measurement by fluorescence spectrometer and UV/VIS 
spectrophotometer.  A plot of fluorescence intensity against UV absorbance (Figure 3.58) 
and the FI/UV equation (Table 3.9) were obtained.  The results show that fluorescence yield 
is equal when one fluorophore is derivatized to each amine molecule. 
 
Table 3.9  The FI/UV equation of amine-fluorescamine derivatives. 
 
Amine-Fluorescamine derivatives FI/UV equation R2 
1-Butylamine-monofluorescamine y = 5661.3x – 24.91 0.993 
1,4-Diaminobutane-monofluorescamine y = 5410.3x – 17.83 0.999 
1,5-Diaminopentane-monofluorscamine y = 5437.1x – 22.64 0.998 
1,7-Diaminoheptane-monofluorescamine y = 5441.6x – 12.60 1.000 
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Figure 3.58  Plots of fluorescence intensity against absorbance at λex of  amine-
monofluorescamine derivatives (n = 5). 
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Fluorescamine derivative of glucosamine 
 
 
 
(A) 
 
       
 
   (B)     (C) 
 
Figure 3.59  HPLC chromatogram of glucosamine-fluorescamine derivatives (50 mM).  
HPLC conditions:  column: Phenomenex luna C18 5µ 150 x 4.60 mm, mobile phase is 
acetonitrile: Milli-Q-water (30:70) with flow rate 1 mL/min, UV detector at λmax = 330 nm.  
Glucosamine-fluorescamine derivatives Rt = 4.5, 5.0, 5.4 min.  (A) Blank  (B) injection 1  
(C) injection 2. 
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Prior to investigation of the aminoglycoside derivatization by fluorescamine, glucosamine 
(with only 1 amine group) was tested as a simple model.  The HPLC chromatogram of 
glucosamine-fluorescamine derivative showed three peaks as in Figure 3.59, probably due to 
the formation of several diastereoisomeric products.  The peak area and peak height of each 
peak were not stable possibly due to derivatization influencing the proportions of the two 
anomers of glucosamine.  However, at least the stereoisomers of glucosamine-fluorescamine 
derivatives were separated on the reversed phase C18 column under the chromatographic 
conditions described. 
 
HR-ESI-MS of peak 1 (Figure 3.60), peak 2 (Figure 3.61) and peak 3 (Figure 3.62) all 
showed similar MS profiles with the expected m/z [M+H]+ ion = 458.1451 (glucosamine-
monofluorescamine derivative, C23H23NO9, M.W. = 457.1373) and m/z [M+Na]
+ ion 
(C23H23NNaO9) = 480 and a probable [M+H-H2O]
+ at m/z = 440.1345. 
 
 
Figure 3.60  HR-ESI-MS of glucosamine-fluorescamine derivative (C23H23NO9, M.W. = 
457.1373) from peak 1 expected at m/z [M+H]+ ion = 458.1451 (found = 458.1445), m/z 
[M+Na]+ ion (C23H23NNaO9) = 480.1249 and [M+H-H2O]
+ at m/z = 440.1345.  
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Figure 3.61  HR-ESI-MS of glucosamine-fluorescamine derivative (C23H23NO9, M.W. = 
457.1373) from peak 2 expected at m/z [M+H]+ ion = 458.1451 (found = 458.1460), m/z 
[M+Na]+ ion (C23H23NNaO9) = 480.1249 (found = 480.1291) and [M+H-H2O]
+ at m/z = 
440.1345 (found = 440.1345).  
 
 
 
Figure 3.62  HR-ESI-MS of glucosamine-fluorescamine derivative (C23H23NO9, M.W. = 
457.1373) from peak 3 expected at m/z [M+H]+ ion = 458.1451 (found = 458.1436), m/z 
[M+Na]+ ion (C23H23NNaO9) = 480.1249 (found = 480.1267) and [M+H-H2O]
+ at m/z = 
440.1345 (found = 440.1339). 
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Reaction of chiral non-fluorescent fluorescamine with a chiral amine begins by nucleophilic 
addition of the amine nitrogen to the C=C double bond of fluorescamine resulting in the 
breakage of a C-O bond and loss of fluorescamine’s chiral centre (to yield the diketone).  
Closing the 5-membered ring by a second nucleophilic attack of the amine nitrogen on the 
benzoyl ketone forms a fluorescent product with two chiral centres (Figure 3.63). 
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Figure 3.63  The reaction mechanism of the fluorescamine derivatization for amines. 
 
As from Figure 3.63, fluorescamine itself is a chiral molecule so when it reacts with a non-
chiral amine it will give rise to a pair of enantiomers.  Glucosamine (Figure 3.64) is an 
example of a chiral molecule which when it reacts with fluorescamine generates two 
diastereoisomers.  The existence of two anomeric forms of glucosamine will lead to the 
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formation of four diastereoisomeric products (Figure 3.65).  From the HPLC chromatogram 
(Figure 3.59), the four diastereoisomeric products of glucosamine-monofluorescamine 
derivatives show just three peaks, where in one peak might be the combination of two 
diastereoisomers and these three peaks are not reproducible in the heights which is probably 
due to the changeable ratios of the four anomers. 
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Figure 3.64  D-Glucosamine, C6H13NO5. 
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Figure 3.65  Structure of four fluorescent stereoisomers formed by the reaction of 
fluorescamine with glucosamine, where R and S relate to the chiral centre of fluorescamine, 
α and β relate to the anomeric centre of glucosamine. 
 
Thus, the derivatization of the polyamine aminoglycoside with fluorescamine was not 
pursued due to the likelihood of highly complex stereochemical mixtures being produced. 
 
Rα Sα 
Rβ Sβ 
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Conclusions of o-phthalaldehyde-mercaptoethanol (OPA/MCE) derivatization 
 
The reaction of o-phthalaldehyde (OPA) and 2-mercaptoethanol (MCE) selectively with 
primary amine gives a 1-alkylthio-2-alkylisoindole as the fluorogenic product.  Investigating 
the derivatization of amines as amine-OPA/MCE, the reaction occurred in alkaline media 
(pH 8.3–10.5) and the optimized pH which gave fewer by-products was 10.5.  By varying 
the composition of the OPA reagent in the reaction, it was demonstrated that the higher the 
concentration of MCE (SH-group additive), the lower the amount of the transformed 
product.  Varying the mole ratios of the OPA/MCE from 1:1 to 1:17, it was shown that the 
optimum ratio of OPA/MCE was 1:10.  At this ratio, when compared to other ratios at a 
strict reaction time, it gave the highest derivative product.  However, at higher ratio than 
1:10, the rate suppression was observed at high thiol concentration.  This implied that the 
free OPA concentration favoured the transformation of the initially formed isoindole if the 
concentration of MCE is too much it might cause OPA-thiol adducts which decrease the free 
OPA concentration.  Stability of derivatives prepared under the same conditions, proved to 
be associated with the chain length of the aliphatic amines:  the longer the chain length the 
slower the decomposition of the total of derivatives formed.  It is important in choosing 
optimum reaction times for the amine in question.  In cases of aliphatic amines with number 
of C from 4 to 12, the optimum reaction time is 1 min, but for larger molecule with many 
amine groups such as aminoglycosides a reaction time required at 10 min.  Thus, this 
suggested that the optimum reaction time need to be considered depend on the compound to 
be derivatized to obtain the maximum responses.  The advantage of amine-OPA/MCE 
derivatization is the simplicity of derivatization method with rapid reaction, short analysis 
time, and no process of extraction.  However, the drawback of OPA/MCE derivatization is 
the instability of the derivative. 
 
Conclusions of fluorescamine derivatization 
 
Fluorescamine is highly reactive with primary amines to produce fluorescent products, also 
fluorescamine and its hydrolysis products are non-fluorescent.  This property makes a clean 
chromatographic separation.  The results showed just one moiety of fluorescamine reacted 
with a diamine.  Therefore, steric hindrance of the bulky fluorescamine molecule made 
difficulty to complete the reaction of fluorescamine with all the amine positions even in 
small aliphatic diamines.  Also to be considered when using fluorescamine as the labelling 
reagent is that fluorescamine, itself is a chiral molecule, thus when it reacts with another 
chiral molecule, there is a greater chance of obtaining many peaks from one sample which 
will complicate its quantification. 
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CHAPTER 4:  DERIVATIZATION OF PRIMARY AND SECONDARY AMINES 
WITH 9-FLUORENYLMETHYL-CHLOROFORMATE (FMOC Cl) 
 
9-Fluorenylmethyl chloroformate (FMOC Cl) reacts with primary and secondary amines 
(Carpino and Han, 1970, 1972; Koole et al., 1989) under alkaline conditions to form 
derivatives (Figure 4.1).  FMOC Cl forms derivatives with amines in a short reaction time in 
buffered aqueous solution at room temperature to yield stable derivatives, so it is useful for 
analytical purposes (Moye and Boning, 1979).  The FMOC Cl was originally introduced into 
analytical practice (Einarsson et al., 1983) as a fluorescent label in amino acid analysis.  
Unfortunately, when a portion of the derivatization mixture was injected directly after the 
reaction, many interference peaks resulted.  This was expected, because FMOC Cl reagent 
remained after the reaction and its hydrolytic by-products (Figure 4.2) have almost identical 
excitation and emission spectra (Lopez, 1996; Varady et al., 2000). 
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Figure 4.1  Reaction of FMOC Cl with an amine. 
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Figure 4.2  Hydrolysis reaction of FMOC Cl. 
 
FMOC Cl, its derivatives and its cleavage products are strong chromophores absorbing at 
λmax = 264 nm which allow spectrophotometric analysis.  FMOC Cl is one of the few 
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protecting groups for amines that is not cleaved under acidic conditions, but it is readily 
cleaved under mildly basic conditions e.g. using piperidine (Figure 4.3) (Bayermann et al., 
1990; Carpino et al., 1990; Greene and Wuts, 1991).  In a subsequent slower step, 
elimination generates dibenzofulvene, an unstable species that rapidly adds nucleophiles, and 
a carbamate residue, which then decomposes with loss of carbon dioxide to release the free 
amine.  However, this deprotection method employs a large excess of secondary amine (in 
this case, piperidine) in dimethylformamide (DMF).  Use of piperidine/DMF is better suited 
to FMOC deprotections on solid-phase than in solution (Sheppeck II et al., 2000). 
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Figure 4.3  Deprotection of amine-FMOC by piperidine. 
 
The derivatization reaction of FMOC Cl was optimized by using 1-butylamine and 1,5-
diaminopentane solutions (1 mM in water) as the models for monoamine and diamine for 
various factors such as:  the reaction time, FMOC Cl concentration, pH of the buffer and 
fluorescence spectrum.  The HPLC chromatograms of blank-FMOC and 1-butylamine-
monoFMOC (Figure 4.4) both show a peak of hydrolysis product of FMOC Cl reagent at Rt 
= 3.6 min.  The HR-ESI-MS of 1-butylamine-monoFMOC (Figure 4.5) proved that the peak 
labelled 2 (Figure 4.4 (B)) is the desired molecule. 
 
It has been reported that a reaction time of 1 min is sufficient for complete derivatization of 
amino acids with FMOC-C1 (Einarsson et al., 1983) and other authors (Gustavsson and 
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Betner, 1990) reported that most amino acids were fully derivatized after 30 s.  In this study, 
the reaction time was examined by allowing the derivatization to proceed for various times 
ranging from 1 to 60 min.  The amine-FMOC derivative was formed within 1 min, but the 
optimum yield was obtained at 5 min after which the yields slightly decreased (Figure 4.6).  
The hydrolysis reaction of FMOC Cl also occurred which was observed as a small amount of 
precipitate and gave undesirable chromatographic peaks.  These undesirable 
chromatographic peaks were observed when the reaction time was greater than 10 min and 
when a high concentration of FMOC Cl reagent was used. 
 
      
 
 
   (A)     (B) 
 
Figure 4.4  HPLC chromatogram of amine-FMOC derivatives, HPLC conditions:  column: 
Phenomenex hypersil C18 5µ 150 x 4.60 mm, mobile phase is acetonitrile: Milli-Q-water 
(65:35) flow rate 1 mL/min, fluorescence detection at λex = 264 nm, λem = 390 nm.   
(A)  Chromatogram of blank-FMOC shows the solvent front at Rt = 1.1 min, peak 1 = 
hydrolysis product of FMOC Cl reagent at Rt = 3.6 min. 
(B)  Chromatogram of 1-butylamine-monoFMOC shows the solvent front at Rt = 1.1 min, 
peak 1 = hydrolysis product of FMOC Cl reagent at Rt = 3.6 min, peak 2 = 1-butylamine-
monoFMOC derivative at Rt = 8.9 min. 
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Figure 4.5  HR-ESI-MS spectra of 1-butylamine-monoFMOC derivative, (M.W. = 
295.1572, C19H21NO2) expected m/z [M+H]
+ ion = 296.1650 (found = 296.1624), [M+Na]+ 
ion m/z = 318.1469 and [2M+Na]+ ion m/z = 613.3042 (found = 613.3045). 
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Figure 4.6  Effect of reaction time of 1-butylamine-mono FMOC derivative and 1,5-
diaminopentane-di FMOC derivative.  Both derivatives show the maximum yield at 5.0 min 
(n = 5).  Peak areas were calculated by height x 0.5 width of peak, and peak areas are 
reported in cm2. 
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Optimization of the concentration of FMOC Cl reagent 
 
The influence of concentration of FMOC Cl reagent on the reaction yield was examined in 
the range of 1-10 mM by reacting with 1 mM of mono- and diamine samples.  The optimum 
condition for 1, 5-diaminopentane-diFMOC derivative was gained when 4 mM FMOC Cl 
reagent reacted with 1 mM 1,5-diaminopentane.  For 1 mM 1-butylamine, a stable peak area 
was observed from 2 mM FMOC Cl reagent (Figure 4.7).  It was concluded that a 2-fold 
excess of FMOC is required to achieve complete reaction. 
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Figure 4.7  Effect of FMOC Cl reagent concentration (n = 5).  Using 1 mM 1-butylamine, 
and 1 mM of 1,5-diaminopentane reacted with various concentration of FMOC Cl reagent.  
Peak areas were calculated by height x 0.5 width of peak, and peak areas are reported in cm2. 
 
Optimization for the effect of pH of the borate buffer 
 
Since the reaction of FMOC Cl with amines is reported to occur better under alkaline 
condition (Price et al., 1987; Gao et al.,1990; Tonin et al., 1991) the optimization of the pH 
of the borate buffer was investigated.  1-Butylamine was used as the model compound for 
this study, using 200 mM borate buffer range of pH 4.0–10.5 for the reaction (Figure 4.8).  
The optimum reaction occurred at pH 9.0-10.5.  In addition to the higher yield of 1-
butylamine-monoFMOC derivative at higher pH there was also a reduction of multiple by-
product peaks, most probably due to the hydrolysis of FMOC Cl reagent.  The optimum pH 
of borate buffer at 9.5 was used for FMOC derivatization. 
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Figure 4.8  Effect of various pH of borate buffer on the 1-butylamine-monoFMOC 
derivative yield (n = 5).  Peak areas were calculated by height x 0.5 width of peak, and peak 
areas are reported in cm2. 
 
Methods to terminate the reaction of FMOC Cl 
 
The excess of FMOC Cl reagent reacts with water to form FMOC OH, which is also 
fluorescent and which may cause interference in the chromatogram.  To overcome this 
problem, a modification of the pre-column derivatization with FMOC described by Price et 
al. (1987) was developed, based on the addition of aspartic acid to the reaction mixture.  In 
their study, after the derivatization of polyamines, the excess of FMOC was reacted with 
aspartic acid to form an aspartic-FMOC derivative.  This derivative distributed into the 
aqueous phase, while the hydrophobic FMOC-polyamines were extracted with pentane.  The 
addition of aspartic acid did not affect the reaction yield and minimized the formation of 
FMOC-alcohol and reaction by-products.  The reactions with different amines were 
examined by the other research groups using adamantanyl amine (Gustavsson and Betner, 
1990), heptylamine (Kirschbaum and Lukkas, 1994), glycine (Stead and Richards, 1996). 
 
In this study, three main methods of termination of the reaction and removal of the excess of 
FMOC Cl were investigated.  In method 1, the excess of FMOC was removed by the 
reaction with alanine 100 mM, method 2 removes the excess of FMOC Cl by extraction of 
amine-FMOC derivatives with pentane after derivatization, and method 3 uses glacial acetic 
acid to stop the reaction at the desired time (Lopez et al., 1996).  In a series of experiments, 
these methods were evaluated alone and in combination against controls as shown in Table 
4.1. 
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Table 4.1  Termination of FMOC Cl reaction experiments. 
 
Termination method  
Experiment No. Addition of alanine pH reduction with 
Glacial acetic acid 
Extraction with 
pentane 
1    
2 √   
3  √  
4 √ √  
5   √ 
6 √  √ 
7  √ √ 
8 √ √ √ 
 
Experiments 1 to 4 were done without extraction with pentane while experiments 5 to 8 used 
pentane for separation of the amine-FMOC derivatives as the last step.  Experiment 1, 5 mM 
1-butylamine reacts with FMOC Cl in alkaline environment without removal of the excess of 
FMOC reagent (Figure 4.9).  In experiment 2, after 5 min of reaction time, the excess of 
FMOC reagent was removed by using alanine (Figure 4.9).  In experiment 3, the reaction 
was stopped by the addition of glacial acetic acid.  In experiment 4, alanine followed by 
glacial acetic acid was used to stop the reaction.  Experiments 5, 6, 7 and 8 involved the 
extraction with pentane at the end of the reaction.  Experiment 5 is equal to experiment 1, 
experiment 6 = experiment 2, experiment 7 = experiment 3 and experiment 8 = experiment 
4, but with the extraction step as the last step before dilution of the sample and injection onto 
HPLC. 
 
The HPLC chromatograms from each experiment above were obtained (Figures 4.9 and 
4.10) and the peak areas of the desired product (n = 5) were compared as histograms (Figure 
4.13).  The identities of the hydrolysis product of FMOC peak at Rt = 5.3 min and the 
alanine-monoFMOC derivative peak at Rt = 1.2 min were confirmed by HR-ESI-MS 
(Figures 4.11 and 4.12). 
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   Experiment 1   Experiment 2 
          
 
   Experiment 3   Experiment 4 
 
Figure 4.9  HPLC chromatogram of 1-butylamine-monoFMOC derivatives by different 
methods of stopping the reaction, HPLC conditions:  column: Phenomenex hypersil C18 5µ 
150 x 4.60 mm, mobile phase is acetonitrile: Milli-Q-water (70:30) with flow rate 1 mL/min, 
fluorescence detector x10 sensitivity at λex = 264 nm, λem = 390 nm.  Retention time of 1-
butylamine-monoFMOC is 6.8 min.  Experiment 1, the chromatogram shows the peaks at Rt 
= 3.0, 5.3, 6.8 min.  Experiment 2, the chromatogram shows the peaks at Rt = 1.2, 3.0, 6.8 
min.  Experiment 3, the chromatogram shows the peaks at Rt = 3.0, 5.3, 6.8, 7.9 min.  
Experiment 4, the chromatogram shows the peaks at Rt = 2.0, 3.0, 5.3, 6.8 min. 
0 0 6 6 mins mins 
0 0 6 6 mins mins 
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Experiment 5    Experiment 6 
          
 
  Experiment 7    Experiment 8 
 
Figure 4.10  HPLC chromatogram of 1-butylamine-monoFMOC derivatives with different 
methods of stopping the reaction, HPLC conditions:  column: Phenomenex hypersil C18 5µ 
150 x 4.60 mm, mobile phase is acetonitrile: Milli-Q-water (70:30) with flow rate 1 mL/min, 
fluorescence detector x10 sensitivity at λex = 264 nm, λem = 390 nm.  Retention time of 1-
butylamine-monoFMOC is 6.8 min.  Experiment 5, the chromatogram shows the peaks at Rt 
= 3.0, 5.3, 6.8, 7.9 min.  Experiment 6, the chromatogram shows the peaks at Rt = 1.2, 3.0, 
6.8 min.  Experiment 7, the chromatogram shows the peaks at Rt = 3.0, 5.3, 6.8, 7.9 min.  
Experiment 8, the chromatogram shows the peaks at Rt = 2.0, 3.0, 5.3, 6.8 min. 
0 0 6 6 mins mins 
0 0 6 6 mins mins 
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Figure 4.11  HR-ESI-MS spectrum of hydrolysis product of FMOC reagent, (M.W. = 
178.0783, C14H10) expected m/z [M+H]
+ ion = 179.0861 (found = 179.0858). 
 
 
 
Figure 4.12  HR-ESI-MS spectrum of alanine-monoFMOC derivative, (M.W. = 311.1158, 
C18H17NO4) expected m/z [M+H]
+ ion = 312.1236 (found = 312.1221) and [M+ Na]+ ion m/z 
= 334.1055 (found = 334.1043). 
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Figure 4.13  Comparison of 1-butylamine-monoFMOC derivatives’ peak area obtained by 
different methods of terminating the reaction.  The 1-butylamine-monoFMOC derivative is 
at Rt = 6.8 min (blue column).  Peak areas were calculated by height x 0.5 width of peak, and 
peak areas are reported in cm2. 
 
The histogram (Figure 4.13) shows 1-butylamine-monoFMOC derivatives (bars marked with 
arrows).  The chromatogram obtained from the direct injection after the derivatization 
(without the extraction) from Experiment 1 gave the highest peak area, but also showed a 
large peak area of hydrolysis product of FMOC Cl (Rt = 5.3 min).  Experiment 2 gave a 
good chromatogram without the hydrolysis peak, but it showed the peak for alanine-
monoFMOC derivative (Rt = 1.2 min).  Using glacial acetic acid to stop the reaction, created 
one more interfering peak at Rt = 7.9 min.  When both alanine and glacial acetic acid were 
used the 1-butylamine-monoFMOC derivative peak was decreased.  The peak areas that 
were obtained from the extraction method seemed to be less than the non-extraction methods 
which might be due to incomplete extraction of amine-FMOC derivative.  Experiment 6 
gave the best chromatogram in terms of less interfering peaks and showed that the alanine-
monoFMOC derivative was left in the aqueous phase after extraction with pentane.  Thus, 
the method in which the reaction was terminated by alanine and the amine derivatives 
extracted with pentane was chosen for derivatization of various amines. 
 
The amine-FMOC derivatives were separated by HPLC and the results from 5 replicates are 
shown in Table 4.2 using isocratic mobile phase of 70% acetonitrile: Milli-Q-water (Figure 
4.14). 
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Figure 4.14  HPLC chromatogram of amines-FMOC derivatives, HPLC conditions:  
column:  Phenomenex hypersil C18 5µ 150 x 4.60 mm, mobile phase is acetonitrile: Milli-Q-
water (70:30) with flow rate 1 mL/min, fluorescence detector x10 sensitivity at λex = 264 nm, 
λem = 390 nm. HPLC chromatogram of mixed amines-FMOC derivatives, 1 = 1-butylamine-
monoFMOC, 2 = 1,4-diaminobutane-diFMOC, 3 = 1,5-diaminopentane-diFMOC, 4 = 1,7-
diaminoheptane-diFMOC, 5 = spermidine-triFMOC. 
 
Table 4.2  The calibration curves of various amine-FMOC derivatives. 
 
Amine-FMOC derivatives Rt (min) Calibration curve equation R2 
1-Butylamine-monoFMOC 5.3 y = 0.091x +0.34 0.986 
Piperidine-monoFMOC 7.4 y = 0.019x – 0.01 0.990 
Piperazine-diFMOC 13.5 y = 0.023x - 0.16 0.999 
1,4-Diaminobutane-diFMOC 7.5 y = 0.054x + 0.41  0.995 
1,5-Diaminopentane-diFMOC 8.6 y = 0.113x - 1.51 0.998 
1,7-Diaminoheptane-diFMOC 13.0 y = 0.062x + 0.97 0.999 
Spermidine-triFMOC 27.7 y = 0.109x – 0.66 0.998 
2 
1 
3 
4 5 
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Figure 4.15  Calibration curves of amine-FMOC derivatives (n = 5).  HPLC condition:  
column:  Phenomenex hypersil C18 5µ 150 x 4.60 mm, mobile phase:  acetonitrile: Milli-Q-
water (70:30) flow rate 1 mL/min, fluorescence detection at λex = 264 nm, λem = 390 nm.  
Peak areas were calculated by height x 0.5 width of peak, and peak areas are reported in cm2. 
 
The calibration curves of amine-FMOC derivatives showed linearity with correlation 
coefficients higher than 0.99 (Figure 4.15, Table 4.2).   
 
 
Figure 4.16  HR-ESI-MS spectrum of 1,5-diaminopentane-diFMOC derivative, (M.W. = 
546.2519, C35H34N2O4) expected m/z [M+H]
+ ion = 547.2597 (found = 547.2610), [M+ Na]+ 
ion m/z = 569.2416 (found = 569.2400) and [M+K]+ ion m/z = 585.3502 (found 585.2159). 
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Peaks collected from the HPLC chromatogram were confirmed by HR-ESI-MS as the 
expected molecular mass for 1,5-diaminopentane-diFMOC derivative (Figure 4.16), 1,7-
diaminoheptane-diFMOC derivative (Figure 4.17), piperidine-monoFMOC (Figure 4.18) and 
piperazine-diFMOC (Figure 4.19). 
 
 
 
Figure 4.17  HR-ESI-MS spectrum of 1,7-diaminopentane-diFMOC derivative, (M.W. = 
574.2832, C37H38N2O4) expected m/z [M+H]
+ ion = 575.2909 and [M+ Na]+ ion m/z = 
597.2729 (found = 597.2745). 
 
 
Figure 4.18  HR-ESI-MS spectrum of piperidine-monoFMOC derivative, (M.W. = 
307.1572, C20H21NO2) expected m/z [M+H]
+ ion = 308.1651 (found = 308.1620) [M+ Na]+ 
ion m/z = 330.1470 and [2M+Na]+ ion m/z = 637.3042 (found = 637.3027). 
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Figure 4.19  HR-ESI-MS spectrum of piperazine-diFMOC derivative, (M.W. = 530.2206, 
C34H30N2O4) expected m/z [M+H]
+ ion = 531.2284 (found = 531.2277) and [M+ Na]+ ion 
m/z = 553.2103 (found = 553.2103). 
 
The relative quantum yield of amine-FMOC derivatives was studied.  A comparative 
analysis of fluorescence yields of the model series was obtained by collecting the elution 
product from HPLC and separate measurement by fluorescence spectrometer and UV/vis 
spectrophotometer.  A plot of fluorescence intensity against absorbance (Figure 4.20) and the 
FI/UV equation (Table 4.3) was obtained. 
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Table 4.3  The FI/UV equation of amine-FMOC derivatives. 
 
Amine-FMOC derivatives FI/UV equation R2 
Piperidine-monoFMOC y = 43929x – 65.31 0.993 
Piperazine-diFMOC y = 20302x - 36.39 0.998 
1,5-Diaminopentane-diFMOC y = 34174x – 89.53 0.999 
1,7-Diaminoheptane-diFMOC y = 32370x + 29.09 0.995 
Spermidine-triFMOC y = 14246x – 91.96 0.997 
 
0
100
200
300
400
500
600
700
0 0.005 0.01 0.015 0.02 0.025 0.03 0.035
UV absorption
F
lu
or
es
ce
nc
e 
in
te
ns
it
y 
   
 .
1,5-diaminopentane-diFMOC 1,7-diaminoheptane-diFMOC
piperidine-monoFMOC piperazine-diFMOC
spermidine-triFMOC
 
Figure 4.20  Fluorescence intensity against UV absorbance of amine-FMOC derivatives (n = 
5).  Peak areas were calculated by height x 0.5 width of peak, and peak areas are reported in 
cm2. 
 
The stability of the amine-FMOC derivatives was examined by using 1 mM of 1-butylamine 
as the model amine reacted with 4 mM FMOC Cl reagent for 5 min in the presence of borate 
buffer pH 9.5.  The reaction was terminated by the addition of alanine and then extracted 
with pentane.  The stability of the sample was monitored over the period 5 min after the 
reaction to 70 min.  The peak area of the derivative remained constant for more than 70 min 
after the derivatization reaction had been stopped.  Over a longer time scale, the 1-
butylamine-monoFMOC derivative was stable for at least 5 days (the sample was kept at 
20oC, and could be stable for longer periods if the sample is stored in a fridge) then the peak 
area gradually decreased to 75% after 2 weeks (Figure 4.21). 
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Figure 4.21  Stability of 1-butylamine-monoFMOC (n = 5).  Peak areas were calculated by 
height x 0.5 width of peak, and peak areas are reported in cm2. 
 
Spermidine and spermine-FMOC derivatives 
 
For biological polyamines spermidine and spermine, their derivatization requires larger 
quantities of reagent because of the presence the secondary amines.  Moreover, in 70% 
acetonitrile: Milli-Q-water the retention time of spermidine-triFMOC derivative was 27.7 
min and that of spermine-tetraFMOC derivative was likely to be even longer.  With a mobile 
phase of acetonitrile: methanol: Milli-Q-water = 85:10:5, the retention time of 1,7-
diaminoheptane-diFMOC derivative was 3.5 min and the retention times of spermidine-
triFMOC derivative and spermine-tetraFMOC derivative were also shorter (Table 4.4).  
Calibration curves of both biological amines were obtained (Figure 4.22).  HR-ESI-MS of 
spermidine-triFMOC derivative and spermine-tetraFMOC derivative were confirmed 
(Figures 4.23 and 4.24). 
 
Table 4.4  Calibration curve equations of biological polyamine-FMOC derivatives, the 
condition of HPLC: column: Phenomenex hypersil C18 5µ 150 x 4.60 mm, mobile phase is 
acetonitrile: methanol: Milli-Q-water (85:10:5) with flow rate 1 mL/min, fluorescence 
detection at λex = 264 nm, λem = 390 nm. 
 
Amine-FMOC derivatives Retention time Calibration curve R2 (n = 5) 
Spermidine 4.6 min y = 17.85x – 0.088 0.999 
Spermine 7.8 min y = 23.43x - 0.125 0.999 
 - 121 - 
0
0.5
1
1.5
2
2.5
0 0.02 0.04 0.06 0.08 0.1 0.12
concentration of amine-FMOC derivatives (mM)
pe
ak
 a
re
a
spermidine-triFMOC spermine-tetraFMOC
 
Figure 4.22  The calibration curve of polyamine-FMOC derivatives (n = 5).  The HPLC 
conditions:  column:  Phenomenex hypersil C18 5µ 150 x 4.60 mm, mobile phase is 
acetonitrile: methanol: Milli-Q-water (85:10:5) flow rate 1 mL/min, fluorescence detection at 
λex = 264 nm, λem = 390 nm.  Peak areas were calculated by height x 0.5 width of peak, and 
peak areas are reported in cm2. 
 
 
Figure 4.23  HR-ESI-MS spectrum of spermidine-triFMOC derivative, (M.W. = 811.3621, 
C52H49N3O6) expected m/z [M+H]
+ ion = 812.3699 and [M+ Na]+ ion m/z = 834.3519 (found 
= 834.3477). 
 
 
Figure 4.24  HR-ESI-MS spectra of spermine-tetraFMOC derivative, (M.W. = 1090.4881, 
C70H66N4O8) expected m/z [M+H]
+ ion = 1091.4959 and [M+ Na]+ ion m/z = 1113.4778 
(found = 1113.7389). 
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Analysis of spermidine and spermine as their hexahydropyrimidine derivatives. 
 
Spermidine and spermine were converted into their respective hexahydropyrimidine ring 
derivatives by reaction with formaldehyde (Figures 4.25 and 4.26) then labelled with FMOC.  
As FMOC does not react with tertiary amines these amines were detectable with shorter 
retention time when compared with the authentic molecules (spermidine and spermine) due 
to smaller molecular weight after labelling with two moieties of FMOC (Figure 4.27). 
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Figure 4.25  Reaction of spermidine with formaldehyde. 
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Figure 4.26  Reaction of spermine with formaldehyde. 
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Figure 4.27  Comparison of the FMOC derivatization products of spermidine, spermine, N-
(4-Aminobutyl) hexahydropyrimidine and 1,4-(Dihexahydropyrimidine)butane. 
 
Table 4.5  Retention time of biological polyamine-FMOC derivatives.  HPLC conditions:  
column:  Phenomenex hypersil C18 5µ 150 x 4.60 mm, mobile phase: acetonitrile: Milli-Q-
water (70:30) flow rate 1 mL/min, fluorescence detection at λex = 264 nm, λem = 390 nm. 
 
Amine-FMOC derivatives Retention time (min) 
Spermidine-triFMOC 27.7 
N-(4-Aminobutyl) hexahydropyrimidine-diFMOC 13.2 
Spermine-tetraFMOC 59.0 
1,4-(Dihexahydropyrimidine)butane-diFMOC 27.1 
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Figure 4.28  Chromatogram of N-(4-aminobutyl) hexahydropyrimidine-diFMOC derivative, 
HPLC conditions:  column: Phenomenex hypersil C18 5µ 150 x 4.60 mm, mobile phase is 
acetonitrile: Milli-Q-water (70:30) flow rate 1 mL/min, fluorescence detection at λex = 264 nm, 
λem = 390 nm, peak 1 = N-(4-aminobutyl) hexahydropyrimidine -diFMOC at Rt = 13.2 min. 
 
 
 
 
Figure 4.29  HPLC chromatogram of 1,4-(dihexahydropyrimidine)butane-diFMOC derivative, 
HPLC conditions:  column: Phenomenex hypersil C18 5µ 150 x 4.60 mm, mobile phase is 
acetonitrile: Milli-Q-water (70:30) flow rate 1 mL/min, fluorescence detection at λex = 264 nm, 
λem = 390 nm, peak 1 = 1,4-(dihexahydropyrimidine)butane-diFMOC at Rt = 27.1 min. 
0 6 12 mins 
0 6 12 18 24 mins 
1 
1 
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Figure 4.30  HR-ESI-MS spectrum of N-(4-aminobutyl) hexahydropyrimidine-diFMOC 
derivative, (M.W. = 601.2940, C38H39N3O4) expected m/z [M+H]
+ ion = 602.3019 (found = 
602.2991) and [M+ Na]+ ion m/z = 624.2838. 
 
FMOC derivatives of spermidine, hexahydropyrimidine of spermidine, spermine and 1,4-
(Dihexahydropyrimidine)butane were examined using a mobile phase of acetonitrile: Milli-
Q-water (70:30) (Table 4.5, Figure 4.28, Figure 4.29).  Molecular weight of N-(4-
aminobutyl) hexahydropyrimidine-diFMOC was confirmed by HR-ESI-MS (Figure 4.30). 
 
FMOC derivatives of non-viral gene therapy (NVGT) vectors  
 
The FMOC derivatization method was applied to investigate three synthetic fatty acyl 
amides of spermine and confirmed the structures by HR-ESI-MS:  1,12-diphthalimido-4,9-
diazadodecane (Figure 4.31, HPLC chromatograms is Figures 4.32 and HR-ESI-MS is 
Figure 4.33), N4,N9-didecanoyl spermine (Figures 4.34 and 4.35) and N4,N9-didodecanoyl 
spermine (Figures 4.36 and 4.37).  These C10 and C12 conjugates are experimental non-viral 
vectors for DNA condensation with potential in gene delivery and therefore in non-viral gene 
therapy (NVGT). 
 
 
 
Figure 4.31  1,12-Diphthalimido-4,9-diazadodecane-diFMOC derivative. 
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Figure 4.32  HPLC chromatogram of 1,12-diphthalimido-4,9-diazadodecane-diFMOC 
derivative, HPLC conditions:  column:  Phenomenex hypersil C18 5µ 150 x 4.60 mm, 
mobile phase is acetonitrile: Milli-Q-water (85:15) flow rate 1 mL/min, fluorescence 
detector x10 sensitivity at λex = 264 nm, λem = 390 nm, (A) blank chromatogram (B) peak 1 
= 1,12-diphthalimido-4,9-diazadodecane-diFMOC derivative at Rt = 9.1 min. 
0 6 12 mins 
0 6 12 mins 
1 
 - 127 - 
 
 
Figure 4.33  HR-ESI-MS spectra of 1,12-diphthalimido-4,9-diazadodecane-diFMOC 
derivative, (M.W. = 906.3629, C56H50N4O8) expected m/z [M+H]
+ ion = 907.3707 (found = 
907.3693) and [M+ Na]+ ion m/z = 929.3526 (found = 929.3512). 
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Figure 4.34  N4,N9-Didecanoyl spermine-diFMOC derivative. 
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Figure 4.35  HR-ESI-MS spectrum of N4,N9-didecanoyl spermine-diFMOC derivative, 
(M.W. = 954.6234, C60H82N4O6) expected m/z [M+H]
+ ion = 955.6312 (found = 955.6334) 
and [M+ Na]+ ion m/z = 977.6132 (found = 977.6116). 
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Figure 4.36  N4,N9-Didodecanoyl spermine-diFMOC derivative. 
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Figure 4.37  HR-ESI-MS spectra of N4,N9-didodecanoyl spermine-diFMOC derivative, (M.W. 
= 1010.6860, C64H90N4O6) expected m/z [M+H]
+ ion = 1011.6938 (found = 1011.6939) and 
[M+ Na]+ ion m/z = 1033.6758 (found = 1033.6771). 
 
FMOC derivatization of aminoglycosides 
 
The FMOC derivatization was carried out at alkaline pH (in borate buffer) in order to 
prevent extensive hydrolysis by reaction with phenols or alcohols (Figure 4.38).  In this 
alkaline environment, the reaction of hydroxyl groups on aminoglycosides such as 
kanamycin (Figure 4.39) is prevented.  Kanamycin reacts with 4 moieties of FMOC only at 
the amine functional groups. 
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Figure 4.38  The reaction of an aliphatic alcohol with FMOC Cl reagent. 
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Figure 4.39  Kanamycin has four primary amino groups. 
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We have proved that kanamycin reacts with four molecules of FMOC Cl to yield 
kanamycin-tetraFMOC derivative which gave the symmetrical peak of HPLC chromatogram 
at peak at Rt = 8.30 min (Figure 4.40).  The elution of kanamycin-FMOC derivative was 
confirmed as tetra-substituted by HR-ESI-MS (Figure 4.41).  The expected formula is 
C78H76N4O19 m/z = 1372.5104, [M+H]
+ = 1373.518, [M+Na]+ = 1395.4998, found = 
1395.5003.  Paramomycin is another aminoglycoside that was also examined, the HPLC 
chromatogram of the FMOC derivative has Rt = 12.2 min (Figure 4.42). 
 
The amine-FMOC derivatives gave predominantly [M+Na]+ ions in addition to monovalent 
ions (M+H)+ as the summary Table shows in Table 4.6. 
 
 
 
 
 
Figure 4.40  HPLC chromatogram of kanamycin-tetraFMOC derivative, HPLC conditions:  
column:  Phenomenex hypersil C18 5µ 150 x 4.60 mm, mobile phase is acetonitrile: Milli-Q-
water (60:40) with flow rate 1 mL/min, fluorescence detector at λex = 264 nm, λem = 390 nm, 
peak 1 = kanamycin-tetraFMOC at Rt = 8.2 min. 
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Figure 4.41  HR-ESI-MS spectrum of kanamycin-tetraFMOC derivatives, expected m/z 
[M+Na]+ = 1395.4998, found = 1395.5003. 
 
 
 
 
 
Figure 4.42  HPLC chromatogram of paramomycin-pentaFMOC derivative, HPLC 
conditions:  column: Phenomenex hypersil C18 5µ 150 x 4.60 mm, mobile phase is 
acetonitrile: Milli-Q-water (60:40) flow rate 1 mL/min, fluorescence detector x10 sensitivity 
at λex = 264 nm, λem = 390 nm, peak 1 = paramomycin-pentaFMOC at Rt = 12.2 min. 
 
 
0 6 12 mins 
1 
 - 132 - 
Table 4.6  Summary of HR-ESI-MS data of FMOC derivatives. 
 
FMOC derivatives Molecular Formula HR-ESI-MS 
calculated 
HR-ESI-
MS found 
C18H18NO4 [M+H]
+ 312.1236 312.1230 Alanine-monoFMOC 
C18H17NO4 C18H17NNaO4 [M+Na]
+ 334.1055 334.1050 
1-Butylamine-monoFMOC 
C19H21NO2 
C19H22NO2 [M+H]
+ 296.1651 296.1645 
C20H22NO2 [M+H]
+ 308.1651 308.1620 Piperidine-monoFMOC 
C20H21NO2 C20H21NNaO2 [M+Na]
+ 330.1469 330.1542 
C34H31N2O4 [M+H]
+ 531.2284 531.2277 Piperazine-diFMOC 
C34H30N2O4 C34H30N2NaO4 [M+Na]
+ 553.2103 553.2103 
1,5-Diaminopentane-diFMOC 
C35H34N2O4 
C35H35N2O4 [M+H]
+ 547.2597 547.2591 
1,7-Diaminoheptane-diFMOC 
C37H38N2O4 
C37H38N2NaO4 [M+Na]
+ 597.2729 597.2724 
Spermidine-triFMOC 
C52H49N3O6 
C52H49N3NaO6 [M+Na]
+ 834.3519 834.3514 
Spermine-tetraFMOC 
C70H66N4O8 
C70H66N4NaO8 [M+Na]
+ 1113.4778 1113.7389 
C56H51N4O8 [M+H]
+ 
 
907.3707 907.3693 1,12-Diphthalimido-4,9-
diazadodecane-diFMOC 
C56H50N4O8 C56H50N4NaO8 [M+Na]
+ 929.3526 929.3512 
C60H83N4O6 [M+H]
+ 955.6307 955.6334 N4,N9-Didecanoyl spermine-
diFMOC C60H82N4O6 C60H82N4NaO6 [M+Na]
+ 977.6132 977.6153 
C64H91N4O6 [M+H]
+ 
 
1011.6938 1011.6913 N4,N9-Didodecanoyl spermine-
diFMOC  
C64H90N4O6 C64H90N4NaO6 [M+Na]
+ 1033.6758 1033.6740 
Kanamycin-tetraFMOC 
C78H76N4O19 
C78H76N4NaO19 [M+Na]
+ 1395.5001 1395.5033 
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Conclusions of FMOC Cl derivatization 
 
The reaction of FMOC is carried out at alkaline pH, in borate buffer, in order to prevent 
extensive reaction with phenolic or alcoholic hydroxyls.  In this way, the polyols of e.g. 
aminoglycosides will not react with FMOC, only the amines will react with FMOC.  The 
amine derivatization reaction is fast, but it also depends upon the structure of the molecule 
e.g. with short chain 1-butylamine, the reaction was complete in under 60 s, but for 
kanamycin up to 5 min was required to complete the reaction. 
 
We proved that the amount of reaction volume can be restricted to 300 µl (from 1-2 ml) and 
on this scale it was not necessary to extract the derivative, rather the whole reaction mixture 
can be directly injected into the HPLC.  This is a convenient analytical method.  However, 
when the reaction was extracted with pentane, the HPLC chromatogram obtained had fewer 
interfering peaks which is better for applying the method for mixed amine samples or 
biological samples so we can separate biological amines in the organic phase and amino acid 
derivatives in the aqueous phase prior to chromatographic separation.  FMOC (fluorescent) 
derivatives of amines are stable at 20oC and in daylight for at least five days. 
 
A disadvantage of FMOC Cl is its reactivity toward water.  After hydrolysis and 
decarboxylation, the resulting fluorescent alcohol elutes in the middle of the chromatogram. 
 
OH  
Hydrolysis product of FMOC Cl 
 
At high concentrations, this hydrolysis peak overlaps with the other analytes in the 
chromatogram which complicates the quantification of the analyses.  Also, FMOC Cl is 
fluorescent, therefore the excess of reagent should be removed before chromatography.  
Comparisons of three methods to terminate the excess of FMOC Cl reagent were made 
using:  alanine, glacial acetic acid, and pentane extraction.  With the pentane extraction, the 
majority of the hydrolysis product of FMOC Cl (the alcohol) is removed, thus minimizing 
interference in the chromatograms. 
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CHAPTER 5:  DERIVATIZATION OF PRIMARY AND SECONDARY AMINES 
WITH DANSYL CHLORIDE 
 
Background to amine dansyl derivatization 
 
In 1952, 5-dimethylaminonaphthalene-1-sulfonyl chloride (dansyl chloride, DNS Cl) was 
introduced by Weber as the reagent for the preparation of fluorescent conjugates of proteins 
(Weber, 1952) and in 1956, the dansylation procedure was first applied to the identification 
of biogenic amines (Seiler and Wiechmann, 1965).  They also published the first method for 
the quantitative estimation of DNS amine derivatives (Seiler and Wiechmann, 1966).  
Currently, dansylation is widely used to prepare fluorescent derivatives which are then 
separated by HPLC and detected by UV as well as by fluorescence. 
Dansylation mechanism 
 
DNS Cl reacts with both primary and secondary amino groups even at slightly alkaline pH 
(Figure 5.1) to yield stable fluorescent derivatives (Seiler, 1970). 
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Figure 5.1  DNS derivatization of amines. 
 
The rate of dansylation increases with increasing pH, but is paralleled by an increased rate of 
hydrolysis of the DNS Cl.  Optimal conditions should give the most effective reaction of 
reactive groups in a limited amount of reagent.  Most amino acids and amines are optimized 
at pH 9.5-10.0 (at 20oC).  DNS Cl is slightly soluble in water, and so dansylation is mostly 
performed in a mixed solvent system of acetone/water which is homogeneous. 
 
Properties of DNS-derivatives 
 
The DNS derivatives are yellow crystalline solids, mostly readily soluble in organic solvents 
and only slightly soluble in water.  The spectroscopic properties of DNS derivatives are 
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dependent on their structures, but are also changed by different solvents and pH (Chen, 
1967; Schmidt-Glenewinkel, 1973; Schneider, 1973; Seiler et al., 1973). 
 
In addition to UV absorption, fluorimetry, quantitative MS and the application of radioactive 
DNS have been used to quantify DNS derivatives.  The intense absorption bands of DNS 
derivatives are in the range of 250-255 and 335-350 nm (Seiler, 1970).  UV absorption is 
less sensitive than fluorimetry in which DNS derivatives have excitation wavelengths 
between 340 and 395 nm and emission fluorescence between 500 and 530 nm.  For amine 
derivatives, the fluorescence intensity is linearly related to the amount of DNS derivatives up 
to a concentration of 10 µM (Seiler, 1970) and even up to 2 mM in our studies (see below). 
 
Stability of DNS Cl reagent 
 
The chromatographic peak of standard DNS Cl was observed by dissolving DNS Cl in 
acetone from concentration 0.1-0.8 mM, then injecting the solution onto the HPLC column, 
HPLC conditions:  mobile phase is acetonitrile: Milli-Q-water (70:30), C18-luna column, 
flow rate 1 mL/min using two detectors in series:  fluorescence detector at λex = 330 nm, λem 
= 510 and then UV detector at λmax = 330 nm.  Chromatograms obtained from the 
fluorescence detector showed the solvent front at retention time (Rt) = 1.0 min, but no other 
peaks were observed.  However, with UV detection, the chromatogram showed at least three 
peaks which are:  (1) the solvent front at Rt = 1.0 min, (2) unknown peak at Rt = 1.9 min, and 
(3) the DNS Cl peak at Rt = 9.0 min (Figure 5.3).  Using UV detection, the DNS Cl peak 
gave a linear calibration curve (Figure 5.2).  The stability of the DNS reagent was good 
within 2 weeks after preparation (stored at 4oC) as the calibration curve of the reagent showed 
good linearity. 
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Figure 5.2  Calibration curve of DNS Cl (freshly prepared) detected by UV, (n = 5). 
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Figure 5.3  HPLC chromatogram of solution of DNS Cl in acetone (10 mM), HPLC 
conditions:  mobile phase is acetonitrile: Milli-Q-water (70:30), C18-luna column, flow rate 1 
mL/min, (A) from fluorescence detector at λex = 330 nm, λem = 510 nm.  The chromatogram 
shows only the solvent front at Rt = 1.0 min, (B) from UV detector at λmax = 330 nm.  The 
chromatogram shows peak 1 = the solvent front at Rt = 1.0 min, peak 2 unknown peak at Rt = 
1.9 min, and peak 3 = DNS Cl at Rt = 9.0 min. 
 
From the HPLC chromatogram above, unchanged DNS Cl would give no interfering peaks in 
fluorescence detection.  The reaction of DNS Cl with amines was found to be pH-dependent.  
The DNS-derivatives will not form if the conditions are not alkaline enough (pH should be 
more than 8.5).  The reaction can be explained in terms of three competing reactions (Fu et 
al., 1998): 
 
R-NH2    +      DNS-Cl   R-NH-DNS    +    HCl        (1) 
H2O        +      DNS Cl                  DNS-OH        +    HCl         (2) 
R-NH-DNS + DNS Cl                  DNS-NH2       +   other products  (3) 
1 3 
0 6 12 18 24 mins 
0 6 12 18 24 mins 
2 
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Where R-NH2 represents polyamine, DNS-OH is dansylic acid and DNS-NH2 is dansyl 
amide.  Desirable reaction (1) is accelerated by alkaline pH from pH 8.5, but at high pH 
reaction (2) also occurred.  Reaction (3) leads to decomposition of R-NH-DNS (polyamine-
DNS derivative).  This reaction (3) could happen in the presence of an excess of DNS Cl 
reagent (Neadle and Pollit, 1965).  Thus, an optimum pH must be found and the 
concentration ratio of DNS Cl to the amines needed to be examined. 
 
A “blank-DNS” reaction was performed where water was used instead of a solution of amine 
to react with DNS Cl reagent followed by removal of the excess of DNS Cl by using alanine 
solution.  The elution of peaks that appeared in the HPLC chromatograms from the 
fluorescence detector and from the UV detector (Figure 5.4) were confirmed by HR-ESI-MS 
for dansylic acid (Figure 5.5), dansyl amide (Figure 5.6) and DNS Cl (Figure 5.7). 
 
 
 
 
(A) 
 
 
 
      (B) 
Figure 5.4  HPLC chromatogram of “Blank-DNS”, HPLC conditions:  mobile phase is 
acetonitrile: Milli-Q-water (70:30) C18-luna column, flow rate 1 mL/min, (A) from 
1 
3 2 1 
6 12 18 mins 
0 6 12 18 mins 
2 
0 
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fluorescence at λex = 330 nm, λem = 510 nm.  The chromatogram shows:  peak 1 = dansylic 
acid at Rt = 1.2 min and peak 2 = dansyl amine at Rt = 2.6 min, (B) from UV detector at λmax 
= 330 nm.  The chromatogram shows peak 1 = dansylic acid, peak 2 = dansyl amide and peak 
3 = DNS-Cl at Rt = 8.9 min. 
 
 
Figure 5.5  HR-ESI-MS spectrum of dansylic acid from peak 1, (M.W. = 251.0616 
C12H13NO3S) expected m/z [M+H]
+ ion = 252.0694 (found = 252.0682) and [M+Na]+ ion = 
274.0513 (found = 274.0504). 
 
 
Figure 5.6  HR-ESI-MS spectrum of dansyl amide from peak 2, (M.W. = 250.0776 
C12H14N2O2S) expected m/z [M+H]
+ ion = 251.0854 (found = 251.0842) and [M+Na]+ ion = 
273.0673 (found = 273.0667). 
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Figure 5.7  HR-ESI-MS spectrum of DNS Cl (M.W. = 269.0277, C12H12ClNO2S) expected 
m/z [M+H]+ from C12H13
35ClNO2S ion = 270.0355 (found = 270.0324) and expected m/z 
[M+H]+ from C12H13
37ClNO2S ion = 272.0317. 
 
HPLC mobile phase conditions 
 
The peaks were separated by isocratic elution.  In order to optimize the mobile phase for 
HPLC, the following mixtures were used: 
  
Acetonitrile: Milli-Q-water (40:60) 
Acetonitrile: Milli-Q-water (60:40) 
Acetonitrile: 0.1 % formic acid in Milli-Q-water (60:40) 
Acetonitrile: 2.5 % formic acid in Milli-Q-water (60:40) 
Acetonitrile: Milli-Q-water (65:35) 
Methanol: acetonitrile: Milli-Q-water (65:20:15) 
Acetonitrile: Milli-Q-water (70:30) 
 
Addition of formic acid to the mobile phase did not make any significant difference to the 
separation of analytes.  Thus, mixtures of acetonitrile, methanol and water and adjustment of 
the ratio of these solvents were used in preparing suitable mobile phases.  The peaks 
produced by hydrolysis of DNS Cl were completely separated from the analytes.  The best 
separation of derivatives was obtained using the mobile phase of 70:30 acetonitrile: Milli-Q-
water. 
 
S
N
O O
Cl  
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Two detectors, fluorescence and UV, were simultaneously employed to detect peaks after 
HPLC separation.  Although amine-DNS derivatives could be monitored by both UV and 
fluorescence detection, the fluorescence detector was more sensitive than the UV under the 
conditions employed.  Both the UV absorbance and fluorescence spectra of the different 
analyte amine derivatives were sufficiently similar to allow the same detection parameters to 
be used throughout. 
 
Due to the differences between the two detection modes, regarding the sensitivity and 
selectivity of the detectors, there are cases where some peaks not detected by UV absorbance 
can be investigated by fluorescence and vice versa as shown in Figure 5.4.  This enables the 
detection of possible non-fluorescent by-products and increases the reliability of the method.  
When detected by UV absorption, the chromatograms gave multiple peaks compared with 
fluorescence detection.  Thus, the selectivity of the fluorescence detector is better (than using 
the UV detector) and from the size of the peaks, it is concluded that fluorescence detection is 
more sensitive than UV for dansylated amines.  An advantage of using fluorescence 
detection is that the fluorescence detector is more selective as only the analyte with the 
appropriate λex and λem will be observed while UV is not so selective and can give rise to 
additional peaks in the HPLC.  The hydrolysis products produced by DNS Cl were observed 
as intense HPLC peaks in chromatograms which eluted rapidly and might not cause any 
interference with the analyte peaks.  However, UV detection revealed that an excess of DNS 
Cl remained after the reaction.  Thus, simultaneous detection minimizes the risk of missing 
trace amounts of an analyte, further increasing the reliability of this analytical method. 
 
Selection of the excitation and emission wavelengths of amine-DNS derivatives 
 
Fluorescence excitation and emission were recorded using a Hitachi F-2000 Fluorescence 
Spectrometer.  Using model primary amines, e.g. 1-butylamine monoDNS derivative showed 
λex = 328 nm, λem = 509 nm and 1,7-diaminoheptane monoDNS derivative showed λex = 334 
nm, λem = 525 nm.  Also studied were primary amine diDNS derivatives e.g. 1,5-
diaminopentane-diDNS derivative, λex = 334 nm, λem = 519 nm, and a typical secondary 
amine (piperidine monoDNS derivative) λex = 332 nm, λem = 510 nm for detection using an 
HPLC system (Table 5.1).  Thus, the HPLC fluorescence detection was typically set at λex = 
330 nm and λem = 510 nm.  It has recently been reported in the literature (during these 
studies) (Loukou and Zotou, 2003; Gaboriau et al., 2003; Geuns et al., 2006; Takao et al., 
2008) that polyamine-dansyl derivatives are detected at λex = 320 nm to 340 nm and λem = 
500 nm to 550 nm when analyzed by HPLC with fluorescence detection. 
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Table 5.1  The excitation (λex) and emission (λem) wavelengths of amine-DNS derivatives. 
 
Amine-DNS derivatives λex (nm) λem (nm) 
1-Butylamine-mono DNS 328 509 
1,5-Diaminopentane-diDNS 334 519 
1,7-Diaminoheptane-monoDNS 334 524 
1,7-Diaminoheptane-diDNS 333 525 
1,8-Diaminooctane-diDNS 332 515 
Piperidine-monoDNS 332 523 
Piperazine-diDNS 336 529 
Spermidine-triDNS derivative 336 522 
Spermine-tetraDNS derivative 335 523 
 
Dansylation methods 
 
Method 1  Without termination of the excess of DNS Cl 
 
1-Butylamine (1 mM) was used against various concentration of DNS Cl (5 mM to 40 mM).  
Results showed that excess DNS Cl peak appeared at Rt = 8.9 min when DNS Cl was used at 
5-fold excess (UV detector, HPLC conditions:  mobile phase is acetonitrile: Milli-Q-water 
(70:30) C18-luna column, flow rate 1 mL/min). However, the reaction was completed when 
DNS Cl was used at 10-fold excess.  Without termination of the excess of DNS Cl, the final 
product separated into two phases.  Small droplets of the excess of DNS Cl were observed, 
thus, this product was inhomogeneous.  This product was stirred and injected onto HPLC, 
however, the results from 5 replicates were non-reproducible. 
 
Method 2  Using alanine to remove the excess of DNS Cl 
 
A solution of L-alanine was used to remove the excess of DNS Cl (Ala-DNS is held in the 
aqueous phase), followed by extraction of the desired amine-DNS derivative with toluene 
which was then evaporated and the residue was redissolved in mobile phase and analyzed by 
HPLC.  With this elimination step, the chromatogram was improved as there were fewer 
interfering peaks, no peak from the excess (e.g. 70-fold or 10-fold) of DNS Cl and the peaks 
of the desired product were reproducible (n = 5). 
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Optimization of DNS Cl derivatization method 
 
Published conditions for DNS derivatization are different from one research group to 
another.  For example, the reaction temperature ranged from 20 to 90oC.  Many conditions 
such as temperature, reaction time, pH of medium, concentration of DNS Cl have effects on 
the yield of DNS derivatization.  The dansylation reaction was optimized for the following 
variables:  the pH of buffer for amine and DNS Cl reaction, the ratio of volume of DNS Cl, 
the reaction time and the temperature. 
 
Optimization of the pH of buffer for DNS Cl reaction with amines 
 
Only the neutral form of an amine will react with DNS Cl (Seiler, 1975), and therefore, the 
optimum pH must be high enough to ensure that the amine is unionized.  However, the pH is 
limited by an increase in side reactions, such as the formation of the sulfonic acid at high 
values (Gros and Labouesse, 1969).  Moreover HCl is released during the dansylation 
reaction, so a buffer is always required.  The effect of the pH of buffer was investigated by 
using borate buffer, pH range from 4.5 to 10.5 (Figure 5.8).  The result showed that under 
acidic conditions, the reaction occurred to only a small extent when compared to the region 
from pH 8.5 to 10.5.  The peak areas were stable and the yields of the derivatives were high.  
When borate buffer and saturated sodium carbonate which has the pH = 9.80 were 
compared, insignificant difference of the yields were obtained (Figure 5.9).  Thus, saturated 
sodium carbonate was used routinely in the DNS Cl reaction because it was more convenient 
for preparation. 
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Figure 5.8  Optimization of pH of borate buffer in the reaction of 1-butylamine and DNS Cl 
(n = 5).  Peak areas were calculated by height x 0.5 width of peak, and peak areas are 
reported in cm2. 
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Figure 5.9  Comparison of the yields of 1-butylamine-monoDNS obtained using borate 
buffer pH 10.5 and saturated sodium carbonate for making the solution alkaline for 
dansylation. 
 
Optimization of the reaction temperature of dansylation 
 
Different temperatures were examined with the fixed reaction time of 15 min to determine 
the optimum conditions for derivatization of polyamine.  A temperature series was run at 20, 
40, 60, and 80oC with 1 mM of 1-butylamine while other solvents and reagent concentrations 
remained constant.  The yields were evaluated by HPLC by measurement of the peak areas.  
Yields of derivatization increased with rising temperature (Figure 5.10).  However, at 
temperatures greater than 60oC, rapid evaporation of acetone from the reaction led to 
solubility problems and bumping of the reaction mixture.  Therefore 60oC was used for the 
remainder of the study. 
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Figure 5.10  Optimization of temperature of dansylation (n = 5).  Peak areas were calculated 
by height x 0.5 width of peak, and peak areas are reported in cm2. 
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Optimization of the reaction time of dansylation 
 
The time effect studies were carried out from 1 min to a maximum of 60 min (Figure 5.11).  
The reactions were run at 60oC with 1 mM of 1-butylamine.  The optimum reaction time for 
1-butylamine was about 15 min which was subsequently used routinely. 
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Figure 5.11  Influence of time on the dansylation reaction of 1 mM 1-butylamine (n = 5).  
Peak areas were calculated by height x 0.5 width of peak, and peak areas are reported in cm2. 
 
Optimization of the concentration ratio of DNS Cl 
 
After optimizing the pH of the reaction, the reaction time, the reaction temperature, intense 
HPLC-peaks overlapping the derivatives were observed due to hydrolysis products generated 
by the reaction of DNS Cl with water.  Cleaner chromatograms were obtained by using a 
minimum amount of DNS Cl. 
 
For the optimization of DNS Cl concentration, 1 mM of model amines were reacted with 
DNS Cl concentration range from 1 to 100 mM.  The desired amine-DNS derivatives 
increased with the increasing DNS solution concentration up to 10 mM then they were stable 
or increased indistinctively.  For the pH optimization, the reaction required an alkaline pH of 
9.5.  For the ranges of pH examined, saturated sodium carbonate solution (pH 9.80) was 
selected to give an optimum pH.  However, different amines required different amounts of 
DNS Cl to complete the reaction; for example to complete the reaction of piperidine and 
DNS Cl required a 5-fold excess of DNS Cl whereas 1-butylamine required 10-fold excess 
of DNS Cl (Figure 5.13).  From Figure 5.13, the peak areas obtained for amine-DNS 
derivative increased by increasing the concentration of DNS Cl.  An excess of DNS Cl was 
needed to achieve complete reaction.  However, the excess of DNS Cl can also give 
competitive reactions with water and the amine-DNS derivative.  So, the optimized 
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concentration of DNS Cl was chosen at 10 mM.  The amine-DNS derivatives were examined 
with 10 mM DNS Cl and the retention times from 5 replicates are shown in Table 5.2.  By 
varying the concentration of the amines, calibration curves were plotted as shown in Figure 
5.14 and the equations were obtained as shown in Table 5.3.  Derivatization conditions of 
DNS Cl, for the rest of the study used 10-fold excess of DNS Cl reagent to amines, at pH 9.8 
saturated sodium carbonate solution for 15 min at 60oC, the reaction was terminated and the 
excess of DNS Cl removed by adding 112 mM L-alanine.  The desired products were 
extracted by toluene to leave the undesired by-products in the aqueous phase.  After 
evaporation of the toluene, the residue was redissolved with mobile phase, filtered through 
0.45 µm nylon filter before injection onto the HPLC.  DNS derivatives are very stable as 
they gave the nearly same peak area after 10 days (stored in the fridge, 4oC).  Using a 
Phenomenex Hypersil C18 5µ 150 x 4.60 mm column, the optimized condition of mobile 
phase was 70:30 acetonitrile: Milli-Q-water.  A good resolution was obtained of the amine-
DNS derivative from the potential interference peaks, e.g. a chromatogram of 1-butylamine-
monoDNS (Figure 5.12). 
 
 
 
 
Figure 5.12  HPLC chromatogram of 1-butylamine-DNS derivative, HPLC conditions:  
column:  Phenomenex Hypersil C18 5µ 150 x 4.60 mm, mobile phase is acetonitrile: Milli-
Q-water (70:30) with flow rate 1 mL/min, fluorescence detector at λex = 330 nm, λem = 510 
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nm, peak 1 = solvent front, peak 2 = dansylic acid, peak 3 = dansylamide and peak 4 = 1-
butylamine-monoDNS derivative. 
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Figure 5.13  Optimization of conditions in the reaction between 1.0 mM 1-butylamine and 
various concentrations of DNS Cl (n = 5).  Peak areas were calculated by height x 0.5 width 
of peak, and peak areas are reported in cm2. 
 
Table 5.2  The retention times of various amine-DNS derivatives.  HPLC conditions:  
column:  Phenomenex Hypersil C18 5µ 150 x 4.60 mm, mobile phase is acetonitrile: Milli-
Q-water (60:40) with flow rate 1 mL/min 
 
Amine-DNS derivatives Type of amine Retention time (min) ± range 
Ethylamine Primary monoamine 4.12 ± 0.17 
1-Butylamine Primary monoamine 7.15 ± 0.15 
Phenylethylamine Primary monoamine 8.10 ± 0.30 
1,4-Diaminobutane Primary diamine 9.20 ± 0.15 
1,7-Diaminoheptane Primary diamine 16.95 ± 0.35 
Piperidine Secondary monoamine 9.35 ± 0.25 
Piperazine Secondary diamine 19.60 ± 0.08 
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Figure 5.14  Calibration curves of amine-DNS derivatives (n = 5).  Peak areas were 
calculated by height x 0.5 width of peak, and peak areas are reported in cm2. 
 
Table 5.3  The calibration curve equations of various amine-DNS derivatives 
 
Amine-dansyl derivatives Calibration curve R2  (n = 5) 
Ethylamine y = 3.42x-0.139 0.991 
1-Butylamine y = 3.65x-0.122 0.996 
2-Phenylethylamine y = 3.72x-0.265 0.988 
1,4-Diaminobutane y = 5.75x + 0.161 0.989 
1,7-Diaminoheptane y = 6.90x-0.612 0.992 
Piperidine y = 9.40x-0.300 0.999 
Piperazine y = 9.11x – 0.144 0.968 
 
At concentrations from 0.2 mM to 1.0 mM, both 1,4-diaminobutane-DNS and 1,7-
diaminoheptane-DNS derivatives show linear calibration curves (Figure 5.15), but from the 
concentration 2.0 mM up to 10 mM, the line of 1,4-diaminobutane-DNS was not linear 
whereas the line of 1,7-diaminoheptane-DNS is remained linear (Figure 5.16).  This result 
might due to “self-quenching” of two DNS groups linked by the short hydrocarbon chain of 
butane compared to a heptane chain. 
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Figure 5.15  Calibration curves of 1,4-diaminobutane-diDNS derivative and 1,7-
diaminoheptane-diDNS derivative which were both linear from concentration 0.2 to 1 mM (n 
= 5).  Peak areas were calculated by height x 0.5 width of peak, and peak areas are reported 
in cm2. 
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Figure 5.16  Calibration curves of 1,4-diaminobutane-diD NS derivative and 1,7-
diaminoheptane-diDNS derivative (n = 5).  This graph shows 1,4-diaminobutane-diDNS 
became non-linear at higher concentrations due to “self-quenching”.  Peak areas were 
calculated by height x 0.5 width of peak, and peak areas are reported in cm2. 
 
Spermine and Spermidine 
 
The same procedure was applied to spermidine and spermine except the composition of 
mobile phase was changed from 60:40 acetonitrile: Milli-Q-water to 65 % methanol: 20 % 
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acetonitrile: 15 % Milli-Q-water due to the shorter retention time gained from 36 min to 6 
min for spermidine and 39 min to 8 min for spermine.  By varying the concentration of 
biological amines, calibration curves were obtained, the results are shown in Figure 5.17 and 
Table 5.4.  Structure of spermidine-triDNS derivative and spermine-tetraDNS derivative 
(Figure 5.18) were confirmed the expected M.W. by HR-ESI-MS. (Figure 5.19 for 
spermidine-triDNS derivative and Figure 5.20 spermine-tetraDNS derivative). 
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Figure 5.17  Calibration curves of natural amine-DNS derivatives (n = 5).  Peak areas were 
calculated by height x 0.5 width of peak, and peak areas are reported in cm2. 
 
Table 5.4  Calibration curve equations of natural amine-DNS derivatives. 
 
Amine-dansyl derivatives Calibration curve R2 (n = 5) 
Spermidine y = 6.47x – 0.380 0.995 
Spermine y = 9.91x + 0.624 0.989 
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 (A) Spermidine-triDNS derivative                                        (B) Spermine-tetraDNS derivative 
 
Figure 5.18  (A) Spermidine-triDNS derivative, (B) spermine-tetraDNS derivative. 
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Figure 5.19  HR-ESI-MS spectra of spermidine triDNS derivative (M.W. = 844.3110, 
C43H52N6O6S3) expected m/z [M+H]
+ ion = 845.3188, doubly charged [M+2H]2+ ion = 
423.1633 (found = 423.1615) and [M+Na]+ ion = 867.3008 (found = 867.2992). 
 
 
 
Figure 5.20  HR-ESI-MS spectra of spermine tetraDNS derivative (M.W. = 1134.4199, 
C58H70N8O8S4) expected m/z [M+H]
+ ion = 1135.4277 (found = 1135.4241) and [M+Na]+ 
ion = 1157.4097 (found = 1157.4061). 
 
Relative quantum yield 
 
The fluorescence intensity and UV absorbance of various polyamine-DNS derivatives were 
determined in order to compare the relative quantum yields.  The derivatives of diamines-
DNS were made in order to obtain both diamines-monoDNS and diamines-diDNS (the 
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chromatogram is shown in Figure 5.21).  The peak of each amine-DNS was collected after 
separation on a semi-preparative HPLC column.  As these derivatives eluted they were 
collected and the molecular mass of all these derivatives were confirmed using HR-ESI-MS:  
1,4-diaminobutane-monoDNS derivative (Figure 5.22), 1,4-diaminobutane-diDNS derivative 
(Figure 5.23), 1,7-diaminoheptane-monoDNS derivative (Figure 5.24), 1,7-diaminoheptane-
diDNS derivative (Figure 5.25). 
 
A series of dilutions of each eluted peak of the model series was prepared and the UV 
absorbance and fluorescence intensity of each were measured.  The HPLC was monitored by 
measurement of absorbance at the λex using Unicam Helios UV-VIS spectrophotometer and 
measurement of fluorescence intensity on a Perkin Elmer Luminescence Spectrometer LS 
50B.  For each compound, a plot of fluorescence intensity against UV absorbance was made 
(Table 5.5, Figure 5.26).  The fluorescence yield of each derivative is proportional to the 
gradient. 
 
 
 
Figure 5.21  HPLC chromatogram of 1,7-diaminoheptane-DNS derivative amine-dansyl 
derivatives, HPLC conditions:  semi-preparative column:  Phenomenex Gemini 10 µ C18 
110A 250 x 10 mm with guard column:  Phenomenex Gemini 5 µ C18 10 x 10 mm.  Mobile 
phase is acetonitrile: Milli-Q-water (70:30) with flow rate 5 mL/min, fluorescence detector at 
0 6 12 mins 
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λex = 330 nm, λem = 510 nm, peak 1 = 1,7-diaminoheptane-monoDNS derivative, peak 2 = 
1,7-diaminoheptane-diDNS derivative. 
 
Figure 5.22  HR-ESI-MS spectrum of 1,4-diaminobutane monoDNS derivative (M.W. = 
321.1511, C16H23N3O2S) expected m/z [M+H]
+ ion = 322.1589 (found = 322.1562) doubly 
charged ion [M+2H]2+ = 161.5834 (found = 161.5814) and [2M+H]+ ion = 643.3100 (found 
= 642.3112). 
 
 
 
Figure 5.23  HR-ESI-MS spectra of 1,4-diaminobutane diDNS derivative (M.W. = 
554.2375, C28H34N4O4S2) expected m/z [M+H]
+ ion = 555.2099 (found = 555.2100) doubly 
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charged ion [M+2H]2+ = 278.1089 (found = 278.1170) and [M+Na]+ = 577.1919 (found = 
577.1923). 
 
 
Figure 5.24  HR-ESI-MS spectrum of 1,7-diaminoheptane monoDNS derivative (M.W. = 
363.1980, C19H29N3O2S) expected m/z (M+H)
+ ion = 364.2059 (found = 364.2036), doubly 
charged ion [M+2H]2+ = 182.6068 (found = 182.6045), [M+Na]+ = 386.1878 and [2M+H]+ = 
727.4038 (found = 727.4035). 
 
 
 
Figure 5.25  HR-ESI-MS spectrum of 1,7-diaminoheptane diDNS derivative (M.W. = 
596.2491, C31H40N4O4S2) expected m/z [M+H]
+ ion = 597.2569 (found = 597.2550) doubly 
charged ion [M+2H]2+ = 299.1324 (found = 299.1293). 
 
Table 5.5  Equation of F.I. and U.V. absorption of various amine-DNS derivatives. 
 
Amines-DNS derivatives Equation of F.I and UV absorption R2 
1-Butyl-monoDNS y = 2623.3x + 15.17 0.997 
1,4-Diaminobutane-monoDNS y = 2782.2x + 8.91 0.991 
1,7-Diaminoheptane-monoDNS y = 2662.8x + 9.42 0.999 
1,4-Diaminobutane-diDNS y = 2011.6x + 7.78 0.994 
1,7-Diaminoheptane-diDNS y = 2179.2x + 18.94 0.997 
Spermidine-triDNS y = 1834.3x + 38.89 0.999 
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Figure 5.26  F.I. and U.V. absorption of various amine-DNS derivatives (n = 5). 
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Figure 5.27  Linear plots for three amine-monoDNS derivatives (n = 5).  The gradients of all 
three samples are similar in value. 
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Figure 5.28  Linear plots for two amine-diDNS derivatives (n = 5).  The gradients for both 
samples are similar in value. 
 
The gradients of all amine-monoDNS are similar (Figure 5.27) as are the gradients from 
amine-diDNS (Figure 5.28), the latter values are smaller when compared with the former.  
The lowest gradient was obtained from amine-triDNS.  From the results, it is concluded that 
the more DNS moieties that are bound to the polyamine molecule, the lower the gradients 
are.  From theory, the gradient should be the same when the number of fluorophores is 
increased.  However, from the experiment, the more fluorophores added, the lower the 
resultant gradient.  A comparison of fluorescence yield showed those of the polyamine 
conjugates to be lower than those of monoamine conjugates.  So, it is shown that two or 
more fluorophores tethered in close proximity interfere with the fluorescence process. 
 
Piperidine- and piperazine-DNS derivatives 
 
The relationship between the number of fluorophores and the intensity of fluorescence was 
examined to determine if the fluorescence intensity doubled when the DNS derivative has 
two fluorophores in its structure.  The experiment initially used piperidine and piperazine as 
the amine models, both are heterocyclic secondary amines piperidine containing one nitrogen 
atom and piperidine containing two (1,4)-nitrogen atoms.  The same concentration of 
piperidine and piperazine was used to react with the DNS Cl reagent.  Piperazine contains 
two secondary amines groups so sufficient DNS Cl to derivatize both amine groups was used 
otherwise the combination of monoDNS derivative and diDNS derivative of this compound 
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would be obtained.  Silica gel TLC was used to confirm and monitor the reaction of DNS-
derivatization using dichloromethane: methanol (4:1) as the mobile phase.  The results 
showed that the DNS Cl to piperidine 5: 1 (mole) was an efficient mole ratio to obtain the 
complete reaction.  If the ratio of piperidine: DNS Cl was 1:1, only 60% product was 
obtained.  Moreover, TLC showed that dansylic acid was still present in the organic phase 
after 3-fold extraction with toluene.  Method 2 (see page 45 in Chapter 2) was used to prepare 
piperidine-monoDNS derivative and piperazine-diDNS derivative.  The retention time of 
piperidine-monoDNS derivative was 8.6 min (Figure 5.29 (A)) and for piperazine-diDNS 
derivative was 15.1 min (Figure 5.29 (B)) when eluted with 65% acetonitrile: 35% Milli-Q-
water.   
 
 
 
 
      (A) 
 
 
  
(B) 
Figure 5.29  HPLC chromatogram of piperidine-monoDNS and piperazine-diDNS derivative, 
HPLC conditions:  mobile phase is acetonitrile: Milli-Q-water (65:35) C18-hypersil column, flow 
rate 1 mL/min, fluorescence detector at λex = 330 nm, λex = 510 nm.  (A) piperidine-monoDNS 
derivative.  The chromatogram shows peak 1 = piperidine-monoDNS derivative at Rt = 8.6 min.  
(B) piperazine-diDNS derivative.  The chromatogram shows peak 1 = piperazine-diDNS 
derivative at Rt = 15.1 min.  
1 
1 
0 6 12 
0 12 18 mins 
mins 
6 
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Figure 5.30  HR-ESI-MS spectra of piperidine-monoDNS derivative (M.W. = 318.1402, 
C17H22N2O2S) expected m/z [M+H]
+ ion = 319.1480 (found = 319.1472) and m/z [2M+H]+ 
ion = 637.2882 (found = 637.2915). 
 
These peaks were proved to be the expected DNS derivatives by HR-ESI-MS (Figure 5.30 
for piperidine monoDNS derivative and Figure 5.31 for piperazine diDNS derivative).  
When the chromatographic peak area per millimole on column for a monoamine (piperidine) 
and diamine (piperazine) were compared, the peak area of piperazine was nearly twice that 
of the monoDNS compound.  The slightly lower than expected values may be due to the 
differences in the chromatographic conditions. 
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Figure 5.31  HR-ESI-MS spectra of piperazine-diDNS derivative (M.W. = 552.1865, 
C28H32N4O4S2) expected m/z [M+H]
+ ion = 553.1943 (found = 553.1911).  The spectrum is 
dominated by the doubly charged peak [M+2H]2+ at m/z = 277.1011 (found = 277.1009). 
 
For piperazine, no quenching effect of two fluorophores bound to piperazine was observed.  
Due to the rigid stereochemistry of (1,4-)piperazine-disulfonamide (diDNS), the two 
fluorophores are held apart from each other. 
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Characteristic of amine-DNS derivatives by HR-ESI-MS 
 
One characteristic of amine-DNS derivatives is doubly charged ions which were observed by 
HR-ESI-MS e.g. spectra of 1,12-diaminododecane-diDNS derivative (Figure 5.32) and 1,5-
diaminopentane-diDNS derivative (Figure 5.33) and the summary table of the doubly 
charged ions in Table 5.8. 
 
 
Figure 5.32  HR-ESI-MS spectrum of 1,12-diaminododecane-diDNS derivative (M.W. = 
666.3273, C36H50N4O4S2) expected m/z [M+H]
+ ion = 667.3352, doubly charged ion 
[M+2H]2+ = 334.1715 (found = 334.1708). 
 
 
Figure 5.33  HR-ESI-MS spectrum of 1,5-diaminopentane-diDNS derivative (M.W. = 
568.2178, C29H36N4O4S2) expected m/z [M+H]
+ ion = 569.2256, doubly charged ion 
[M+2H]2+ = 285.1167. (found = 285.1158). 
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DNS derivatives of a series of non-viral gene therapy (NVGT) vectors 
 
The DNS derivatization method was applied to synthetic spermine fatty acyl amides, N4,N9-
didecanoyl spermine-diDNS (Figure 5.34), N4,N9-dihexadecanoyl spermine-monoDNS (Figure 
5.36), N1,N12-di-trifluoroacetyl-N4,N9-spermine-diDNS (Figure 5.38), N1,N4,N9-tri-t-Boc-N12-
DNS spermine (Figure 5.40), N4,N9-digeranoyl spermine-monoDNS (Figure 5.42), N1-DNS-N4-
decanoyl-N9-cholesteryl carbamate spermine (Figure 5.44), N4,N9-oleoyl spermine monoDNS 
(Figure 5.46) and N4,N9-dioctadecanoyl spermine-monoDNS (Figure 5.48). 
 
These conjugates are experimental non-viral vectors for DNA condensation with potential in 
gene delivery and therefore in non-viral gene therapy (NVGT).  The DNS labelling method 
was applied to these molecules and HPLC chromatograms of these spermine derivatives 
were obtained, the data for retention time are shown in Table 5.6.  The HR-ESI-MS of N4,N9-
didecanoyl spermine-diDNS (Figure 5.35), N4,N9-dihexadecanoyl spermine-monoDNS 
(Figure 5.37), N1,N12-di-trifluoroacetyl-N4,N9-diDNS spermine (Figure 5.39), N1,N4,N9-tri-t-
Boc-N12-DNS spermine (Figure 5.41), N4,N9-digeranoyl spermine-monoDNS (Figure 5.43), 
N
1-DNS-N4-decanoyl-N9-cholesteryl carbamate spermine (Figure 5.45), N4,N9-oleoyl 
spermine monoDNS (Figure 5.47) and N4,N9-dioctadecanoyl spermine-monoDNS (Figure 
5.49) were all satisfactorily obtained. 
 
Table 5.6  Retention time of non-viral gene therapy (NVGT) vectors-DNS derivative, HPLC 
conditions:  mobile phase:  acetonitrile: 1% formic acid in Milli-Q-water (90:10) C8-luna 
column, flow rate 1 mL/min, fluorescence detector at λex = 330 nm, λex = 510 nm. 
 
NVGT vectors-DNS derivative Retention time (min) 
N
4,N9-Didecanoyl spermine-diDNS  10 
N
4,N9-Digeranoyl spermine-monoDNS  19 
N
4-Decanoyl-N9-cholesteryl carbamate spermine-mono DNS  21 
N
4,N9-Oleoyl spermine monoDNS  13 
N
4,N9-Dioctadecanoyl spermine-monoDNS  24 
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Figure 5.34  N4,N9-Didecanoyl spermine-diDNS. 
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Figure 5.35  HR-ESI-MS spectrum of N4,N9-didecanoyl spermine-diDNS derivative (M.W. 
= 976.5894, C54H84N6O6S2) expected m/z [M+H]
+ ion = 977.5972 (found = 977.5947) and 
[M+Na]+ ion = 986.7472 (found = 986.7472). 
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Figure 5.36  N4,N9-Dihexadecanoyl spermine-monoDNS. 
 
 
Figure 5.37  HR-ESI-MS spectrum of N4,N9-dihexadecanoyl spermine-monoDNS derivative 
(M.W. = 911.7261, C54H97N5O4S) expected m/z [M+H]
+ ion = 912.7339 (found = 912.7374). 
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Figure 5.38  N1,N12-Di-trifluoroacetyl-N4,N9-diDNS spermine. 
 
 
 
Figure 5.39  HR-ESI-MS spectra of N1,N12-di-trifluoroacetyl-N4,N9-diDNS spermine 
derivative (M.W. = 860.2824, C38H46F6N6O6S2) expected m/z [M+H]
+ ion = 861.2902 (found 
= 861.2927) doubly charged ion [M+2H]2+ = 431.1490 (found = 431.1491) and [M+Na]+ ion 
= 883.2722 (found = 883.2754). 
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Figure 5.40  N1,N4,N9-Tri-t-Boc-N12-DNS spermine. 
 
 
Figure 5.41  HR-ESI-MS spectrum of N1,N4,N9-tri-t-Boc-N12-DNS spermine derivative 
(M.W. = 735.4241, C37H61N5O8S) expected m/z [M+H]
+ ion = 736.4319 (found = 736.4287) 
and [M+Na]+ ion = 758.4139. 
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Figure 5.42  N4,N9-Digeranoyl spermine-monoDNS derivative. 
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Figure 5.43  HR-ESI-MS spectrum of N4,N9-Digeranoyl spermine-monoDNS derivative 
(M.W. = 735.4757, C42H65N5O4S) expected m/z [M+H]
+ ion = 736.4835 (found = 736.4850). 
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Figure 5.44  N1-DNS-N4-decanoyl-N9-cholesteryl carbamate spermine C60H99N5O5S. 
 
 
Figure 5.45  HR-ESI-MS spectrum of N1-DNS-N4-decanoyl-N9-cholesteryl carbamate 
spermine derivative (M.W. = 1001.7367, C60H99N5O5S) expected m/z [M+H]
+ ion = 
1002.7445. (found = 1002.7408) and [M+Na]+ ion = 1024.7264 (found = 1024.7357). 
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Figure 5.46  N4,N9-Oleoyl spermine monoDNS derivative. 
 
 
 
 
Figure 5.47  HR-ESI-MS spectra of N4,N9-Oleoyl spermine monoDNS derivative (M.W. = 
963.7574, C58H101N5O4S) expected m/z [M+H]
+ ion = 964.7652. (found = 964.7666), doubly 
charged [M+2H]2+ = 482.8865 and [M+Na]+ ion = 986.7472 (found = 986.7472). 
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Figure 5.48  N4,N9-Dioctadecanoyl spermine-monoDNS derivative. 
 
 
 
Figure 5.49  HR-ESI-MS spectra of N4,N9-Dioctadecanoyl spermine-monoDNS derivative 
(M.W. = 967.7887, C58H105N5O4S) expected m/z [M+H]
+ ion = 968.7965. (found = 
968.7984), doubly charged ion [M+2H]2+ = 484.9022 (found = 484.9026) and [M+Na]+ ion 
= 990.7785 (found = 990.7806). 
 
DNS derivatization of aminoglycosides 
 
Glucosamine was examined by using method 2 for dansylation.  The glucosamine-
monoDNS derivative is a polar molecule which contains many OH groups so it can elute 
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rapidly under reversed-phase conditions (Figure 5.50).  Glucosamine-monoDNS derivative 
was confirmed by HR-ESI-MS (Figure 5.51). 
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Figure 5.50 Calibration curve of glucosamine-DNS derivatives (n = 5). 
 
Figure 5.51  HR-ESI-MS spectra of glucosamine-monoDNS derivative (M.W. = 412.1304, 
C18H24N2O7S) expected m/z [M+H]
+ ion = 413.1383 (found = 413.1384) and [M+Na]+ ion = 
435.1202 (found= 435.1205). 
 
Using method 1 to derivatize 0.1 mM glucosamine with DNS Cl reagent, the glucosamine-
DNS derivative eluted at Rt = 1.60 min (HPLC conditions:  mobile phase:  acetonitrile: Milli-
Q-water (40:60) C18-Hypersil column, flow rate 1 mL/min, fluorescence detector at λex = 
330 nm, λex = 510 nm).  The reaction was completed using a 4-fold excess of DNS Cl (Figure 
5.52). 
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Figure 5.52  Peak area of glucosamine-DNS derivative versus the concentration of DNS Cl 
(n = 5), glucosamine (1 mL, 1 mM) against DNS Cl (1 mL of various concentrations).  Peak 
areas were calculated by height x 0.5 width of peak, and peak areas are reported in cm2. 
 
Kanamycin-DNS derivatives 
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Figure 5.53  Kanamycin-tetraDNS derivative. 
 
 
 
Figure 5.54  HR-ESI-MS spectra of kanamycin-tetraDNS derivative (M.W. = 1416.4422, 
C66H80N8O19S4) expected m/z [M+H]
+ ion = 1417.4500 (found = 1417.4496) and [M+Na]+ 
ion = 1439.4320. 
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Method 2 was used for dansylation to prepare kanamycin-tetraDNS derivative (Figure 5.53).  
The HPLC chromatogram was obtained (Figure 5.55), the desired peak collected and the 
product was confirmed as the tetrasubstituted derivative by HR-ESI-MS (Figure 5.54). 
 
 
 
      (A) 
 
 
      (B) 
Figure 5.55  HPLC chromatogram of kanamycin-tetraDNS derivative, HPLC conditions:  
mobile phase is acetonitrile: Milli-Q-water (70:30) C8-luna column, flow rate 1 mL/min, 
fluorescence detector at λex = 330 nm, λex = 510 nm.  (A) The chromatogram of blank  (B) 
The chromatogram shows peak 1 = kanamycin-tetraDNS derivative at Rt = 4.9 min. 
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Table 5.8  Summary of HR-ESI-MS from dansylation. 
 
DNS derivatives Molecular Formula HR-ESI-MS 
calculated 
HR-ESI-
MS found  
Aspartic acid-monoDNS 
C16H18N2O6S 
C16H19N2O6S (M+H)
+ 367.0964 
 
367.0942 
Piperidine-monoDNS 
C17H22N2O2S 
C17H23N2O2S (M+H)
+ 
 
319.1475 319.1472 
 
Piperazine-monoDNS 
C16H21N3O2S 
C16H22N3O2S (M+H)
+ 
 
320.1437 320.2235 
Piperazine-diDNS 
C28H32N4O4S2 
C28H33N4O4S2 (M+H)
+ 
C28H34N4O4S2 (M+2H)
2+ 
553.1938 
277.1011 
553.1911 
277.1009 
1,4-Diaminobutane-monoDNS 
C16H23N3O2S 
C16H24N3O2S (M+H)
+ 
 
322.1589 322.1562 
1,4-Diaminobutane-diDNS 
C28H34N4O4S2 
C28H35N4O4S2 (M+1)
+ 
 
555.2094 555.2091 
1,7-Diaminoheptane-monoDNS 
C19H29N3O2S 
C19H30N3O2S (M+H)
+ 
 
364.2053 364.2036 
1,7-Diaminoheptane-diDNS 
C31H40N4O4S2 
C31H41N4O4S2 (M+H)
+ 
 
597.25564 597.2250 
1,12-Diaminododecane-diDNS 
C36H50N4O4S2 
C36H52N4O4S2 (M+2H)
2+ 
 
334.1696 334.1708 
C43H53N6O6S3 (M+H)
+ 
 
845.3183 845.3163 Spermidine-triDNS 
C43H52N6O6S3 
 C43H52N6NaO6S3 
(M+Na)+ 
867.3003 867.2992 
N-(4-Aminobutyl) 
hexahydropyrimidine-monoDNS 
C20H30N4O2S 
C20H31N4O2S (M+H)
+ 
 
391.2162 391.2148 
N-(4-Aminobutyl) 
hexahydropyrimidine-diDNS 
C32H41N5O4S2 
C32H42N5O4S2 (M+H)
+ 
 
624.2678 624.2676 
C58H71N8O8S4 (M+H)
+ 1135.4272 1135.4241 Spermine-tetraDNS 
C58H70N8O8S4 C58H70N8NaO8S4 
(M+Na)+ 
1157.4097 1157.4061 
1,4-(Dihexahydropyrimidine) 
butane-diDNS 
C36H48N6O4S2 
C36H49N6O4S2 (M+H)
+ 693.3251 693.3275 
C47H59N7O6S3 (M+H)
+ 
 
914.3767 914.3772 1-(Hexahydropyrimidine)-5-aza-
aminooctane-triDNS 
C47H59N7O6S3 C47H59N7NaO6S3 
(M+Na)+ 
936.3586 936.3560 
N
4,N9-Oleoyl spermine-
monoDNS C58H101N4O4S2 
C58H102N4O4S2 (M+H)
+ 
 
964.7647 964.7666 
N
4,N9-Didecanoyl spermine-
diDNS 
C54H84N6O6S2 
C54H85N6O6S2 (M+H)
+ 
 
977.5972 977.5947 
C60H100N5O5S (M+H)
+ 
 
1002.7440 1002.7434 N4-Decanoyl-N9-cholesteryl 
carbamate spermine-mono DNS 
C60H99N5O5S C60H99N5NaO5S (M+Na)
+
 1024.7264 1024.7357 
N
4,N9-Digeranoyl spermine- 
monoDNS 
C42H65N5O4S 
C42H66N5O4S (M+H)
+ 
 
736.4830 736.4850 
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N
4,N9-Dioctadecanoyl spermine-
monoDNS 
C58H105N5O4S 
C58H106N5O4S (M+H)
+ 
 
968.7965 968.7984 
Kanamycin-tetra DNS 
C66H80N8O19S4 
C66H81N8O19S4  (M+H)
+ 1417.4500 1417.4496 
 
Conclusions of DNS Cl derivatization 
 
DNS Cl reacts with primary and secondary amines with the result of full derivatization if the 
molar ratio to DNS Cl is enough, resulting in diDNS derivatives for diamines such as 1,4-
diaminobutane, 1,5-diaminopentane, 1,7-diaminoheptane, triDNS derivative for spermidine 
and tetraDNS derivative for spermine.  However, the monoDNS derivative of each diamine 
was obtained when we used lower DNS Cl ratios whilst investigating the phenomenon of 
fluorescence yield.  Peaks in HPLC chromatograms from spermine-tetraDNS derivatives are 
eluted after 30 min even when a C8 column was used (with isocratic mobile phase of 
acetonitrile: Milli-Q-water = 70:30) due to the hydrophobic nature of the molecule and its 
high molecular weight.  However, by converting spermine into 1,4-dihexahydropyrimidine-
butane (the dihexahydropyrimidine derivative of spermine) before dansylation, the retention 
time was reduced to ~19 min.  The excess of DNS Cl reagent was destroyed using a solution 
of alanine.  Polyamines were analysed on an Reversed-phase ODS Hypersil, ODS luna, C8 
luna column with an isocratic mobile phase mixture of acetonitrile and Milli-Q-water at a 
flow rate of 1 mL/min with fluorescence detection at excitation and emission wavelength of 
330 and 510 nm, respectively and UV detection at λmax = 330 nm.  The reaction time of DNS 
Cl at 20oC gave a lower yield than at 60oC and it is better to set the temperature at 60oC 
rather than at room temperature which might vary. 
 
Several advantages of DNS Cl derivatization are:  its high degree of reproducibility, 
precision, sensitivity and the high stability of the derivatives.  However, when compared 
with other derivatization methods, DNS Cl requires more time than the others.  The DNS Cl 
derivatization might not be suitable for large molecules.  If the molecule has many reactive 
amino groups, then when it is (poly)-labelled with DNS Cl the product is more lipophilic and 
therefore slower to elute from the HPLC column.  In this study, the simultaneous use of two 
detectors connected in series for the determination of polyamine-DNS derivatives, to detect 
both UV and fluorescence benefits in not missing a peak that might detected by only one 
detector, thus increasing the reliability of the method.  On the basis of peak size, 
fluorescence detection showed higher sensitivity for amine-DNS derivatives.  However, both 
detectors were shown to be accurate and produced calibration curves of good linearity. 
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CHAPTER 6:  THERMOSPERMINE SYNTHESIS 
 
Spermidine (3.4) and spermine (3.4.3) are major polyamines in most organisms.  Spermine is 
probably present in all eukaryotes; however, it is rare in prokaryotes or might be replaced by 
thermine (norspermine, 3.3.3) and thermospermine (3.3.4) e.g. in certain species of 
thermophilic bacteria.  Thermus thermophilus is an extreme thermophile and the major 
polyamines in this bacterium, grown under the optimal conditions at 800C, are thermine and 
thermospermine (Figure 6.1) (Oshima, 1979). 
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Thermospermine (3.3.4) 
 
Figure 6.1  Thermine (C9H24N4) has a 3.3.3 methylene distribution, one methylene less than 
spermine (3.4.3), Thermospermine (C10H26N4) with its 3.3.4 methylene arrangement is an 
isomer of spermine (3.4.3). 
 
Thermus aquaticus is a species of thermophillus that thrives at 700C.  It is the source of the 
heat-resistant enzyme Taq DNA polymerase, one of the most important enzymes in 
molecular biology due to its use in the polymerase chain reaction (PCR) DNA amplification 
technique. 
 
Using current methods, thermine (3.3.3) and thermospermine (3.3.4) are difficult to 
distinguish from spermine (3.4.3) (Oshima, 1983; Knott et al., 2007).  It is also possible that 
some literature reports of spermine biosynthesis may in fact be partly or wholly due to 
thermospermine (Hamana and Matsuzaki, 1984; Hosoya et al., 2004).  Thus, 
thermospermine has been synthesised in order to develop improved methods for its 
separation from spermine and their analysis.  The synthesis started with spermidine (3.4) and 
used the method of Ganem and Chantrapromma (1983) (Figure 6.2). 
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Figure 6.2  Thermospermine synthesis (Method 1). 
 
Method 1 step 1  N-(4-Aminobutyl)hexahydropyrimidine (2) 
 
N-(4-Aminobutyl)hexahydropyrimidine (2) was prepared by the reaction of spermidine and 
formaldehyde (equal mole ratios) to give the stable hexahydropyrimidine ring as a viscous 
oily liquid which displayed a molecular weight greater than that of spermidine by the desired 
12 mass units (found 158.1630, C8H20N3 requires m/z [M+H]
+ = 158.1657).  The product 
obtained from formaldehyde (2 equiv.) gave the HR-ESI-MS (Figure 6.3).  This spectrum 
shows a peak at m/z 158.1630 (required = 158.1657) corresponding to the [M+H]+ ion 
derived from N-(4-aminobutyl)hexahydropyrimidine (2) together with a trace peak at m/z 
146.1673 (required = 146.1657) corresponding to the [M+H]+ ion of the starting material 
spermidine.  However, the major peak was at m/z 170.1635 (required = 170.1657) which 
corresponds to the [M+H]+ ion of the N-(N′-methylene-4-iminobutyl)-hexahydropyrimidine 
(13) (Figure 6.4) which had an additional molecule of formaldehyde reacted at the remaining 
primary amino group. 
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Figure 6.3  HR-ESI-MS spectrum of spermidine (1) (M.W. = 145.1579, C7H19N3) expected 
m/z [M+H]+ ion = 146.1657 (found = 146.1673), N-(4-aminobutyl) hexahydropyrimidine (2) 
(M.W. = 157.1579, C8H19N3) expected m/z [M+H]
+ ion = 158.1657 (found = 158.1630), N-
(N′-methylene-4-iminobutyl)-hexahydropyrimidine (13) (M.W. = 169.1579, C9H19N3) 
expected m/z [M+H]+ ion = 170.1657 (found = 170.1635). 
 
NH N
N
CH
2
13  
 
Figure 6.4  N-(N′-Methylene-4-iminobutyl)-hexahydropyrimidine (13), C9H19N3 (M.W = 
169.1579). 
 
Even with 1.1 equiv. of formaldehyde a small peak of m/z = 170.1648 (required = 170.1657) 
was observed (Figure 6.5), but was virtually eliminated when 0.9 equiv. of formaldehyde 
were used (Figure 6.6).  The reaction were examined in different mole ratio of formaldehyde, 
the results were obtained (Table 6.1).  The desired product, N-(4-aminobutyl) 
hexahydropyrimidine (2), was examined by NMR spectroscopy (Figures 6.7, 6.8, and 6.9) 
and the peaks were assigned. 
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Figure 6.5:  HR-ESI-MS spectrum of products by the reaction of 1.1 equiv. of formaldehyde 
against spermidine.  The spectrum shows spermidine (1) (M.W. = 145.1579, C7H19N3) 
expected m/z [M+H]+ ion = 146.1657 (found = 146.1673), N-(4-aminobutyl) 
hexahydropyrimidine (2) (M.W. = 157.1579, C8H19N3) expected m/z [M+H]
+ ion = 158.1657 
(found = 158.1632), N-(N′-methylene-4-iminobutyl)-hexahydropyrimidine (13) (M.W. = 
169.1579, C9H19N3) expected m/z [M+H]
+ ion = 170.1657 (found = 170.1648). 
 
 
 
 
Figure 6.6  HR-ESI-MS spectrum of products by the reaction of 0.9 equiv. of formaldehyde 
against spermidine.  The spectrum shows spermidine (1) (M.W. = 145.1579, C7H19N3) 
expected m/z [M+H]+ ion = 146.1657 (found = 146.1664), N-(4-aminobutyl) 
hexahydropyrimidine (2) (M.W. = 157.1579, C8H19N3) expected m/z [M+H]
+ ion = 158.1657 
(found = 158.1630), N-(N′-methylene-4-iminobutyl)-hexahydropyrimidine (13) (M.W. = 
169.1579, C9H19N3) expected m/z [M+H]
+ ion = 170.1657 (found = 170.1642). 
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Table 6.1  Comparison of the amount of the desired product N-(4-aminobutyl) 
hexahydropyrimidine (2) at expected m/z [M+H]+ ion = 158.1657: N-(N′-methylene-4-
iminobutyl)-hexahydropyrimidine (13) at expected m/z [M+H]+ ion = 170.1657; starting 
material spermidine (1) at expected m/z [M+H]+ ion = 146.1657 when prepared using 
different ratios of formaldehyde to spermidine. 
 
mole ratio of formaldehyde to spermidine (1) (2) (13) 
2.0 equiv. 1.8% 43.2% 55.0% 
1.1 equiv. 7.1% 76.1% 16.8% 
0.9 equiv. 7.6% 81.4% 11.0% 
 
 
 
 
Figure 6.7  Expansion of 1H-NMR spectrum (400 MHz, CDCl3) of N-(4-aminobutyl) 
hexahydropyrimidine (2). 
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Figure 6.8  13C-NMR spectrum (100 MHz, CDCl3) of N-(4-aminobutyl) 
hexahydropyrimidine (2). 
 
 
 
Figure 6.9  13C-NMR DEPT spectrum (100 MHz, CDCl3) of N-(4-aminobutyl) 
hexahydropyrimidine (2). 
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δH (CDCl3) (400 MHz) 3.29 (2H, s, C(8)H2), 2.73 (2H, m C(1)H2), 2.64 (2H, m, C(7)H2), 
2.44 (1H, s, NH), 2.62 (2H, m, C(4)H2), 2.17 (2H, b, C(5)H2), 1.62 (2H, s, NH2), 1.54 (2H, 
p, C(3)H2), 1.41 (4H, m, C(2) H2, C(6)H2). 
 
δC (CDCl3) (100 MHz) 24.15 (C(6)), 26.96 (C(3)), 31.47 (C(2)), 41.72 (C(1)), 44.99 (C(7)), 
52.94 (C(4)), 55.24 (C(5)), 69.74 (C(8)). 
 
After N-(4-aminobutyl) hexahydropyrimidine (2) was obtained, the protection of the primary 
amine by using BOC (tert-Butyl carbamates) was considered.  However, BOC reacts with 
both primary (Figure 6.10) and secondary amines (Figure 6.11) of N-(4-aminobutyl) 
hexahydropyrimidine (2) and yielded a mixture of mono- and diBOC products as confirmed 
by HR-ESI-MS (Figure 6.12). 
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Figure 6.10  N-(4-Aminobutyl) hexahydropyrimidine (2) monoBOC derivative. 
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Figure 6.11  N-(4-Aminobutyl)hexahydropyrimidine (2) diBOC derivative. 
 
 
Figure 6.12  HR-ESI-MS spectrum of N-(4-aminobutyl) hexahydropyrimidine (2) with 
mono BOC on primary amine (M.W. = 257.2103, C13H27N3O2) expected m/z [M+H]
+ ion = 
258.2181 (found = 258.2166) and N-(4-aminobutyl) hexahydropyrimidine (2) with diBOC 
(M.W. = 357.2627, C18H35N3O4) expected m/z [M+H]
+ ion = 358.2706 (found = 358.2685). 
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Method 1 step 2  Protection of primary amine group of N-(4-aminobutyl) 
hexahydropyrimidine (2) by the method of Ganem. 
 
N-(4-Aminobutyl) hexahydropyrimidine (2) was reacted with benzaldehyde which is a 
selective protecting group for the remaining primary amine to obtain 4-(N-
benzylideneaminobutyl)hexahydropyrimidine (3) (Figure 6.13). 
 
NH N
N
 
 
Figure 6.13  4-(N-Benzylideneaminobutyl)hexahydropyrimidine (3), C15H23N3 (M.W = 
245.1892). 
 
HR-ESI-MS of 4-(N-benzylideneaminobutyl)hexahydropyrimidine (3) (Figure 6.14) shows 
the presence of an ion at m/z 246.1970 (found = 246.1945) corresponding to [M+H]+ ion of 
this compound but also apparently a large peak at m/z = 158.1657 (found = 158.1628) for 
unreacted starting material.  Another possibility is that this peak (m/z = 158.1657) arose 
from deprotection of the product when the MS solution was made up. 
 
 
Figure 6.14  HR-ESI-MS spectrum of N-(4-aminobutyl)hexahydropyrimidine (2) (M.W. = 
157.1579, C8H19N3) expected m/z [M+H]
+ ion = 158.1657 (found = 158.1628) and the 
desired product of 4-(N-benzylideneaminobutyl) hexahydropyrimidine (3) (M.W. = 
245.1892, C15H23N3) expected m/z [M+H]
+ ion = 246.1970 (found = 246.1945). 
 
 - 180 - 
The product was examined by NMR. 
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δH (CDCl3) (400 MHz) 8.24 (H, s, C(9) H), 7.68 (2H, m, C(10)H, C(11)H), 7.37 (3H, m, 
C(12)H, C(13)H, C(14)H), 3.58 (2H, t, C(1)H2), 3.07 (2H, s C(8)H2), 2.55 (2H, t, C(7)H2), 
2.48 (2H, t, C(4)H2), 2.34 (2H, t, C(5)H2), 1.67 (2H, m, C(3)H2), 1.58 (4H, m, C(2) H2, 
C(6)H2). 
 
Dansylation method 2 (Chapter 2, page 45) was also used to investigate the purity of the 4-
(N-benzylideneaminobutyl)hexahydropyrimidine (3).  The HPLC chromatogram (Figure 
6.17) showed the main peak at Rt = 6.4 min.  HR-ESI-MS showed mainly 4-(N-
benzylideneaminobutyl)hexahydropyrimidine (3)-monoDNS derivative (Figure 6.15, HR-
ESI-MS as Figure 6.19) with a trace amount of N-(4-aminobutyl) hexahydropyrimidine (2)-
monoDNS derivative (Figure 6.16, HR-ESI-MS as Figure 6.18).  This might be evidence for 
the loss of the benzylidine group prior to MS because from the previous study N-(4-
aminobutyl) hexahydropyrimidine (2) forms the diDNS derivative.  Thus it appears that the 
primary amino group was still protected when the dansylation reaction was carried out. 
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Figure 6.15  4-(N-Benzylideneaminobutyl)hexahydropyrimidine (3)-monoDNS derivative. 
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Figure 6.16  N-(4-Aminobutyl)hexahydropyrimidine (2)-monoDNS derivative. 
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Figure 6.17  HPLC chromatogram of 4-(N-benzylideneaminobutyl)hexahydropyrimidine (3)-
monoDNS derivative.  HPLC conditions:  mobile phase is acetonitrile: Milli-Q-water (70:30), 
C8-luna column, flow rate 1 mL/min, fluorescence detector at λex = 330 nm, λem = 510 nm.  
The chromatogram shows peak 1 = 4-(N-benzylideneaminobutyl)hexahydro-pyrimidine (3)-
monoDNS derivative at Rt = 6.4 min, peak 2 = spermidine triDNS derivative at Rt = 11.0 
min. 
 
 
 
Figure 6.18  HR-ESI-MS spectrum of N-(4-aminobutyl)hexahydropyrimidine (2) –
monoDNS derivative (M.W. = 390.2089, C20H30N4O2S) expected m/z [M+H]
+ ion = 
391.2168 (found = 391.2134) and dimer ion m/z [2M+H]+ ion = 781.4346 (found = 
781.4233). 
0 6 12 mins 
1 
2 
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Figure 6.19  HR-ESI-MS spectrum the desired product of 4-(N-benzylideneaminobutyl)-
hexahydropyrimidine (3)-monoDNS (M.W. = 478.2403, C27H34N4O2S) expected m/z 
[M+H]+ ion = 479.2481 (found = 479.2491) (this figure was expanded from Figure 6.18). 
 
Method 1 step 3  Michael addition of acrylonitrile 
 
N
1
-(N-Benzylidene-(1-hexahydropyrimidinebutyl)-N3-propionitrile (4) was prepared by 
Michael addition of the unprotected secondary amine of 4-(N-benzylideneaminobutyl)-
hexahydropyrimidine (3) with acrylonitrile to yield N1-(N-benzylidene-(1-hexahydro-
pyrimidinebutyl)-N3-propionitrile (4) (Figure 6.20) (80% yield). 
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Figure 6.20:  N1-(N-Benzylidene-(1-hexahydropyrimidinebutyl)-N3-propionitrile (4), 
C18H26N4 (M.W = 298.2157). 
 
By HR-ESI-MS spectra (Figure 6.22), the desired product was found at m/z [M+1]+ ion = 
299.2201.  However, a contamination of C11H22N4 (the possible structures shown in Figure 
6.21) was also found at m/z [M+1]+ ion = 211.1895.  Depending upon whether the 
benzylidine group was lost when the sample was prepared for MS or whether it was absent 
in the starting material. 
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Figure 6.21  C11H22N4 (M.W = 210.1844). 
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Figure 6.22  HR-ESI-MS spectra of the desired product of N1-(N-benzylidene-(1-
hexahydropyrimidinebutyl)-N3-propionitrile (4) (M.W = 298.2157, C18H26N4), expected m/z 
[M+H]+ = 299.2235 (found = 299.2201) and a contamination product (Figure 6.26) at M.W 
= 210.1844, C11H22N4, expected m/z [M+H]
+ ion = 211.1922 (found = 211.1895). 
 
Method 1 step 4  Deprotection of the amino groups 
 
Both the protection functions were removed simultaneously by heating under reflux with 2M 
HCl in methanol to yield 12-amino-4,8-diaza-dodecanenitrile (5) (Figure 6.23) which was 
confirmed by HR-ESI-MS (Figure 6.24) and the structure was confirmed by NMR (Figure 
6.25, 6.26). 
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Figure 6.23  12-Amino-4,8-diaza-dodecanenitrile (5), C10H22N4 (M.W. = 198.1844). 
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Figure 6.24  HR-ESI-MS spectra of desired product 12-amino-4,8-diaza-dodecanenitrile (5), 
(M.W. = 198.1844, C10H22N4) expected m/z [M+H]
+ ion = 199.1923 (found = 199.1923). 
 
 
 
 
Figure 6.25  Expansion 1H-NMR (400 MHz, CDCl3) spectra of 12-amino-4,8-diaza-
dodecanenitrile (5). 
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Figure 6.26  Expansion of 13C-NMR (100 MHz, CDCl3) spectra of 12-amino-4,8-diaza-
dodecanenitrile (5). 
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δH (CDCl3) (400 MHz) 2.88 (2H, t, C(9) H2), 2.67 (4H, m, C(5)H2, C(7)H2), 2.57 (2H, t, 
C(8)H2), 2.48 (2H, m, C(1)H2), 2.46 (2H, m, C(4)H2), 1.65 (4H, m, C(2)H2, C(6)H2), 1.44 
(2H, m, C(3)H2). 
 
δC (CDCl3) (100 MHz) 18.64, 27.34, 29.95, 31.40, 41.96, 45.05, 47.81, 48.29, 49.80, 118.71. 
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Step 5:  Thermospermine 
 
CoCl2 catalyzed reduction of the 12-amino-4,8-diaza-dodecanenitrile (5) by sodium 
borohydride yielded the desired thermospermine, 1,12-diamino-4,8-diazadodecane, (6) 
(Figure 6.27) as a yellowish oily liquid.  HR-ESI-MS (Figure 6.28) showed a major peak at 
m/z = 203.2236 corresponding to the [M+H]+ ion of spermine and thermospermine. 
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Figure 6.27  Thermospermine, C10H26N4 (M.W = 202.2157). 
 
 
 
Figure 6.28  HR-ESI-MS spectrum of desired product thermospermine, (M.W. = 202.2157, 
C10H26N4) expected m/z [M+H]
+ ion = 203.2236 (found = 203.2236). 
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Method 2  Thermospermine synthesis by using phthalimide as the protecting group. 
 
The alternative method of thermospermine synthesis was done by using phthalimide as the 
protecting group (Figure 6.29). 
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Figure 6.29  Thermospermine synthesis (method 2). 
 
Method 2 step 1  N-(4-Aminobutyl)hexahydropyrimidine (2) 
 
N-(4-Aminobutyl)hexahydropyrimidine (2) was prepared by the reaction of spermidine and 
formaldehyde as in method 1 step 1. 
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Method 2 step 2  2-(N-Butylhexahydropyrimidine)isoindoline-1,3-dione 
 
N-(4-Aminobutyl)hexahydropyrimidine (2) was reacted with phthalimide which is a 
selective protecting group for the remaining primary amine to obtain the 2-(N-butyl-
hexahydropyrimidine) isoindoline-1,3-dione (7) (Figure 6.30) which was confirmed by HR-
ESI-MS (Figure 6.31) and by NMR (Figure 6.32). 
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Figure 6.30  2-(N-Butylhexahydropyrimidine)isoindoline-1,3-dione (7), C16H21N3O2 (M.W 
= 287.1634). 
 
δH (CDCl3) (400 MHz) 7.846 (2H, m, C(10) H, C(11)H), 7.814 (2H, m, C(9)H, C(12)H), 
4.101 (2H, s, C(8)H2), 3.703 (2H, t, C(1)H2), 3.204 (2H, t C(7)H2), 3.015 (2H, t, C(4)H2), 
2.898 (2H, t, C(5)H2), 1.912 (2H, quin, C(3)H2), 1.824 (2H, quin, C(2)H2), 1.695 (2H, quin, 
C(6) H2). 
 
 
 
Figure 6.31  HR-ESI-MS spectrum of 2-(N-butylhexahydropyrimidine)isoindoline-1,3-dione 
(7) (M.W. = 287.1634, C16H21N3O2) expected m/z [M+H]
+ ion = 288.1712 (found = 
288.1719). 
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Figure 6.32  1H NMR of 2-(N-butylhexahydropyrimidine)isoindoline-1,3-dione (7). 
 
Method 2 step 3  Adding acrylonitrile to 2-(N-butylhexahydropyrimidine) isoindoline-
1,3-dione (7) 
 
2-(N1-Butylhexahydropyrimidine)-isoindoline-1,3-dione-N3-propionitrile (8) was prepared 
by Michael addition of the unprotected secondary amine of 2-(N-
butylhexahydropyrimidine)isoindoline-1,3-dione (7) by acrylonitrile (80% yield) (Figure 
6.33).  This amine was confirmed by HR-ESI-MS (Figure 6.34) and examined by NMR 
(Figure 6.35, 6.36, 6.37). 
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Figure 6.33  2-(N1-Butylhexahydropyrimidine)-isoindoline-1,3-dione-N3-propionitrile (8), 
C19H24N4O2 (M.W = 340.1899). 
 
δH (CDCl3) (400 MHz) 7.804 (2H, m, C(10) H, C(11)H), 7.691 (2H, m, C(9)H, C(12)H), 
3.659 (2H, m, C(8)H2), 3.659 (2H, t, C(1)H2), 2.863 (2H, t, C(14)H2), 2.732 (2H, m, 
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C(13)H2), 2.683 (2H, m, C(4)H2),  2.490 (4H, m, C(5)H2, C(7)H2), 1.850 (2H, quin, C(3)H2), 
1.683 (2H, quin, C(2)H2), 1.567 (2H, m, C(6) H2). 
 
 
Figure 6.34  HR-ESI-MS spectrum of 2-(N1-butylhexahydropyrimidine)-isoindoline-1,3-
dione-N3-propionitrile (8), (M.W. = 340.1899, C19H24N4O2) expected m/z [M+H]
+ ion = 
341.1977 (found = 341.1971). 
 
 
Figure 6.35  1H NMR of 2-(N1-butylhexahydropyrimidine)-isoindoline-1,3-dione-N3-
propionitrile (8). 
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Figure 6.36  Expansion of 1H NMR of 2-(N1-butylhexahydropyrimidine)-isoindoline-1,3-
dione-N3-propionitrile (8). 
 
 
Figure 6.37  13C NMR of 2-(N1-butylhexahydropyrimidine)-isoindoline-1,3-dione-N3-
propionitrile (8). 
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Method 2 step 4  Deprotection of the hexahydropyrimidine ring of 2-(N1-
butylhexahydropyrimidine)-isoindoline-1,3-dione-N3-propionitrile (8) 
 
By reflux with 2 M HCl-methanol (15 mL) at 80oC for 8 h., the methylene group from 
hexahydropyrimidine ring of 2-(N1-butylhexahydropyrimidine)-isoindoline-1,3-dione-N3-
propionitrile (8) was removed to yield 12-(1,3-dioxoisoindolin-2-yl)-4,8-diaza-
dodecanenitrile (9) (Figure 6.38) (85% yield). 
 
HR-ESI-MS spectrum of 12-(1,3-dioxoisoindolin-2-yl)-4,8-diaza-dodecanenitrile (9) (M.W. 
= 328.1899, C18H24N4O2) expected m/z [M+H]
+ ion = 329.1977 (found = 329.1965) and also 
found 2-(N1-butylhexahydropyrimidine)-isoindoline-1,3-dione-N3-propionitrile (8) (M.W. = 
340.1899, C19H24N4O2) expected m/z [M+H]
+ ion = 341.1977 (found = 341.2005). 
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Figure 6.38  12-(1,3-Dioxoisoindolin-2-yl)-4,8-diaza-dodecanenitrile (9), C18H24N4O2 
(M.W. = 328.1899). 
 
Method 2 step 5  Removal of the phthalimide group to give 12-amino-4,8-diaza-
dodecanenitrile (5) 
 
12-(1,3-Dioxoisoindolin-2-yl)-4,8-diaza-dodecanenitrile (9) was treated with hydrazine 
monohydrate in CH2Cl2/ THF (1:1) and reflux for 4 h at 80
oC to yield 12-amino-4,8-diaza-
dodecanenitrile (5) (50% yield) (Figure 6.39).  This amine was confirmed by HR-ESI-MS. 
 
HR-ESI-MS spectra of desired product 12-amino-4,8-diaza-dodecanenitrile (5), (M.W. = 
198.1844, C10H22N4) expected m/z [M+H]
+ ion = 199.1923 (found = 199.1920) 
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Figure 6.39  12-Amino-4,8-diaza-dodecanenitrile (5), C10H22N4 (M.W. = 198.1844). 
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Dansylation (Chapter 2, page 45) was used to investigated 12-amino-4,8-diaza-
dodecanenitrile (5).  The HPLC chromatogram of 12-amino-4,8-diaza-dodecanenitrile (5)-
triDNS derivative was obtained (Figures 6.40 and 6.41), the derivative was eluted at 12.5 
min (HPLC conditions:  C-8 luna column, mobile phase:  acetonitrile: Milli-Q-water (70:30), 
flow rate = 1 mL/min) and confirmed by HR-ESI-MS (Figures 6.42 and 6.43). 
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Figure 6.40  12-Amino-4,8-diaza-dodecanenitrile (5)-triDNS derivative. 
 
 
 
 
 
Figure 6.41  HPLC chromatogram of 12-amino-4,8-diaza-dodecanenitrile (5)-DNS derivative.  
HPLC conditions:  mobile phase is acetonitrile: Milli-Q-water (70:30), C8-luna column, flow 
rate 1 mL/min, fluorescence detector at λex = 330 nm, λem = 510 nm.  The chromatogram shows 
peak 1 = 12-amino-4,8-diaza-dodecanenitrile (5)-diDNS derivative at Rt = 5.0 min, peak 2 = 
12-amino-4,8-diazadodecanenitrile (5)-triDNS derivative at Rt = 12.5 min. 
0 6 12 mins 
1 2 
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Figure 6.42  HR-ESI-MS spectra of 12-amino-4,8-diaza-dodecanenitrile (5)-monoDNS 
derivative (M.W. = 431.2355, C22H33N5O2S) expected m/z [M+H]
+ ion = 432.2433 (found = 
432.2416) and 12-amino-4,8-diaza-dodecanenitrile (5)-diDNS derivative (M.W. = 664.2865, 
C34H44N6O4S2) expected m/z [M+H]
+ ion = 665.2943 (found = 665.2920). 
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Figure 6.43  HR-ESI-MS spectra of 12-amino-4,8-diaza-dodecanenitrile (5)-triDNS 
derivative (M.W. = 897.3376, C46H55N7O6S3) expected m/z [M+H]
+ ion = 898.3454 (found = 
898.3441) and doubly charged [M+2H]2+ ion = 449.6766 (found = 449.6742) (at Rt = 12.5 
min). 
 
Method 2 step 6  Thermospermine 
 
The last step is to reduce triple bond of nitrile of 12-amino-4,8-diaza-dodecanenitrile (5) to 
obtain thermospermine by using sodium borohydride.  The molecular weight of the desired 
thermospermine was confirmed by HR-ESI-MS (Figure 6.44). 
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Figure 6.44  HR-ESI-MS spectrum of desired product thermospermine, (M.W. = 202.2157, 
C10H26N4) expected m/z [M+H]
+ ion = 203.2236 (found = 203.2232) and doubly charged ion 
[M+2H]2+ = 102.1156 (found = 102.1130). 
 
Method 2 alternative step 4  Alternative deprotection method for 12-amino-4,8-diaza-
dodecanenitrile (5) by simultaneous removal of phthalimide and hexahydropyrimidine 
from 2-(N1-butylhexahydropyrimidine)-isoindoline-1,3-dione-N3-propionitrile (8) 
 
2-(N1-Butylhexahydropyrimidine)-isoindoline-1,3-dione-N3-propionitrile (8) was treated 
with hydrazine monohydrate in CH2Cl2/ THF (1:1) and reflux for 4 h at 80
oC to remove the 
phthalimide group to yield 3-(N1-(4-aminobutyl) hexahydropyrimidine)propanenitrile 
(Figure 6.45).  This amine was confirmed by HR-ESI-MS (Figure 6.46). 
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Figure 6.45  3-(N1-(4-Aminobutyl) hexahydropyrimidine)propanenitrile, C11H22N4 (M.W. = 
210.1844). 
 
From this MS result, it suggested that the deprotection reaction of the phthalimide group by 
hydrazine monohydrate simultaneously removed the methylene from the 
hexahydropyrimidine ring of N-(4-aminobutyl) hexahydropyrimidine (2).  This result was 
confirmed by removal of hexahydropyrimidine ring from N-(4-aminobutyl) 
hexahydropyrimidine (2) by the same method (Figure 6.47).  The HR-ESI-MS of this 
starting material, N-(4-aminobutyl) hexahydropyrimidine (2) was confirmed as M.W. of = N-
(4-aminobutyl) hexahydropyrimidine (2) = 157.1579 (C8H19N3) expected m/z [M+H]
+ ion = 
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158.1657 (found = 158.1640).  The product of spermidine (1), M.W. = 145.1579 (C7H19N3) 
was confirmed by HR-ESI-MS as expected m/z [M+H]+ ion = 146.1657 (found = 146.1638) 
which was obtained from the reaction of hydrazine. 
 
 
Figure 6.46  HR-ESI-MS spectrum of 3-(N1-(4-aminobutyl) hexahydropyrimidine) 
propanenitrile (M.W. = 210.1844, C11H22N4) expected m/z [M+H]
+ ion = 211.1923 (found = 
211.1924) and also found 12-amino-4,8-diaza-dodecanenitrile (5), (M.W. = 198.1844, 
C10H22N4) expected m/z [M+H]
+ ion = 199.1923 (found = 199.1921). 
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Figure 6.47  Scheme of removal of hexahydropyrimidine ring from N-(4-aminobutyl) 
hexahydropyrimidine (2). 
 
Thermospermine synthesised by method 1 has a problematic step at step 2 when using 
benzaldehyde as the protecting group which the environment needed to be dry, a small 
amount of water will cleave the benzaldehyde group.  Thus, the risk of getting incomplete 
reaction started from this step.  By using phthalimide as the protecting group in method 2 
step 2, the reaction was set at milder conditions (at 20oC) and gave more yield of desired 
product.  By alternative way of remove the protecting group by method 2 step 4, the yield of 
the aminonitrile, 12-amino-4,8-diaza-dodecanenitrile (5) was increased (75% yield). 
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Spermine and Thermospermine 
 
A comparison of the NMR spectra between spermine and thermospermine was performed.  
The NMR of spermine is shown in Figures 6.48, 6.49 and 6.50 and the NMR of 
thermospermine in Figures 6.51, 6.52 and 6.53. 
 
Figure 6.48  1H NMR of spermine. 
 
Figure 6.49  1H NMR of spermine. 
 - 199 - 
 
Figure 6.50  COSY of spermine. 
 
 
 
Figure 6.51  1H NMR of thermospermine. 
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Figure 6.52  1H NMR of thermospermine. 
 
 
 
 
Figure 6.53  COSY NMR of thermospermine. 
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Analysis of Thermospermine and Spermine 
 
Method 1 Analysis by HR-ESI-MS 
 
Hexahydropyrimidine derivative of spermine 
 
Dihexahydropyrimidine rings derivative of spermine, 1,4-(dihexahydropyrimidine)butane 
(11) was prepared by the reaction of spermine (10) against formaldehyde (2 equiv.) (Figure 
6.54) and the result was confirmed by HR-ESI-MS (Figure 6.55). 
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Figure 6.54  1,4-(Dihexahydropyrimidine) butane (11) synthesis. 
 
 
Figure 6.55  HR-ESI-MS spectrum of desired product 1,4-dihexahydropyrimidine-butane 
(11) (M.W. = 226.2157, C12H26N4) expected m/z [M+H]
+ ion = 227.2236 (found = 227.2218) 
and doubly charged ion [M+2H]2+ = 114.1157 (found = 114.1181) also found was the 
product of incomplete reaction where spermine had been derivatized with only one 
hexahydropyrimidine ring, 1-hexahydropyrimidine-5-aza-8-aminooctane (M.W. = 214.2157, 
C11H26N4) expected m/z [M+H]
+ ion = 215.2236 (found = 215.2222) 
 - 202 - 
From this result, it is concluded that the reaction of spermine (10) with formaldehyde (2 
equiv.) was not complete so the mole ratio of formaldehyde was increased to 2.5 equiv. and 
the result was confirmed by HR-ESI-MS (Figure 6.56). 
 
 
Figure 6.56  HR-ESI-MS spectra of desired product 1,4-(dihexahydropyrimidine) butane 
(11) (M.W. = 226.2157, C12H26N4) expected m/z [M+H]
+ ion = 227.2236 (found = 227.2217) 
also found was the product of incomplete reaction where spermine had been derivatized with 
only one hexahydropyrimidine ring, 1-hexahydropyrimidine-5-aza-8-aminooctane (M.W. = 
214.2157, C11H26N4) expected m/z [M+H]
+ ion = 215.2236 (found = 215.2237). 
 
The mole ratio of formaldehyde was increased to 2.5 equiv., however, the m/z [M+H]+ ion = 
215.2236 was still obtained.  It is possible that this value of [M+H]+ ion at 215.2236 arose 
from hexahydropyrimidine ring of thermospermine, 1-(hexahydropyrimidine)-4-aza-
aminooctane (12), which means that thermospermine might contaminate in the commercial 
spermine. 
 
Hexahydropyrimidine derivative of thermospermine 
 
Hexahydropyrimidine ring derivative of thermospermine, 1-(hexahydropyrimidine)-4-aza-
aminooctane (12) was prepared by the reaction of thermospermine (6) against formaldehyde 
0.1 mL (2 equiv.) (Figure 6.57).  The product was confirmed by HR-ESI-MS (Figure 6.58). 
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Figure 6.57  1-(Hexahydropyrimidine)-4-aza-aminooctane (12) synthesis. 
 
 
 
Figure 6.58  HR-ESI-MS spectra of desired product 1-(hexahydropyrimidine)-4-aza-
aminooctane (12) (M.W. = 214.2157, C11H26N4) expected m/z [M+H]
+ ion = 215.2236 
(found = 215.2216) and doubly charged ion [M+2H]2+ = 108.1157 (found = 108.1175) also 
the starting material of thermospermine (6), (M.W. = 202.2157, C10H26N4) expected m/z 
[M+H]+ ion = 203.2236 (found = 203.2223) and peak of N-(4-aminobutyl) 
hexahydropyrimidine (2) (M.W. = 157.1579, C8H19N3), expected m/z [M+H]
+ ion = 
158.1657 (found = 158.1639). 
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From the result of HR-ESI-MS, it suggested that not all of thermospermine was converted to 
N
11-(hexahydropyrimidine)-4-aza-aminooctane (12), as the MS showed peak at [M+H]+ ion 
= 203.2236 of the starting material and also the peak of N-(4-aminobutyl) 
hexahydropyrimidine (2) at [M+H]+ ion = 158.1657, however, the peak of 1,4-
(dihexahydropyrimidine)butane (11) not found. 
 
Method 2:  Analysis by the reaction with dideuteriated formaldehyde. 
 
Spermidine 
 
The reaction of spermidine (1) with dideuteriated formaldehyde gave the desired product of 
N-(4-aminobutyl) hexahydropyrimidine dideuteriated but this reaction might give the other 
possible product (Figure 6.59), the presence of both products were confirmed by HR-ESI-
MS (Figure 6.60). 
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N-(4-(Dideuterioratedmetyl-1-ene)iminobutyl)-hexahydropyrimidine-2,2-dideuteriate  
 
Figure 6.59  The products from the reaction of spermidine (1) with dideuteriated 
formaldehyde. 
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Figure 6.60  HR-ESI-MS spectra of spermidine (1) (M.W. = 145.1548, C7H15N3D2) 
expected m/z [M+H]+ ion = 146.1626 (found = 146.1636), and the peak of N-(4-aminobutyl) 
hexahydropyrimidine dideuteriate (M.W. = 159.1704, C8H17N3D2) expected m/z [M+H]
+ ion 
= 160.1783 (found = 160.1774) and the peak of N-(4-(1-ine dideuteriorated)-aminobutyl)-
hexahydropyrimidine dideuteriate (M.W. = 173.1829, C9H15N3D4) expected m/z [M+H]
+ ion 
= 174.1908 (found = 174.1887) 
 
The result showed the desired product of N-(4-aminobutyl) hexahydropyrimidine 
dideuteriate at m/z [M+H]+ ion = 160.1783 as the main peak and the expected peak of N-(4-
(1-ine dideuteriated)-aminobutyl)-hexahydropyrimidine dideuteriate at m/z [M+H]+ ion = 
174.1908, however, there was another peak at m/z [M+H]+ ion = 146.1626 which might be 
from the contamination of 3, 3 amine (Figure 6.61) from the commercial spermidine. 
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Figure 6.61  The reaction between spermidine and dideuteriated formaldehyde. 
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Spermine 
 
Spermine was reacted with dideuteriated formaldehyde to obtain the desired product 1,4-
dihexahydropyrimidine-2,2,2′,2′-tetradeuterio-butane (Figure 6.62) confirmed by HR-ESI-
MS (Figure 6.63).  The mole ratio of dideuteriated formaldehyde used was 2.5 equiv., 
however, the m/z [M+H]+ ion = 217.2361 was obtained.  It is possible that in the commercial 
spermine contains thermospermine which will give the same [M+H]+ ion value. 
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Figure 6.62  1,4-Dihexahydropyrimidine-2,2,2′,2′-tetradeuterio-butane (spermine-di-
2,2,2′,2′-dideuterohexahydropyrimidine). 
 
 
 
Figure 6.63  HR-ESI-MS spectra of 1,4-(dihexahydropyrimidine-2,2,2′,2′-tetradeuterio) 
butane (M.W. = 230.2408, C12H22N4D4) expected m/z [M+H]
+ ion = 231.2486 (found = 
231.2472), doubly charged ion of [M+2H]2+ at 116.1282 (found = 116.1258) and also the 
trace of C11H24N4D2, M.W. = 216.2283 expected m/z [M+H]
+ ion = 217.2361 (found = 
217.2371). 
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Thermospermine 
 
The reaction of thermospermine with dideuteriate formaldehyde was carried out and the 
desired product of 1-(hexahydropyrimidine dideuterio)-4-aza-aminooctane was obtained 
(Figure 6.64) which was confirmed by HR-ESI-MS (Figure 6.65).  The HR-ESI-MS showed 
the major peak of the desired product, 8-(1-hexahydropyrimidine-2,2-dideuteri)-4-aza-
aminooctane, at [M+H]+ ion = 217.2361 but also found the contamination of 1,4-
(dihexahydropyrimidine-2,2,2′,2′-tetradeuterio) butane at [M+H]+ ion = 231.2486.  Which 
indicates that thermospermine is not pure. 
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Figure 6.64  8-(1-Hexahydropyrimidine-2,2-dideuterio)-4-aza-aminooctane. 
 
 
 
Figure 6.65  HR-ESI-MS spectra of 8-(1-hexahydropyrimidine-2,2-dideuterio)-4-aza-
aminooctane (M.W. = 216.2283, C11H24N4D2) expected m/z [M+H]
+ ion = 217.2361 (found 
= 217.2348) doubly charged ion [M+2H]2+ = 109.1219 (found = 109.1201) also found the 
peak of contamination of 8-(1-hexahydropyrimidine-2,2-dideuteri)-4-aza-aminooctane 
(M.W. = 230.2408, C12H22N4D4) expected m/z [M+H]
+ ion = 231.2486 (found = 231.2478). 
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Method 3  By the reaction of formaldehyde: dideuteriated formaldehyde (1:1). 
 
Spermidine 
 
Formaldehyde: dideuteriated formaldehyde (1:1) solution was used to react with spermidine 
in equal mole ratio, the desired products were the mixture of N-(4-aminobutyl)hexahydro-
pyrimidine (2) and N-(4-aminobutyl) hexahydropyrimidine dideuteriate which were 
confirmed by HR-ESI-MS (Figure 6.66). 
 
 
Figure 6.66  HR-ESI-MS spectrum of N-(4-aminobutyl) hexahydropyrimidine (2) (M.W. = 
157.1579, C8H19N3) expected m/z [M+H]
+ ion = 158.1657 (found = 158.1650) and N-(4-
aminobutyl) hexahydropyrimidine dideuteriate (M.W. = 159.1704, C8H17N3D2) expected m/z 
[M+H]+ ion = 160.1783 (found = 160.1777). 
 
Spermine 
 
The possible products from the reaction of spermine against formaldehyde: dideuteriated 
formaldehyde (1:1) solution (2 equiv.) was shown in Figure 6.67 and confirmed by HR-ESI-
MS (Figure 6.68). 
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Figure 6.67  The possible products from the reaction of spermine against formaldehyde: 
dideuteriated formaldehyde (1:1) solution (2 equiv.). 
 
 
Figure 6.68  HR-ESI-MS spectrum of desired product 1,4-(dihexahydropyridine)butane(11) 
(M.W. = 226.2157, C12H26N4) expected m/z [M+H]
+ ion = 227.2236 (found = 227.2223), the 
product of 1-(hexahydropyrimidine)-5-aza-aminooctane (M.W. = 228.2283, C12H24N4D2) 
expected m/z [M+H]+ ion = 229.2361 (found = 229.2343) 1,4-(dihexahydropyrimidine 
tetradeuteriate) butane (M.W. = 230.2408, C12H22N4D4) expected m/z [M+H]
+ ion = 
231.2486 (found = 231.2480). 
 
 
Thermospermine 
 
The possible products from the reaction of thermospermine against formaldehyde: 
dideuteriated formaldehyde (1:1) solution (2 equiv.) was shown in Figure 6.69 and 
confirmed by HR-ESI-MS (Figure 6.70). 
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Figure 6.69  The possible products from the reaction of thermospermine against 
formaldehyde: dideuteriated formaldehyde (1:1) solution (2 equiv.). 
 
 
Figure 6.70  HR-ESI-MS spectra of desired product 1-(hexahydropyrimidine)-4-aza-
aminooctane (12) (M.W. = 214.2157, C11H26N4) expected m/z [M+H]
+ ion = 215.2236 
(found = 215.2225) and 1-(hexahydropyrimidine dideuteriate)-4-aza-aminooctane (M.W. = 
216.2283, C11H24N4D2) expected m/z [M+H]
+ ion = 217.2361 (found = 217.2355). 
 
Method 4  By labelling the thermospermine and hexahydropyrimidine ring of 
thermospermine with dansyl chloride. Later, method 2 of dansylation was used to investigate 
these products. 
 
Spermidine 
 
N-(4-Aminobutyl) hexahydropyrimidine (2) reacts with DNS Cl to give N-(4-aminobutyl) 
hexahydropyrimidine (2)-diDNS derivative (Figure 6.71).  HPLC chromatogram of this 
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product showed shorter retention time than spermidine (1)-triDNS derivative (Figure 6.72).  
The elution of N-(4-aminobutyl) hexahydropyrimidine (2)-diDNS derivative was confirmed 
by HR-ESI-MS (Figure 6.73). 
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Figure 6.71  N-(4-Aminobutyl) hexahydropyrimidine (2)-diDNS derivative (M.W. = 
623.2599, C32H41N5O4S2) 
 
 
 
 
 
Figure 6.72  HPLC chromatogram of N-(4-aminobutyl) hexahydropyrimidine (2)-diDNS 
derivative.  HPLC conditions:  mobile phase is acetonitrile: Milli-Q-water (70:30), C8-luna 
column, flow rate 1 mL/min, fluorescence detector at λex = 330 nm, λem = 510 nm.  The 
chromatogram shows peak 1 = N-(4-aminobutyl) hexahydropyrimidine (2)-diDNS derivative 
at Rt = 7.0 min, peak 2 = spermidine-triDNS derivative at Rt = 11.5 min. 
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Figure 6.73  HR-ESI-MS spectra of N-(4-aminobutyl) hexahydropyrimidine (2)-diDNS 
derivative (M.W. = 623.2599, C32H41N5O4S2) expected m/z [M+H]
+ ion = 624.2678 (found = 
624.2638) and doubly charged ion [M+2H]2+ = 312.6378 (found = 312.6346). 
 
Spermine and thermospermine 
 
Spermine and thermospermine react with DNS Cl to give the same molecular weight 
derivatives as tetraDNS derivatives (Figure 6.74) which both cannot be distinguished by HR-
ESI-MS (Figure 6.76) or by HPLC chromatogram (Figure 6.75) as they will be eluted at the 
same retention time (at 30 min, HPLC conditions:  mobile phase is acetonitrile: Milli-Q-
water (70:30), C8-luna column, flow rate 1 mL/min).  However, by the reaction with 
formaldehyde, spermine will be changed into 1,4-(dihexahydropyrimidine)butane (11) which 
reacts with only two moiety of DNS Cl while thermospermine will be changed into 1-
(hexahydropyrimidine)-4-aza-aminooctane (12) which reacts with three moiety of DNS Cl.  
Thus, by this method, spermine and thermospermine will be distinguished by HPLC. 
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(A) Spermine-tetraDNS derivative 
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(B) Thermospermine-tetraDNS derivative 
 
Figure 6.74  The tetraDNS derivatives of (A) spermine and (B) thermospermine, both have 
the same molecular formula C58H70N8O8S4, M.W. = 1134.4199. 
 
 
 
 
Figure 6.75  HPLC chromatogram of spermine-tetraDNS derivative.  HPLC conditions:  
mobile phase is acetonitrile: Milli-Q-water (70:30), C8-luna column, flow rate 1 mL/min, 
fluorescence detector at λex = 330 nm, λem = 510 nm.  The chromatogram shows peak 1 = 
spermine-tetraDNS derivative at Rt = 28.5 min. 
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Figure 6.76  HR-ESI-MS spectrum of spermine or thermospermine-tetraDNS derivative 
(M.W. = 1134.4199, C58H70N8O8S4) expected m/z [M+H]
+ ion = 1135.4277 and doubly 
charged ion [M+2H]2+ = 568.2177 (found = 568.2125). 
 
When spermine reacts with formaldehyde, two possible products could be obtained.  One 
possible product contains one ring of hexahydropyrimidine and another one from the 
completed reaction which adds two methylene groups to spermine yield 1,4-
(dihexahydropyrimidine)butane (11).  The reaction of formaldehyde with thermospermine 
leads to production of 1-(hexahydropyrimidine)-4-aza-aminooctane (12).  Both one ring of 
hexahydropyrimidine of spermine and 1-(hexahydropyrimidine)-4-aza-aminooctane (12) 
react with DNS Cl reagent to yield triDNS derivatives which both have the same molecular 
weight.  Thus, HPLC chromatogram cannot differentiate these two molecules.  So it is 
necessary to get the reaction complete to obtain only one product of 1,4-
(dihexahydropyrimidine)butane (11) from the reaction of spermine against formaldehyde. 
 
1,4-(Dihexahydropyrimidine)butane (11) reacted with DNS Cl to yield 1,4-
(dihexahydropyrimidine)butane (11)-diDNS derivative (Figure 6.77).  HPLC chromatogram 
of this derivative was obtained (Figure 6.78) and confirmed the elution at Rt = 10 min by 
HR-ESI-MS (Figure 6.79). 
 
N
S
O
O N N
N N
NS
O
O
 
 
Figure 6.77  1,4-(Dihexahydropyrimidine)butane (11)-diDNS derivative. 
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Figure 6.78  HPLC chromatogram of 1,4-(dihexahydropyrimidine)butane (11)-diDNS 
derivative.  HPLC conditions:  mobile phase is acetonitrile: Milli-Q-water (70:30), C8-luna 
column, flow rate 1 mL/min, fluorescence detector at λex = 330 nm, λem = 510 nm.  The 
chromatogram shows peak 1 = 1,4-(dihexahydropyrimidine)butane (11)-diDNS derivative at 
Rt = 10.0 min. 
 
By dansylation thermospermine, the peak of 1-(hexahydropyrimidine)-4-aza-aminooctane 
(12)-triDNS derivative was eluted at Rt = 18 min (HPLC condition; C-8 luna, mobile phase: 
acetonitrile: Milli-Q-water (70: 30) flow rate = 1 mL/min).  HPLC chromatogram is shown 
in Figure 6.80, the elution was confirmed by HR-ESI-MS (Figure 6.81). 
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Figure 6.79  HR-ESI-MS spectra of 1,4-(dihexahydropyrimidine)butane (11)-diDNS 
derivative (M.W. = 692.3178, C36H48N6O4S2) expected m/z [M+H]
+ ion = 693.3256 (found = 
693.3256) and doubly charged ion [M+2H]2+ = 347.1667 (found = 347.1654). 
 
 
 
 
 
Figure 6.80  HPLC chromatogram of 1-(hexahydropyrimidine)-4-aza-aminooctane (12)-
triDNS derivative.  HPLC conditions:  mobile phase is acetonitrile: Milli-Q-water (70:30), 
C8-luna column, flow rate 1 mL/min, fluorescence detector at λex = 330 nm, λem = 510 nm.  
The chromatogram shows peak 1 = N-(4-aminobutyl) hexahydropyrimidine (2)-diDNS 
derivative at Rt = 7.0 min, peak 2 = 1,4-(dihexahydropyrimidine)butane (11)-diDNS 
derivative at Rt = 12.0 min, peak 3 = 1-(hexahydropyrimidine)-4-aza-aminooctane (12)-
triDNS derivative at Rt = 19.0 min. 
0 6 12 18 24 mins 
3 
2 1 
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Figure 6.81  HR-ESI-MS spectra of 1-(hexahydropyrimidine)-4-aza-aminooctane (12)-
triDNS derivative (M.W. = 913.3689, C47H59N7O6S3) expected m/z [M+H]
+ ion = 914.3767 
and doubly charged ion [M+2H]2+ = 457.6923 (found = 457.6932). 
 
1,4-(Dihexahydropyrimidine tetradeuterio)butane was reacted with DNS Cl to obtain the 
diDNS derivative (Figure 6.82) and injected onto HPLC.  After purification by HPLC the 
identity of the homogenous product was confirmed by HR-ESI-MS (Figure 6.83). 
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Figure 6.82  1,4-(Dihexahydropyrimidine tetradeuterio)butane-diDNS derivative. 
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Figure 6.83  HR-ESI-MS spectra of 1,4-(dihexahydropyrimidine tetradeuterio)butane-
diDNS derivative (M.W. = 696.3429, C36H44N6O4S2D4) expected m/z [M+H]
+ ion = 
697.3508 (found = 697.3473) and [M+Na]+ = 719.3327 (found = 719.3288). 
 
1-(Hexahydropyrimidine dideuterio)-4-aza-aminooctane was reacted with DNS Cl to obtain 
the triDNS derivative (Figure 6.84) and injected onto HPLC.  The chromatogram was 
obtained and was confirmed by HR-ESI-MS (Figure 6.85). 
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Figure 6.84  1-(Hexahydropyrimidine dideuterio)-4-aza-aminooctane–triDNS derivative. 
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Figure 6.85  HR-ESI-MS spectra of 1-(hexahydropyrimidine-2,2- dideuterio)-4-aza-
aminooctane–triDNS derivative (M.W. = 915.3814, C47H57N7O6S3D2) expected m/z [M+H]
+ 
ion = 916.3892 (found = 916.3863). 
 
The analysis of spermidine, spermine and thermospermine were examined.  The reaction to 
turn these molecules into hexahydropyrimidine derivatives was proved by HR-ESI-MS.  
Moreover, in the case of spermine and thermospermine, their hexahydropyrimidine 
derivatives were separated well after labelling with the fluorophores which can be visualized 
by the different retention time from HPLC chromatograms and also the retention times were 
shorter than their original molecules (spermidine, spermine and thermospermine). 
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General conclusions 
 
The increasing interest in natural and synthetic polyamines, and investigations into their 
roles in physiological and biochemical processes, has led to a need for the development of 
simpler and more efficient methods for their quantitative and qualitative determination. 
 
The difficulties encountered in identifying and measuring the quantity of e.g. cellular 
polyamines are especially that the only reactive centres are the amine groups.  Aliphatic 
mono-, di- and polyamines do not have chemical structures that permit their investigation by 
UV spectrophotometry as they lack chromophores.  Thus, for many analytical techniques, 
the sensitivity of detection of these amines depends on derivatization reactions.  Specificity 
is also limited by the quality of the chromatographic separation procedures with these basic 
molecules. 
 
The most widely employed procedures for the detection and determination of separated 
primary and secondary amines are TLC visualised with ninhydrin reagent.  The use of 
fluorescamine as a spray reagent enables the analysis of these amines in picomole amounts.  
Other techniques include ion-exchange and ion-paired RP-HPLC combined with pre- or 
post-column derivatization and UV or fluorescence monitoring.  However, these methods 
have been replaced by more sensitive and specific techniques, pre-column derivatization 
followed by RP-HPLC separation is now the preferred method for the separation and 
quantitation of polyamines. 
 
A number of reagents have been used for the pre-chromatographic derivatization of 
polyamines.  Among many suitable reagents, 5-dimethylaminonaphthalene-1-sulfonyl 
chloride (DNS Cl), fluorescamine, 9-fluorenylmethyl carbamate (FMOC Cl) and o-
phthalaldehyde/mercaptoethanol (OPA/MCE) have been widely applied for pre- 
chromatographic derivatization of polyamines.  Many factors influence the derivatization 
procedures for amines such as the pH value of the reaction, concentration of the reagents, 
reaction temperature and reaction time. 
 
In this research, attempts have been make to optimize the derivatization methods of different 
fluorophores with respect to the time duration, temperature, pH of the reactions.  In addition, 
the HPLC mobile phase has been optimized to achieve good base-line resolution and to 
increase the sensitivity of the amine detection by RP-HPLC.  Furthermore, the studies 
investigate the chemical reaction of these fluorophores with biogenic polyamines and 
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synthetic intermediates using mass spectrometry to confirm the chemical identity of the 
derivatives. 
The ideal fluorophore reagent should react rapidly and quantitatively under mild conditions.  
The reagent should give only a single, stable derivative per amine.  The derivatives should be 
detectable with high sensitivity and the reagent itself or its degradation products should not 
interfere with the chromatographic separation. 
 
In this work, four fluorophores have been used for labelling polyamines i.e. OPA/MCE, 
fluorescamine, FMOC-Cl and DNS Cl.  The first two fluorophores are more selective 
reagents, reacting only with primary amines in contrast with the latter two acid chlorides 
which react with both primary and secondary amino groups. 
 
1,7-Diaminoheptane forms the di-derivatives of OPA/MCE while this diamine forms only a 
mono-fluorescamine derivative.  This might due to the bulky molecule of fluorescamine 
itself creating a steric hindrance to further reaction. 
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1,7-Diaminoheptane-diOPA/MCE derivative 
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1,7-Diaminoheptane monofluorescamine derivative 
 
With these amines, two protons need to be lost from the nitrogen atom in order to create the 
closed five-membered ring which is isoindole when OPA/MCE is used and oxidised pyrrole 
when fluorescamine is used.  Thus those reagents are specific for primary amines.  
Fluorescent molecules tend to be rigid molecules with delocalized electron systems which in 
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these cases are the lone pair electrons on the nitrogen atoms that delocalize in the aromatic 
ring.  These electronic properties give these derivatives high fluorescence intensity. 
The application of OPA/MCE is more advantageous than using fluorescamine as the 
derivatives of OPA/MCE have a relatively high quantum yield in comparison with the 
derivatives of fluorescamine.  However, the derivatives formed by OPA/MCE are not very 
stable, especially polyamines containing unreacted secondary amino groups e.g. spermidine 
and spermine.  Some disadvantages of pre-column derivatization by OPA/MCE are that the 
process of derivatization needs to be more carefully controlled in the reaction conditions to 
achieve good reproducibility because of poor stability and also the difficulties in reagent 
preparation. 
 
Although the stability of both spermidine-diOPA/MCE derivatives and spermine-
diOPA/MCE derivative were low, the spermidine-diOPA/MCE derivative was more stable, 
perhaps due to the lower number of secondary amino functional groups in the molecule.  
Protecting these secondary amines of spermidine and spermine with FMOC Cl after 
OPA/MCE, enabled the molecule to be fully derivatized as spermidine-diOPA/MCE-
monoFMOC and spermine-diOPA/MCE-diFMOC. 
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Spermine-diOPA/MCE-diFMOC 
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The derivatization products of spermidine-diOPA/MCE-monoFMOC and spermine-
diOPA/MCE-diFMOC gave HPLC peaks with good symmetrical shape and efficient 
derivatization in terms of increased fluorescent responses and better reproducibility. 
 
The OPA/MCE method for aminoglycosides is easy and simple to perform.  The reaction 
time (10 min) is also practical, and no extraction process is needed.  The derivatives of 
aminoglycosides-OPA/MCE are more stable than those of the simple (model) aliphatic 
amines.  The HR-ESI-MS suggested that the derivative of kanamycin and OPA/MCE was 
kanamycin-triOPA/MCE instead of the expected tetra-OPA/MCE.  Furthermore, the HR-
ESI-MS analysis of the derivative peak showed neomycin-pentaOPA/MCE instead of the 
expected hexaOPA/MCE as with kanamycin-triOPA/MCE.  This might due to the steric 
effect of the two amine groups on the same 2-deoxy streptamine ring allowing only one 
molecule of OPA/MCE to react at one of the amine positions of this ring. 
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The expected kanamycin tetra-OPA/MCE 
 
Fluorescamine reacts in seconds with amines in borate buffer and unreacted reagent is 
hydrolyzed in water to yield a non-fluorescent product.  The many complicated peaks that 
are obtained by using this reagent arise from its structure which is chiral and thus, if the 
reactant also is a chiral molecule, then diastereoisomeric products often give rise to more 
than one peak by HPLC. 
 
In contrast with the selective fluorophores above, the acid chloride reagents DNS Cl and 
FMOC Cl react with both primary and secondary amines. 
 
9-Fluorenylmethyl chloroformate (FMOC-Cl) reacts rapidly only with primary and 
secondary amine groups forming stable and highly fluorescent derivatives under mild 
conditions.  The resulting carbamate derivatives exhibit high fluorescent responses and are 
stable at 20oC for several days.  The disadvantage of FMOC is that it also reacts with water, 
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to give fluorescent FMOC-OH which displays similar HPLC behaviour and may therefore 
interfere with some of the HPLC peaks of amine-FMOC derivatives.  Also, the FMOC Cl 
reagent is fluorescent and, as it is used in excess, this can distort or complicate the 
quantitative (and qualitative) analysis.  FMOC Cl gave fully derivatized amines with linear 
polyamines such as the diFMOC of 1,7-diaminoheptane. 
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Spermidine-triFMOC     Spermine-tetraFMOC 
 
The FMOC derivatization method was then applied to kanamycin, and the elution of 
kanamycin-FMOC derivatives was confirmed by HR-ESI-MS as mainly the desired 
tetrasubstituted derivative in contrast with the kanamycin-triOPA/MCE described above. 
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Compared with using OPA/MCE, kanamycin was fully labelled by FMOC Cl.  This might 
due to the reactivity of the FMOC Cl or the flexibility of the linker between the kanamycin 
nitrogen and the fluorophores.  With OPA/MCE, the amine nitrogen atom is built into the 
fluorophores in a reaction with several steps. 
 
DNS Cl reacts with primary and secondary amines with the result of full derivatization if the 
molar ratio of DNS Cl is sufficiently high (10-fold or greater excess).  DiDNS derivatives 
form for diamines such as 1,7-diaminoheptane, the triDNS derivative for spermidine, and the 
tetraDNS derivative for spermine. 
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The monoDNS derivatives of a series of simple aliphatic diamines were prepared for 
investigation of the fluorescence yield.  These monoDNS derivatives were prepared by 
reducing the mole ratio of DNS Cl (to 2-fold) to yield single derivatives. 
 
The OPA/MCE, FMOC Cl and DNS Cl analysis methods were applied to the determination 
of lipopolyamines with potential in non-viral gene therapy, polyamine conjugates such as 
N
4,N9-dioleoylspermine, neochol and also intermediate molecules which were synthesized in 
the Blagbrough research group.  By careful control of the dansylation reaction conditions, 
most of these compounds yielded only a monoDNS derivative probably due to steric 
hindrance. 
 
Within the series of fluorophores the relative fluorescence yields of mono- and multiple 
derivatized amines were determined by measurement of the fluorescent intensity versus UV 
absorption of the HPLC eluent collected from peaks of the amine-fluorophore derivatives 
(confirmed by HR-ESI-MS).  Ideally, the slope for each sample is proportional to that 
sample’s fluorescence quantum yield.  Amine-difluorophore derivatives and amine-
trifluorophore derivatives should present the same slope as amine-derivatives.  However the 
results showed that all the amine-difluorophore derivatives have similar slopes in their group 
but a lower in values than the amine-monofluorophore derivative.  For the amine-
trifluorophore derivative, the slope is even lower than the slope of the amine-difluorophore 
derivatives.  Thus, the fluorescence intensity did not increase in proportion to the number of 
fluorophores that were attached to the polyamine, so two or more fluorophores tethered in 
close proximity interfere with (quench) the fluorescence process.  However, it is possible to 
use the slope for predicting how many fluorophores are attached to a specific polyamine. 
 
Thermospermine (3.3.4), a regioisomer of spermine (3.4.3) was synthesised from spermidine 
(3.4) as the starting material.  The reaction of spermidine and formaldehyde created N-(4-
aminobutyl)hexahydropyrimidine, this step forming a six-membered ring leaves one primary 
amine unreacted with four methylene carbons from the stable hexahydropyrimidine ring. 
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in water
    1 h
   20oC
spermidine (3.4) N-(4-aminobutyl)hexahydropyrimidine  
 
After this step, a selective primary amine protecting groups benzaldehyde (to form an imine) 
and phthalimide were added to N-(4-aminobutyl) hexahydropyrimidine.  These two 
protecting groups were then compared. 
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4-(N-benzylideneaminobutyl)hexahydropyrimidine
in toluene, 3 h, 130oC 
2-(N-butylhexahydropyrimidine)isoindoline-1,3-dione 
 
The phthalimide protecting group was added under milder reaction conditions and gave 
a higher yield than benzaldehyde.  Acrylonitrile was added to secondary amine group 
using the same condition for both starting materials.  After that, deprotection of the 
protecting group and removal of CH2 from the hexahydropyrimidine were applied in 
one step.  The final step was reduction of the nitrile group using sodium borohydride to 
obtain the desired thermospermine (3.3.4). 
 
FMOC and dansyl derivatives of spermine (3.4.3) and thermospermine (3.3.4) were 
not separate by HPLC.  By the reaction of formaldehyde, the two isomers yield different 
products which can be separated by HPLC after labelling with any fluorophores.  By using 
dideuteriated formaldehyde to react with spermine and thermospermine, the expected 
molecular weight was confirmed by HR-ESI-MS. 
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Reaction of spermine with dideuteriated formaldehyde 
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Reaction of thermospermine with dideuteriated formaldehyde 
 
In conclusion, these studies have proven by experiment the benefits of using different 
fluorophores to label polyamines which allow them to be detected by simple isocratic HPLC 
systems.  The relative fluorescence yield of mono-, di- and tri-derivatives of different 
fluorophores showed two aspects.  Firstly, that the di- or tri-fluorophore derivatives have 
lower fluorescence yield than the mono-fluorophore derivative which means that the two (or 
more) fluorophores when tethered in close proximity interfere with (quench) the fluorescence 
process.  Secondly, that plots of fluorescence intensity and UV absorbance can used to 
predict the relative of the number of fluorophores that are bound to polyamines which also 
tell about the behaviour of the fluorophores.  In these studies, the optimum conditions of 
derivatization of polyamines by four fluorophores and optimum isocratic HPLC conditions 
were developed.  We have shown that a simple isocratic HPLC system combined with some 
chemical reaction and derivatization by fluorophores can separate the two isomers of 
spermine and thermospermine.  By reacting dideuteriated formaldehyde with spermine and 
thermospermine then directly using HR-ESI-MS is a simple alternative way of analysis to 
distinguish between these two isomers. 
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PHARMACEUTICAL ANALYSIS OF POLYAMINES AND 
AMINOGLYCOSIDES 
Sawanya Buranaphalin, Dr I S Blagbrough*, Dr M G Rowan* 
Department of Pharmacy and Pharmacology, University of Bath, Bath BA2 7AY 
prsisb@bath.ac.uk 
 
Fluorescence derivatives have long been used in the polyamines which lack chromophores in their 
molecules.  In this study, fluorescence derivatization was extended to examine partially protected 
polyamines, aminoglycosides and synthetic intermediates in the preparation of complex lipophilic 
polyamine compounds required for non-viral gene delivery investigations.  Fluorescence spectroscopy 
and poly-derivatization with a panel of extrinsic fluorophores (e.g. dansyl chloride, o-phthalaldehyde, 
9-fluorenylmethoxycarbonyl chloride and fluorescamine derivatives) will enable optimization of 
synthetic routes in with analysis of intermediates.  A variety of natural products which contain several 
amine functional groups:  2 (putrescine, cadaverine), 3 (spermidine), 4 (spermine, kanamycin), 5 
(tobramycin, paromomycin), up to 6 (neomycin) and also synthetic intermediates such as 
diphthalimido spermine, trifluoroacetate spermine, tri-Boc spermine were examined. 
 
After derivatization, the di- and polyamines were separated by the reversed-phase high performance 
liquid chromatography (RP-HPLC) on the ODS column (150 x 4 mm I.D., 5 µm) using suitable 
isocratic systems, a flow rate of 1 ml min-1 and fluorescence detection.  Where necessary, the 
contaminants, produced during the derivatization reaction, were almost eliminated by extraction steps.  
The identity of fluorescent derivatives was confirmed by liquid chromatography-mass spectrometry to 
monitor for partial derivatization of polyamino compounds. 
 
The results show that synthesis of polyamine derivatives in quantitative yield depends on the time of 
reaction, the temperature and the ratio of fluorophore reagent.  A number of model chromatographic 
separations of polyamine-fluorophores were achieved.  Linearity of derivatization was calculated for 
amines and regression coefficient ranged from 0.968 to 0.999.  The repeatability of the method was 
good.  In some cases, the derivatization reactions failed to yield the desired products due to 
incompatibility of the reaction conditions with protecting groups present in the substrate.  Relative 
quantum yields of the polyamine-fluorophores derivatives also examined to determine the effect of 
intramolecular quenching which was appeared to give less fluorescence intensity in some polyamine-
fluorophores derivatives.  This methodology will provide a useful way to analyse semi-synthetic 
analogues of those natural products which are being developed as vehicles for non-viral gene delivery. 
 
Acknowledgements:  Thai Government Collaborative Research Network. 
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ANALYSIS OF LINEAR AND BRANCHED POLYAMINE NATURAL 
PRODUCT CONJUGATES FOR EFFICIENT BIOPHARMACEUTICAL 
DELIVERY 
 
Sawanya Buranaphalin, Michael G. Rowan, and Ian S. Blagbrough 
Department of Pharmacy and Pharmacology, University of Bath, Bath BA2 7AY, U.K. 
 
The development of the innovative, nano- and biotechnologies for drug delivery, together with the use of 
natural products and their conjugates in drug discovery and as biomarkers make the application of linear 
polyamines, e.g. spermidine and spermine, and aminoglycosides (branched naturally occurring 
polyamines e.g. neomycin with 6 amines) important as pharmaceutical leads for the efficient delivery of 
biopharmaceuticals e.g. siRNA delivery and DNA delivery for gene therapy. 
 
Our continuing research on organic nano-bioparticles as vehicles for non-viral gene delivery has 
afforded a library of semi-synthetic polyamine conjugates which are efficient at DNA condensation 
and DNA delivery.  These compounds e.g. N4,N9- dioleoyl-spermine and a cholesteryl neomycin 
conjugate have been synthesized in our laboratories.  However, their quantitative analysis is 
challenging as they lack any chromophore.  In order to analyse these polyamine-containing molecules, 
fluorescence derivatization was used.  We have developed methods for poly-derivatization with a 
panel of extrinsic fluorophores (e.g. dansyl chloride, o-phthalaldehyde, 9-fluorenylmethoxycarbonyl 
chloride and fluorescamine) followed by HPLC with fluorescence and UV absorption detection.  
These methods enable optimization of synthetic routes with analysis of intermediates. 
 
Reaction and chromatographic conditions were optimized with each of the above fluorophores using a 
series of model mono- and diamines and finally applied to natural and semi-synthetic polyamines.  
Linear responses were obtained over the concentration range (0.01-1.0 mM).  The relative quantum 
yields of the polyamine-fluorophore derivatives were examined to determine the effect of 
intramolecular quenching.  This methodology will provide a useful way to analyse semi-synthetic 
analogues of these important natural products which are being developed as efficient vehicles for non-
viral gene delivery. 
 
We thank the CRN for financial support (studentship to SB). 
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ANALYSIS OF LINEAR AND BRANCHED POLYAMINE NATURAL PRODUCT 
CONJUGATES FOR EFFICIENT BIOPHARMACEUTICAL DELIVERY 
 
 
Sawanya Buranaphalin, Michael G. Rowan, and Ian S. Blagbrough 
Department of Pharmacy and Pharmacology, University of Bath, Bath BA2 7AY, U.K. 
 
Investigation of organic nano-bioparticles as vehicles for non-viral gene delivery has afforded a library 
of semi-synthetic polyamine conjugates which are efficient at DNA condensation and DNA delivery.  
We are continuing our studies with compounds containing linear polyamines, e.g. spermidine and 
spermine which are then applied to drug delivery.  However, their quantitative analysis is challenging as 
they lack any chromophore.1  In order to analyse these polyamine-containing molecules, fluorescence 
derivatization has been applied. 
 
One aim of this study was to extend fluorescence derivatization to examine partially protected 
polyamines and synthetic intermediates in the preparation of complex lipophilic polyamine conjugates 
required for non-viral gene delivery investigations. 
 
We have developed methods for poly-derivatization with a panel of extrinsic fluorophores (e.g. dansyl 
chloride,1 OPA (o-phthalaldehyde),2 FMOC (9-fluorenylmethoxycarbonyl chloride)2,3 and 
fluorescamine) followed by HPLC with both fluorescence and UV absorption detection.  The target 
analytes, e.g. natural and semi-synthetic polyamines, possess multiple amino-functions, primary and 
secondary including some which are sterically hindered.  The reaction and chromatographic 
conditions were optimized for each fluorophore using a series of model mono- and diamines and 
finally applied to the linear and branched polyamine natural product conjugates.  The methods we 
have developed enable the analytical optimization of synthetic routes.  Our results show that synthesis 
of polyamine derivatives in quantitative yield depends on the reaction conditions:  time, temperature, 
and the molar ratio of derivatization reagent to substrate amine.  The chemical structures of the 
resulting derivatives were confirmed by off-line high resolution electrospray ionization mass 
spectrometry (HR ESI-MS).  Linear responses were obtained over the concentration range (0.01-1.0 
mM).  The relative quantum yields of the polyamine-fluorophore derivatives were examined to 
determine the effect of intramolecular quenching. 
 
Off-line MS analysis of the reaction products demonstrated complete derivatization of both primary 
and secondary amino groups with dansyl and FMOC fluorescent derivatives and of primary amine 
groups for OPA and fluorescamine derivatives.  Dansyl derivatization of polyamines showed no 
apparent steric hindrance.  Under the HR ESI-MS ionization conditions used, the expected [M+H]+ 
and also the doubly charged [(M+2H)/2]++ ions were often observed with dansyl derivatives, 
presumably because this fluorophore contains basic amino groups that can be protonated easily, 
whereas FMOC derivatives gave predominantly [M+Na]+ ions.  The OPA reaction with polyamines is 
rapid, but the products have poor stability.  The derivatization of polyamines with fluorescamine gave 
multiple products (HPLC analysis).  In summary, this methodology to detect and quantify polyamines 
and their conjugates provides a useful way to analyse semi-synthetic analogues of these important 
natural products which are being developed as efficient vehicles for non-viral gene delivery and as 
anti-cancer lead compounds where quantitative analysis is important. 
 
We acknowledge the CRN for financial support (studentship to SB) and we also thank the EPSRC 
National Mass Spectrometry Centre (Swansea) for rapid and efficient HR MS analytical services. 
 
1.  Minocha R., Long S., J. Chromatogr. A, 2004, 1035, 63-73. 
2.  Koros A., Hanczko R., Jambor A., Qian Y., Perl A., Molnar-Perl I., J. Chromatogr. A, 2007, 1149, 
46-55. 
3.  Lozanov V., Petrov S., Mitev V., J. Chromatogr. A 2004, 1025, 201-208. 
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CONJUGATES FOR EFFICIENT BIOPHARMACEUTICAL DELIVERY 
Sawanya Buranaphalin, Michael G. Rowan, and Ian S. Blagbrough 
Department of Pharmacy and Pharmacology, University of Bath, Bath BA2 7AY, U.K. 
 
Objectives: 
The applications of linear polyamines, e.g. spermidine and spermine and branched polyamines e.g. 
aminoglycosides as the innovative biotechnologies for drug delivery are continuing researched in our 
group.  The organic nano-bioparticles as vehicles for non-viral gene delivery has afforded a library of 
semi-synthetic polyamine conjugates which are efficient at DNA condensation and DNA delivery.  
However, their quantitative analysis is challenging as they lack any chromophore1.  In order to analyse 
these polyamine-containing molecules, fluorescence derivatization was used.   
 
Methods: 
We have developed methods for poly-derivatization with a panel of extrinsic fluorophores (e.g. dansyl 
chloride2, o-phthalaldehyde, 9-fluorenylmethoxycarbonyl chloride3 and fluorescamine) followed by 
HPLC with fluorescence and UV absorption detection.  These methods enable optimization of 
synthetic routes with analysis of intermediates. Reaction and chromatographic conditions were 
optimized with each of the above fluorophores using a series of model mono- and diamines and 
finally applied to natural and semi-synthetic polyamines. The resulted derivatives were confirmed by 
off-line high resolution electrospray ionization mass spectrometry.  Linear responses were obtained 
over the concentration range (0.01-1.0 mM).  The relative quantum yields of the polyamine-
fluorophore derivatives were examined to determine the effect of intramolecular quenching.  
 
Results: 
The results show that synthesis of polyamine derivatives in quantitative yield depends on the time of 
reaction, the temperature and the ratio amount of the labels chromophore.  Protonated polyamines e.g. 
putrescine, spermidine and spermine are polycations when made the derivatization of these molecules 
with the chromophore. Off-line MS analysis of the reaction products demonstrated complete 
derivatization of both primary and secondary amino groups with dansyl and FMOC fluorescence 
derivatives and of primary amine groups for OPA and fluorescamine derivatives. Under the ionization 
condition used the derivatives showed bivalent cation [(M+2H)/2]++ in addition to monovalent ions 
(M+H)+ with Dansyl derivatives because this chromophore contain basic amino groups that can be 
protonated easily whereas FMOC derivatives gave prominent [M+Na]+ ions.  Derivatization of 
polyamines showed no apparent steric hindrance. OPA reaction is rapid but the products have poor 
stability.  The derivatization with fluorescamine gave multiple products with polyamines and chiral 
compounds due to the presence of a chiral cetre in the fluorophore 
 
Conclusions: 
This methodology will provide a useful way to analyse semi-synthetic analogues of these important 
natural products which are being developed as efficient vehicles for non-viral gene delivery. 
 
We thank the CRN for financial support (studentship to SB). 
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